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ABSTRACT
Nephromyces, a genus in the phylum Apicomplexa, has recently been
described as having a mutualistic relationship with its host: tunicates in the
Molgulidae family (Saffo et al. 2010). If true, Nephromyces would be the only
known example of a mutualistic apicomplexan genus. In addition to the possible
switch to mutualism, Nephromyces is one of a few apicomplexan groups
containing bacterial endosymbionts. To test the hypothesis that endosymbiotic
bacteria facilitated the transition of Nephromyces from parasitism, the metabolic
capabilities of Nephromyces and its bacterial endosymbionts need to be
determined. The transition from obligate parasite to endosymbiont is predicted
to involve different selective pressures leading to wide spread genomic changes.
Identifying these changes will lead to a better understanding of the dynamics
between the different biological players in this system.
Using data from Illumina HiSeq, we have assembled and annotated the
transcriptomes of Nephromyces and Cardiosporidium cionae. Using data from a
combination of platforms; Illumina MiSeq, HiSeq, and Pacific Biosciences, we
have partially assembled a pan-genome for Nephromyces and have assembled the
genomes of its bacterial endosymbionts. Using amplicon sequencing, we have
estimated the genetic diversity and prevalence of multispecies infections of
Nephromyces and its bacterial endosymbionts in its host Molgula manhattensis. In
addition to the implementation of next-generation sequencing technologies, this
work is also based on laboratory cultures and species isolation experiments.
With the aforementioned data we are able to describe the transcriptome

of Nephromyces and Cardiosporidium as well as the genomes of all three bacterial
endosymbionts, providing a basic overview of the metabolism of this system.
Nephromyces and Cardiosporidium both encode a complete purine degradation
pathway, which enables them to break uric acid into pyruvate and glycine,
additionally Nephromyces is also able to create malate from uric acid. This could
represent the primary route of carbon, nitrogen and energy acquisition in
Nephromyces. The genomes of the bacterial endosymbionts are severely reduced,
but relatively enriched for vitamin and amino acid biosynthesis (at least in the
Betaproteobacteria and Bacteroidetes symbionts). It is likely that the bacterial
endosymbionts are supplementing vitamins and amino acids to the limited diet of
uric acid found in Nephromyces. Our amplicon data reveals that nearly all M.
manhattensis are infected with multiple species of Nephromyces. The community
of Nephromyces forms a tightly integrated system of metabolic interdependencies based of the different bacterial endosymbionts.
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PREFACE
The data chapters 2-4 have been prepared for submission as manuscripts
and the manuscript format is in use. Chapter 2 has been submitted to the journal
Genome Biology and Evolution (GBE) as a research article it includes the
following sections in order; abstract, introduction, material and methods, results,
discussion, acknowledgments, and references. Chapter 3 will be submitted to the
journal Proceeding of the National Academy of Sciences (PNAS) as a research
article it includes the following sections in order; abstract, introduction, results,
discussion, material and methods, and references. Chapter 4 will be submitted to
the Journal of Eukaryotic Microbiology (J.Euk.Microbiol.) as a research article it
includes the following sections in order; abstract, introduction, material and
methods, results, discussion, acknowledgments, and references.
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CHAPTER 1
INTRODUCTION
Apicomplexa is a large, diverse phyla thought to be composed entirely of
parasites of metazoans (Morrison 2009). It is believed that every species of
metazoan is host to at least one species of apicomplexan parasite. Some
apicomplexans are of particular significance to humans including Plasmodium,
the etiological agent of malaria. Plasmodium is estimated to have driven the
evolution of 4.3 percent of the human genome (Whitfield 2002; McManus et al.
2017). Another apicomplexan of note is Toxoplasma, which is able to infect all
warm-blooded animals and is estimated to infect a third of the global human
population (Wilking et al. 2016). Cryptosporidium is a waterborne apicomplexan
responsible for 90% of occurrences of severe diarrhea in children under five, and
a continuing challenge for municipal water treatment (Sow et al. 2016). In
addition to the medical significance of apicomplexans, there has been research
into apicomplexans on the effects of parasitism on an organisms genome, due to
their long 700-900 million year history as a lineage of obligate parasites (Kuo et
al. 2008).
Obligate parasites face different challenges than free-living organisms,
resulting in different evolutionary pressures and unusual life histories as well as
dramatic genomic changes in parasitic lineages (Janouskovec & Keeling 2016).
One of the problems faced by parasites is the host’s immune system. The need to
evade the host’s immune system results in a complex evolutionary arms race
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between host and parasite, and is a core component of the red queen hypothesis
(van Valen 1973). Apicomplexans have developed numerous and diverse
strategies for evading their host’s immune system, including the var family of
genes in Plasmodium. Var proteins are cell surface antigens which are capable of
reorganizing into a wide number of protein conformations to keep the host from
recognizing the infection (Kyes et al. 2007). Another strategy, used by
Toxoplasma is to suppress immune response by silencing signal pathways and by
forming the latent bradyzoite cyst stage, which causes chronic infection (Blader &
Saeij 2014).
In addition to evasion of the host’s immune system, intracellular parasites
have ready access to an abundance of pre-formed metabolites. Access to these
pre-formed metabolites leads to one of the most common and pronounced
consequences of parasite genome evolution, the loss of many basic biosynthesis
pathways, which are critical in free-living organisms (Janouskovec & Keeling
2016). This loss of biosynthesis capabilities is particularly pronounced in
Apicomplexa. Amino acid biosynthesis, vitamin and cofactor biosynthesis, purine
synthesis, purine degradation, and fatty acid biosynthesis have all been lost in
Apicomplexa (Woo et al. 2015). Because these losses are observed throughout
the phylum, it was believed that these losses occurred early in apicomplexan
evolution. However, there has been a recent proposal that these losses are a
continuous gradual process (Zarowiecki & Berriman 2015). In either case, loss of
biosynthetic pathways creates a dependence on the host for not only primary
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carbon and nitrogen, but also a dependence on salvaging the hosts premade
metabolites. This has led to a number of intricate and elegant strategies for host
manipulation.
As a consequence of the extraction of nutrients and metabolites, a
parasite’s growth and reproduction imposes a cost to their host. The total impact
on the host by the parasite is known as virulence (Read 1994). If a parasite’s
virulence is too great the host will die, either directly due to the parasite, or as a
consequence of being weakened; i.e., the host is too weak to find food, the host
becomes easy prey for predators, or the weakened immune system makes the
host vulnerable to other pathogens. If the host dies before the parasite can
complete its life cycle, or before it can infect a new host, then the parasites fitness
falls to zero. This leads to a complex balance between parasite growth and
transmission to a new host. Factors involved in transmission and virulence
include host genotype, parasite genotype, host health, parasite load, as well as
external factors such as other parasites infecting the same host simultaneously
(Frank 1996a). The interplay of these factors creates a dynamic relationship
between host and parasite and has led to a wide variety of strategies (Alizon et al.
2009). One common strategy, adopted by many parasite species, is to lower their
virulence to the host (Cressler et al. 2016). Parasites often achieve this by
lowering their reproduction levels. Lower parasite density means lower
virulence to the host, and as long as there is still good transmission to other
hosts, this low-density strategy is often successful. A different strategy is
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exemplified by Plasmodium. Plasmodium merozoites proliferate within the host’s
liver cells through schizogony by simultaneously inhibiting cell death (thereby
avoiding immunity) until parasite levels are high enough to cause cell death,
releasing release sporozoites into the bloodstream. The high density of
sporozoites overwhelms the immune system and creates a high likelihood that a
mosquito feeding on the host will ingest blood with sporozoites, maximizing
transmission success. After simultaneous release sporozoites re-infect the liver to
repeat the cycle again. This cycle causes the episodic fevers seen in malaria
patients. The episodic overwhelming of the host immune system causes the high
virulence found with Plasmodium infections. Plasmodium falciparum is
particularly virulent, even among Plasmodium species. Some of the virulence of P.
falciparum has been attributed to the large number of other human parasites
found in the same locations. With the presence of other parasites the likelihood of
multiple parasitic infections increases, which then leads to the virulence of all
pathogens present being cumulative. Rather than a long sustained infection with
low probability of transmission over a longer time, with the possibility of host
death from other pathogens, P. falciparum, has adopted a high density, high
virulence infection combined with periods hidden from the immune system,
which maximizes transmission over a short period of time.
Although transmission strategies are diverse there are predictable
patterns of a disease’s epidemiology and the type of strategy a parasite is using.
Parasites with high virulence are characterized by low prevalence in a population
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or by low prevalence with sporadic outbreaks (Frank 1996b). Parasites using this
strategy may reach high cellular densities in an effort to maximize transmission
before the host dies. Alternatively, high-sustained prevalence in a host population
indicates low virulence. Parasites using this strategy often maintain low cell
densities with lower transmission rates over a longer period of time. Parasite
virulence and transmission strategies are not dichotomous, but rather a
continuum. Parasites with the highest, sustained prevalence being the least
virulent and parasites with the lowest prevalence being the most virulent. Of
course such predictions about virulence only apply to parasites that have coevolved with their host, and does not apply to parasites infecting a new or
incidental host. In these instances, virulence is often extremely high and often
results in the host death before transmission, leading to a self-limiting infection
pattern, i.e. Ebola in humans.
The relationship between prevalence and virulence is important for this
work because Nephromyces mutualistic relationship with their hosts, Molgula
tunicates was solely based on the nearly 100% year round infection prevalence
(Saffo et al. 2010). As infection prevalence only predicts virulence, and not
host/endosymbiont relationship, this characterization may have been unfounded
and premature. Characterization of mutualism based solely on infection
prevalence for Nephromyces is particularly surprising, because it becomes the
only mutualistic genus in a phylum composed entirely of parasites. However,
there are other indicators, besides prevalence, suggesting that the relationship
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between Nephromyces and its host is unusual. Unlike other pathogens with low
virulence, Nephromyces reaches extremely high cell densities inside its host. This
high cell density becomes apparent when you compare Nephromyces to its closest
known relative Cardiosporidium cionae, a blood parasite that infects a number of
solitary tunicates outside of the Molgulidae family (Ciancio et al. 2008; Kumagai
et al. 2010). As with Nephromyces, C. ciona has a high sustained infection
prevalence reaching ~95% in Ciona intestinalis. Such high, sustained prevalence
indicates that, like Nephromyces, C. ciona is largely avirulent. However,
Nephromyces reaches over an order of magnitude higher cell densities than Ciona.
In two such closely related organisms with closely related hosts with similar
epidemiology in other respects, the difference in relative cell densities is
striking. Typically, the higher the parasite load the greater the virulence, but
paradoxically Nephromyces can remain avirulent and reach extremely high cell
densities. Rather than focus on the proposed mutualistic relationship between
Nephromyces and its host, which remains unclear, this work will focus on the
apparent paradox in Nephromyces’ epidemiology.
In order to consider the unusual epidemiology of Nephromyces, it is
necessary to examine its other life history traits. The phylum Apicomplexa has a
tremendous amount of variation in hosts, cell types infected, transmission
methods, host manipulation strategies, life cycles, reproduction, and morphology
(Roos 2005). Even with so much diversity, Nephromyces stands out as unusual for
an apicomplexan. One of the most unusual aspects of Nephromyces’ biology is
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where it lives. Nephromyces is only found and completes its entire life cycle inside
the renal sac (Saffo 1982). Specifically, Nephromyces is found in the lumen of the
renal sac and, unlike other apicomplexans, is extra-cellular, with no part of its life
cycle inside or joined to its host’s cells. The renal sac is a large, ductless, structure
present only in tunicates in the Molgulidae family (Goodbody 1965). The function
of the renal sac has not been determined, and despite its name, the renal sac does
not function as a typical kidney (Saffo 1978). The renal sac was named for the
large deposits of uric acid and calcium oxalate, nitrogenous compounds that are
the major constituents of kidney stones (Saffo & Lowenstam 1978). Localized
deposits of uric acid are not exclusive to Molgula tunicates and many ascidians
have crystallized uric acid deposits located in various tissues, but the deposits in
Molgula are by far the largest (Lambert et al. 1998).
Another unusual aspect about Nephromyces is the presence of bacterial
endosymbionts. Even though it is not unusual for Eukaryotes to have bacterial
endosymbionts, it is unusual in the phylum Apicomplexa. The only other
apicomplexan known to harbor a bacterial endosymbiont is C. ciona. Bacterial
endosymbionts are a common way for an organism to add novel functionality to
its metabolism, and the acquisition and maintenance of bacterial endosymbionts
is a major driver of eukaryotic evolution Prominent examples include the
alphaproteobacterium that became the mitochondria and the cyanobacterium
that gave rise to the chloroplast (John & Whatley 1975; Mereschkowsky 1905).
More recent bacterial endosymbionts provide their hosts with a wide variety of
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metabolic capabilities including vitamin and co-factor biosynthesis, amino acid
biosynthesis, methanogenesis, photosynthesis, and protection from parasitoids.
(Moran et al. 2005; Gijzen et al. 1991; Marin et al. 2005; Hansen et al. 2012).
These functions allow their hosts to colonize new habitats and take advantage of
novel food sources.
One of the consequences of a parasitic lifestyle is the loss of biosynthetic
capabilities, and bacterial endosymbionts can supplement a host’s metabolism. It
was hypothesized that Nephromyces bacterial endosymbionts were an important
factor in Nephromyces’ colonization of the renal sac and its paradoxical
epidemiology (Saffo et al. 2010). Therefore, it was necessary to determine how
Nephromyces bacterial endosymbionts were contributing to the host’s
metabolome. One hypothesis suggested that bacterial endosymbionts of
Nephromyces are capable of degrading the abundant amounts of uric acid in the
renal sac(Saffo et al. 2010). The degradation of uric acid was also proposed as the
host benefit that made Nephromyces mutualistic instead of parasitic.
A previous study had found three different bacterial endosymbionts in
Nephromyces: an alphaproteobacteria, a betaproteobacteria, and a bacteroidetes
(Seah et al. 2011). This study also detailed how these different bacterial
endosymbionts were never found together in the same Nephromyces cell. No
explanation of how a species of a single-celled organism could maintain three
different endosymbionts without the endosymbionts ever being together was
given. What this study failed to recognize is there were multiple species of
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Nephromyces inside the same renal sac, and that different Nephromyces species
contained a single type of bacterial endosymbiont (Chapter 4).
Organisms harboring multiple endosymbionts are not uncommon
(Bennett & Moran 2013; Moran et al. 2008; Gruwell et al. 2010). Many organisms
that are dependent on bacterial endosymbionts contain two or three different
endosymbionts. Multiple endosymbionts are often required due to the
evolutionary consequences of a free-living bacteria becoming an endosymbiont
(Wernegreen 2017, 2015; Mccutcheon & Moran 2011; Moran 1996). One driver
of bacterial endosymbionts’ evolution is a tiny population size relative to freeliving bacterial. Another is when only a few, or just a single bacterium, is
vertically transmitted to subsequent host generations. Small population size,
coupled with extreme bottlenecks repeated every host generation, produces
profound effects from genetic drift and results in an accelerated Muller’s ratchet
(Moran 1996). One of the consequences of the accelerated Muller’s ratchet on
bacterial endosymbionts is a severe reduction of all non-essential genes. Some of
the genes commonly lost are DNA repair genes (Kuwahara et al. 2007). The loss
of DNA repair genes combined with the effects of genetic drift leads to high
mutation rates, a low ratio of synonymous/non-synonymous mutations, and an
AT bias. Over time this results in endosymbiont genomes, which are small, gene
poor, and AT rich (Moran 2002).
The genomic instabilities of bacterial endosymbionts can quickly make
them a burden and a liability to the host. As bacterial endosymbionts decrease in
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function, the host must support their symbionts to a greater and greater degree.
If a host is dependent on their symbionts, this can result in reduced fitness if the
endosymbiont requirements outpace the host’s ability to meet them. A common
solution to the problem of symbiont degradation is acquiring additional bacterial
endosymbionts. In such cases either the original bacterial endosymbiont is
replaced in favor of the new endosymbiont, or both bacterial endosymbionts can
be maintained together (McCutcheon & Moran 2007). When both bacterial
endosymbionts are retained, the metabolisms of the bacterial endosymbionts can
become tightly intertwined. One such example from McCutcheon and Moran
(2007) involves the endosymbionts of the glassy winged sharpshooter
Homalodisca vitripennis, which maintains two bacterial endosymbionts Sulcia
muelleria and Baumannia cicadellinicola. These two endosymbionts show tight
metabolic integration, with S. muelleria capable of biosynthesizing 8 of 10
essential amino acids, menaquinone, and fabF for fatty acid biosynthesis.
Baumannia cicadellinicola is capable of biosynthesizing the remaining two
essential amino acids, a number of vitamins and cofactors, but not menaquinone,
and has the rest of the genes needed for fatty acid biosynthesis except fabF
(McCutcheon & Moran 2007).
The genus Nephromyces contains three different bacterial endosymbionts,
and although all three types of bacterial endosymbiont are regularly found in the
same renal sac, no species of Nephromyces is known to contain more than one
type of bacterial endosymbiont. It is currently unknown if the different
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endosymbionts are providing the same metabolic functions or not. If the bacterial
endosymbionts are providing different functions, it is unclear if there is any
interaction between the endosymbionts, as is seen in H. vitripennis. A significant
difference between the two systems is that H. vitripennis contains multiple
symbionts, and Nephromyces only contain one endosymbiont per organism. Given
the very different habitats of Cardiosporidium and Nephromyces and the rarity of
endosymbionts in apicomplexans, it seemed likely that the bacterial
endosymbionts might have contributed to Nephromyces ability to colonize the
renal sac and even to the unusual epidemiology of Nephromyces.
In order to explore; one, how Nephromyces is able to remain avirulent and
reach such high cell densities, two, how Nephromyces was able to thrive in the
unusual renal sac environment, three, what the relationship between
Nephromyces and its host is, four, determine what effects this possibly mutualistic
relationship had on Nephromyces genome, five, the role of the bacterial
endosymbionts, and six, the differences between Nephromyces and other
apicomplexans, we used a combination of next generation sequencing, culturing,
and amplicon sequencing. Using Illumina HiSeq we sequenced and assembled the
transcriptomes of Nephromyces, Cardiosporidium, their respective bacterial
endosymbionts, Molgula manhattensis, and Ciona intestinalis (Chapter 2). Using a
combination of Illumina MiSeq, HiSeq, and Pacific Biosciences we sequenced and
partially assembled Nephromyces genome, and assembled two of Nephromyces
bacterial endosymbionts genomes (alphaproteobacteria and bacteroidetes)
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(Chapter 3). Using amplicon sequencing targeting 18s rRNA, 16s rRNA, and COI,
we identified the diversity of Nephromyces and its bacterial endosymbionts
(Chapter 4). With these data, in combination with culturing and isolation
experiments, we were able to make substantial progress on characterizing the
biology of both Nephromyces and Cardiosporidium, as well as their bacterial
endosymbionts. This includes the unusual epidemiology, how Nephromyces
survives in the renal sac, the role of the bacterial endosymbionts, and how
Nephromyces compares to Cardiosporidium and other apicomplexans. In addition,
we have uncovered some unexpected results, including a highly unusual basis for
an apicomplexan metabolism and genus specific co-dependent species complex.
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Chapter 2
Nephromyces encodes a urate metabolism pathway and peroxisomes,
demonstrating these are not ancient losses of apicomplexans
by
Christopher Paight1, Claudio H. Slamovits2, Mary Beth Saffo3 & Christopher E
Lane1*
is submitted to the journal Genome Biology and Evolution
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CHAPTER 2
Abstract
The Phylum Apicomplexa is a quintessentially parasitic lineage, whose members
infect a broad range of animals. One exception to this may be the apicomplexan
genus Nephromyces, which has been described as having a mutualistic
relationship with its host. Here we analyze transcriptome data from Nephromyces
and its parasitic sister taxon, Cardiosporidium, revealing an ancestral purine
degradation pathway thought to have been lost early in apicomplexan evolution.
The predicted localization of many of the purine degradation enzymes to
peroxisomes, and the in silico identification of a full set of peroxisome proteins,
indicates that loss of both features in other apicomplexans occurred multiple
times. The degradation of purines is thought to play a key role in the unusual
relationship between Nephromyces and its host. Transcriptome data confirm
previous biochemical results of a functional pathway for the utilization of uric
acid as a primary nitrogen source for this unusual apicomplexan.

Key words: Apicomplexan, tunicates, Peroxisomes, Purine degradation,
Nephromyces, Cardiosporidium
Introduction
Apicomplexans are most well known for being parasites of humans and
livestock. Species in the genus Plasmodium, for instance, are the etiological agents
of malaria. Apicomplexan species show tremendous variation in transmission
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methods, life cycles, host range, host manipulation strategies, cell-types infected,
metabolic capabilities, immune evasion strategies, and virulence (Roos 2005;
Reid et al. 2012; Kemp et al. 2013; Cardoso et al. 2016). Because of this
variability, there are few apicomplexan characteristics shared throughout the
phylum. Among the few universal apicomplexan features are a parasitic lifehistory and an inability to degrade purines (Janouskovec & Keeling 2016).
Nephromyces, a derived apicomplexan genus of uncertain phylogenetic
placement, appears to be an exception to both of these traits.
Nephromyces was misclassified as a fungus for more than a 100 years,
based on long hyphal-like cell structures, flagellated spores interpreted by some
as chytrid zoospores and cell walls made of a chitin (Giard 1888). It was not until
the application of molecular methods that Nephromyces was confirmed as a
member of the derived apicomplexans (Saffo et al. 2010). Although some
analyses have tentatively placed it sister to adeleids, coccidia, or piroplasmida,
the precise phylogenetic position of Nephromyces remains unresolved (Saffo et al.
2010; Janouškovec et al. 2015). Nephromyces species are monoxenous (infecting
a single host) and are found exclusively in the Molgulidae family of tunicates
(Saffo & Davis 1982). In a phylum composed of obligate parasites, the feature that
distinguishes Nephromyces is its apparent mutualistic relationship with its
tunicate hosts. The mutualistic relationship has been inferred based primarily on
the nearly 100% infection rate and lack of clearance from the host ( Saffo 1978,
1988, 1990, Saffo et al. 2010). We use this label with caution, given how complex
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host-symbiont dynamics can be, how the costs and benefits of both “harmful” and
“beneficial” symbioses can be difficult to determine, and how they can vary with
genomic changes in hosts and symbionts (Leung & Poulin 2008; Saffo 2104;
Mushegian & Ebert 2016).
A shift in lifestyle from obligate parasite to mutualistic symbiont is quite
rare, and completely unknown from deep within a eukaryotic lineage with such a
long evolutionary history of parasitism. One common consequence of a parasitic
lifestyle is a loss of genes essential to free living organisms (Greganova et al.
2013; Janouškovec et al. 2015; Zarowiecki & Berriman 2015; Petersen et al.
2015). In an intracellular environment, if precursor molecules can be scavenged,
there is less selective pressure to maintain biosynthesis pathways, and many are
consequently lost (Keeling 2004; Sakharkar et al. 2004; Morrison et al. 2007). In
phyla such as Apicomplexa, these losses can be extreme and over half of the
genes found in their photosynthetic sister group, chromerids, have been lost in
apicomplexans (Woo et al. 2015).
With so many basic metabolic functions lost, and with such dependence on
the host, it is difficult to see how the relationship between host and parasite
could change to a mutualistic interaction. However, one way for an organism to
rapidly change its metabolic capabilities is to take on a bacterial symbiont.
Nephromyces has done just that, leading to the hypothesis that bacterial
endosymbionts inside Nephromyces perform some of the metabolic functions lost
in Apicomplexa, and potentially contribute something beneficial to the tunicate
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host (Saffo 1990; Saffo et al. 2010). Bacterial endosymbionts are common across
the tree of life (although rare in apicomplexans) and perform a wide variety of
functions for their hosts (Nowack & Melkonian 2010). These include amino acid
metabolism and vitamin metabolism (Moran et al. 2005), nitrogen metabolism
(Lopez-Sanchez et al. 2009), defense (De Souza et al. 2009), chemotrophic energy
production (Urakawa et al. 2005), and photosynthesis (Marin et al. 2005), to
name a few.
A tempting hypothesis for the functional role of Nephromyces bacterial
endosymbionts is the break down of purines to urea in the purine degradation
pathway (Saffo 1990). In support of this hypothesis Nephromyces infected
tunicates have quite high levels of the enzyme urate oxidase, which catalyzes
conversion of uric acid to 5-hydroxyisourate, but the enzyme is undetectable in
uninfected tunicates (Mahler et al. 1955; Saffo 1988). Coupled with the fact that
all known apicomplexans and tunicates have lost the purine degradation
pathway, these data were suggestive of a bacterial contribution to purine
degradation.
In a yet unexplained quirk of tunicate biology, many tunicate species have
localized deposits of uric acid (Lambert et al. 1998; Saffo & Lowenstam 1978;
Goodbody 1965). Storage as a form of excretion, nitrogen storage for future
release, and structural support, are among the proposed functions of tunicate
urate deposits (Goodbody 1965; Saffo 1988; Lambert et al. 1998). Tunicates in
the Molgulidae family have the largest uric acid deposits, which are localized to a
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specialized, ductless structure, called a renal sac (Saffo & Lowenstam 1978).
These uric acid deposits occur regardless of infection status, indicating a tunicate
origin of these purine deposits. Despite the name, the renal sac has many features
(most notably, the absence of any ducts or macroscopic openings) atypical for an
excretory organ, and its biological function has yet to be determined.
Nephromyces infects feeding molgulid tunicates after the post-metamorphic onset
of host feeding and completes its entire lifecycle within the renal sac. Four factors
led to the conclusion that the bacterial endosymbionts within Nephromyces are
the source of urate oxidase activity in this system: 1) the colonization of
Nephromyces within a structure with high concentrations of urate, 2) the absence
of urate oxidase activity in the molgulid hosts (Saffo, 1988, 1991), 3) the high
urate oxidase activity found in Nephromyces (including its bacterial symbionts:
Saffo, 1988, 1991), coupled with 4) the lack of obvious ultrastructural evidence of
peroxisomes in Nephromyces (Saffo, 1990).
It is logical to think that the addition of bacterial endosymbionts to
Nephromyces might have been key to colonizing this novel purine–rich niche, and
is how Nephromyces escaped the “evolutionary dead end” of a parasitic lifestyle.
In order to test this directly, and examine the metabolic relationships between
the tunicate host, Nephromyces, and its bacterial endosymbionts, we sequenced
the community transcriptome. To identify possible evolutionary or physiological
changes involved in coevolution of Nephromyces with its molgulid hosts, we also
sequenced the transcriptome of a sister taxon of Nephromyces, Cardiosporidium
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cionae (Ciancio et al., 2008; Saffo et al., 2010), an apicomplexan parasite found in
the blood in a broad range of non-molgulid ascidian hosts, including Ciona
intestinalis, Styela clava, Halocynthia roretzi, and Ascidiella aspersa (Ciancio et al.
2008; Dong et al. 2006). Interestingly, Cardiosporidium cionae also harbors
bacterial endosymbionts, which allows for a more direct comparison between
Nephromyces and Cardiosporidium.
Here we confirm the exceptionally high levels of urate oxidase activity in
tunicates with Nephromyces, and extend this result to include high expression
levels of all the genes in the purine degradation pathway (xanthine
dehydrogenase, urate oxidase, 5-hydroxyisourate hydrolase, 2-oxo-4-hydroxy-4carboxy-5-ureidoimidazoline decarboxylase, and allantoinase). The breakdown
of purines starts by conversion to xanthine. Xanthine then enters the ureide
pathway and the enzyme xanthine dehydrogenase catalyzes the reaction of
xanthine to urate (Xi et al. 2000; Nishino et al. 2008). Urate oxidase catalyzes the
oxidation of uric acid to 5-hydroxyisourate. Following conversion the enzyme 5hydroxyisourate hydrolase catalyzes 5-hydroxyisourate to 5-hydroxy-2-oxo-4ureido-2,5-dihydro-1H-imidazole-5-carboxylate (Kahn & Tipton 1998). This is
further processed into (s)-allantoin by the enzyme 2-oxo-4-hydroxy-4-carboxy-5ureidoimidazoline decarboxylase (Jung et al. 2006). Allantoinase catalyzes (s)allantoin into allantoate. From this point there are a few different pathways with
different endpoints that organisms are able to shuttle allantoate to (Cusa et al.
1999). A common end point is to process allantoate into urea and
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ureidoglycolate, to be further converted into carbon dioxide and ammonia.
Alternatively, ureidoglycolate can be converted to glyoxylate, or the urea may be
excreted as waste (Schultz et al. 2001; Werner et al. 2009).
We confirm that all the genes necessary for purine degradation are
encoded by Nephromyces and Cardiosporidium, and not their endosymbiotic
bacteria. Whereas the expression of urate oxidase by Nephromyces and
Cardiosporidium is unexpected, a parallel issue is where the urate oxidase is
physically located in the cell, given that apicomplexans reportedly lack
peroxisomes (Schlüter et al. 2006). Urate oxidase activity is restricted to
peroxisomes in eukaryotes, due to the numerous toxic byproducts that are
produced in the break down of uric acid. Research into peroxisomes in
Apicomplexa has a complex and contradictory history, with studies reporting
both the presence (Kaasch & Joiner 2000; Gabaldon et al. 2016) and absence
(Ding et al. 2000; Schlüter et al. 2006; Gabaldon 2010) of peroxisomes in
Apicomplexa. Recent work by Moog et. al (2017) and Ludewig-Klingner et al.
(2018) demonstrates compelling support for peroxisomes in coccidians. Both
studies present comprehensive bioinformatic (and also proteomic, in part)
evidence for the presence of peroxisomal biogenesis factors (peroxins) and
typical peroxisomal metabolic enzymes (including predicted relevant targeting
signals) in coccidians (Moog et al. 2017; Ludewig-Klingner et al. 2018). However,
neither paper provides explicit experimental evidence (for example, microscopic)
for the formation of peroxisomes in these organisms. Although direct evidence is
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still absent, both studies point to (Lige et al. 2009)and their identification of
peroxisome-like vesicles in T. gondii, for possible microscopic support.
Our data demonstrate that Nephromyces encodes a complete purine
degradation pathway and a number of proteins predicted to be targeted to, or
involved in, peroxisome biogenesis, maintenance and protein import, providing
novel support of peroxisomes in Apicomplexa. Additionally, we propose the
functional significance of purine degradation in Nephromyces, and reject the
hypothesis that bacterial endosymbionts facilitated an escape from parasitism by
providing genes in the purine degradation pathway.

Methods
Molgula manhattensis collection and laboratory culture
Molgula manhattensis tunicates were collected from a dock in Greenwich
Bay, Rhode Island (41°39'22.7"N 71°26'53.9"W) on July 2014. For transcriptomic
analysis, a single renal sac was separated from one tunicate, and all extraneous
tissue removed. The intact renal sac was placed in liquid nitrogen for 5 min and
then stored at -80°C for later RNA extraction. Gonads were dissected from five,
sexually mature, M. manhattensis, collected from the same population in
Greenwich Bay, Rhode Island August 2014. Eggs and sperm were mixed with
sterile seawater and divided evenly between two petri dishes. Plates were
incubated at room temperature for two days with daily 100% water changes.
Tunicate larvae attached to the bottom and sides of the petri dishes by day three.
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By day four, larvae had metamorphosed into adults and were actively feeding.
Plates were moved to an incubator at 18° C with a 24 hr. dark cycle to limit
growth of contaminants. Tunicates were fed by 100% water exchange with
cultures of Isochrysis galbana and Chaetoceros gracilis three days a week. After
several weeks tunicates were moved to aerated beakers to meet their increased
nutrient and gas exchange requirements. Feeding regimen remained the same
except that food volume was increased with tunicate growth. Tunicates were
grown for six months until they were ~10mm across. Each renal sac was placed
into a 1.5ml Eppendorf tube and flash frozen in liquid nitrogen. PCR screens
confirmed Nephromyces was absent from lab-raised individuals. Lab grown
tunicates were split into two groups. Renal sacs were harvested from three
tunicates to use as transcriptome controls. A second group was infected with
Nephromyces oocysts. Oocysts were collected from a wild M. manhattenensis and
serially diluted by 50x to limit co-infections from multiple species, and raised for
genomic analysis.

Cardiosporidium cionae collection, isolation and concentration
Ciona intestinalis were collected from docks in Snug Harbor RI (41.3890° N,
71.5201° W), in August 2017. Tunics were removed and the body wall was
opened to allow access to the heart. A sterile syringe was used to remove cardiac
blood as cleanly as possible. Blood was kept at 4° C until Cardiosporidium
infection was verified using Giemsa stain to visualize Cardiosporidium. Heavily
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infected samples were pooled together and centrifuged at 500 g for 5 minutes.
The resulting supernatant was removed and the samples were frozen in liquid
nitrogen and stored at -80° C. Samples with low rates of infection were enriched
for Cardiosporidium using sucrose gradients (Ogedengbe et al. 2015; Arrowood
and Sterling 2016). Gradients of 20, 25, 30, 35, 40% sucrose solutions in
phosphate buffer were layered together. Approximately 5 ml of tunicate blood
was added to the column and centrifuged at 500 g for 30 mins at 4° C. The 25%
and 30% layers were collected (based on visual screens showing high
Cardiosporidium cell density and low tunicate cell density), washed in PBS,
pelleted and then frozen in liquid nitrogen and stored at -80° C.

RNA Extraction
RNA extraction buffer (Zymo Research LLC. Irvine, CA) was added to samples and
ground with a pestle. Following grinding, the Zymo Quick-RNA kit (Zymo
Research LLC. Irvine, CA) was used and the manufacturer’s protocol was
followed. RNA was converted to cDNA and sequenced at the School of Medicine
Genome Resource Center, University of Maryland. Five separate paired-end RNA
libraries (two from infected renal sac, and three uninfected renal sac) were
multiplexed on one lane of the Illumina HiSeq platform, resulting in 326,299,923;
327,957,761 and 316,754,780 reads for the three renal sacs without
Nephromyces, and 40,606,230 from the wild M. manhattensis renal sac. For
Cardiosporidium, three samples of C. intestinalis blood were used: one with
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unseparated blood, one enriched with cells collected at the 25% sucrose gradient,
and one enriched with cells from the 30% sucrose gradient were multiplexed on
one lane of the Illumina HiSeq platform, resulting in 92,250,706; 109,023,104 and
110,243,954 respectively. Transcriptome data was assembled and proteins were
predicted with the Trinity/Trinotate pipeline version 2.4.0 run on the server at
Brown University Center for Computation and Visualization (Haas et al. 2014).
Reads assembled into 115,457; 388,535 109,446 contigs from infected,
uninfected samples, and C. intestinalis respectively. Protein sequences were
predicted using Transdecoder (Haas et al. 2014). Transcriptome completeness
was assessed with Busco v3 against the Eukaryotic reference data sets (Simão et
al. 2015).
Genomic DNA Extraction
The renal sacs from 8 lab grown M. manhattensis individuals were
dissected and their renal fluid was pooled in a 1.5ml Eppendorf tube. Contents
were centrifuged at 8000 g for 5 min to pellet Nephromyces cells, and following
centrifugation the renal fluid was discarded. Five hundred microliters of CTAB
buffer with 5ul of proteinase K and ceramic beads were added to the pelleted
Nephromyces cells. The sample was placed in a bead beater for 3 min. and then on
a rotator for 1.5hrs at room temp. Five hundred microliters of chloroform was
added, mixed gently and centrifuged for 5 min. The top layer was removed and 2x
the sample volume of ice cold 100% EtOH and 10% sample volume of 3M sodium
acetate were added to the sample and incubated a -20oC overnight. The sample
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was centrifuged at 16000Xg for 30min. and the liquid was removed. Ice cold 70%
EtOH was added and centrifuged at 16000xg for 15min. Liquid was removed and
sample air dried for 2 min. DNA was re-eluted in 50ul of deionized water.
Illumina Sequencing
A nanodrop (2000c, ThermoScientific) was used to assess DNA purity and
DNA concentration, and an agarose gel was run to assess genomic DNA
fragmentation. Following quality control, an Illumina library was constructed.
Library prep and sequencing were done at the URI Genomics and Sequencing
Center (URIGSC). The completed library was sequenced on the Illumina MiSeq
platform at the URIGSC and the HiSeq platform at the University of Baltimore
sequencing center on three lanes.
Pacific Biosciences Sequencing
Using the contents of 150 (done in batches of 10 then pooled) M.
manhattensis renal sacs, the same DNA extraction protocol was performed as for
Illumina sequencing. DNA was sequenced using three SMRT cells on the Pacific
Biosciences platform at the University of Baltimore sequencing center.
Illumina sequence data assembly
One MiSeq lane and three lanes of HiSeq, all from the same library, were
trimmed using Trimmomatic (Bolger et al. 2014) and then assembled using
Spades assembler (Bankevich et al. 2012) on the URI server BlueWaves.
Pacific Biosciences sequence data assembly
Pacific Biosciences reads were error corrected using pbsuite/15.8.24
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(English et al. 2012) on the Brown University server, Oscar. Reads were then
assembled using Canu (Koren et al. 2014). Contigs generated by Canu were
combined with Illumina MiSeq/HiSeq short reads with Abyss v2.02 (Jackman et
al. 2017).

Sequence annotation
Genes in the urate pathway were identified initially using KEGG
GhostKOALA and KASS and subsequently by BLASTP searches against NCBI’s nr
protein database (Kanehisa et al. 2016). All candidate genes were screened using
InterProScan to predict function (Finn et al. 2017). A curated database of
phylogenetically representative species with good quality annotations for the
three purine degradation genes and malate synthase were downloaded from
NCBI. These genes were then used to construct gene trees.
Sequences were aligned with MAFFT (Katoh & Standley 2013) using FFTNS-i. Maximum likelihood phylogenetic trees were constructed performed with
RAxML (Stamatakis 2014) using the GAMMA model with 1000 seed trees and
1000 bootstrap replicates. Trees were viewed and modified using Figtree (v1.4.0,
http://tree.bio.ed.ac.uk/software/figtree/).
Protein sequences were used to search against PeroxisomeDB (Schlüter et
al. 2009) and BLAST hits lower than e-20 were retained and used in a BLASTP
query against NCBI’s Refseq protein database (Schlüter et al. 2009). Additional
peroxisomal genes were identified with KAAS (Moriya et al. 2007). As many of
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these peroxisome genes are encoded by M. manhattensis, all copies that had a
closest hit to opisthokonta or bacteria were removed. Transcripts from
uninfected M. manhattensis were used to screen additional tunicate genes using
cd-hit at a 90% identity level (Li & Godzik 2006). Remaining genes were tested
for signal motifs and subcellular location predictions with Wolf PSORTII, Ppero,
TargetP, topcons, and Predotar (Supplementary Table 1)(Nakaia & Horton 1999;
Wang et al. 2017; Emanuelsson et al. 2007; Bernsel et al. 2009; Small et al. 2004).
Nephromyces specific RNAseq reads were mapped to our genomic
assembly using bowtie2 (Langmead & Salzberg 2012) with the –very sensitive
flag set. Following mapping, Bedtools (Quinlan & Hall 2010) was used to quantify
coverage across contigs, which were separated based on coverage levels. Contigs
identified as Nephromyces were annotated using Maker2 with ab initio gene
predictions from Augustus (Holt & Yandell 2011; Stanke et al. 2004).
Results
The contents of a single renal sac from an individual Molgula manhattensis
resulted in 195,694 transcripts from M. manhattensis, Nephromyces, and the
bacterial endosymbionts. After binning by species, 60,223 transcripts were
attributed to Nephromyces. The cardiac fluid from 40 infected Ciona intestinalis
individuals resulted in 109,446 transcripts, including 15,541 Cardiosporidium
transcripts. The BUSCO algorithm was used to assess the completeness of the
transcriptomes and reported 81.8% complete transcripts and 6.3% partial for the
Nephromyces data and 69.7% complete and 11.9% partial for Cardiosporidium.
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The Nephromyces genome assembly consisted of 1176 contigs greater than
5kb with a maximum length of 287,191 bp and an average length of 36 kb (Paight
et al, in prep). This dataset was used to search for purine degradation genes to
determine their genomic context. All of the purine degradation genes, as well as
malate synthase, were predicted and annotated in the genome by Maker2. All
genes but URAD contained introns, and neighboring genes on the identified
contigs had top BLAST hits to apicomplexans in all cases (Table 1), indicating that
they are encoded in the Nephromyces genome, not the endosymbiotic bacteria or
host Molgula manhattensis. Phylogenetic trees for xanthine dehydrogenase, uric
oxidase, malate synthase and allantoicase consistently resolved the monophyly of
Nephromyces, Cardiosporidium, and Chromerids (Figure 1). Chromerids are the
photosynthetic and the closest free-living relatives of Apicomplexa (Moore et al.
2008), indicating a vertical inheritance of this pathway from the common
ancestor of apicomplexans.
The presence of urate oxidase also provides further support for
peroxisomes in some lineages of Apicomplexa (Moog et al. 2017; LudewigKlingner et al. 2018), because urate oxidase activity is confined to peroxisomes in
eukaryotes (Usuda et al. 1994). In addition to urate oxidase, Nephromyces and
Cardiosporidium encode more peroxisome-associated proteins than Plasmodium,
and nearly the same complement of genes encoded by Toxoplasma (Table 2).
There are a few notable differences between Toxoplasma and
Nephromyces/Cardiosporidium, including the absence of PEX3, PEX16, VLACS,
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Table 1. Genomic context of the annotated purine degradation genes and malate synthase,
in the Nephromyces genomic assembly. The phylogenetic affiliation of neighboring genes
on each contig was identified by top hit against the NCBI nr database using BLASTp. Every
contig encoding a target gene included other apicomplexan genes, and genes that did not
hit apicomplexans had no strong affinity for other organisms.
Gene

Introns in
gene

Contig

Contig length
(kb)

Predicted
Genes on
Contig

Genes with top
apicomplexan
BLAST hits

XDH
UO
uraH
URAD
ALLC
MS

4
7
2
0
10
6

Neph_3686418
Neph_3687015
Neph_3685393
Neph_3687674
Neph_3687655
Neph_3671841

24.5
82.5
94.3
30.9
116.3
7

4
12
6
6
16
2

2
7
4
5
11
1
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Figure 1 A) Xanthine Dehydrogenase XDH
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C) Allantoicase ALLC
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B) Urate Oxidase UO

D) Malate Synthase MLS
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Figure 1. Maximum likelihood protein trees of A) Xanthine
Dehydrogenase, B) Urate oxidase, C) Allantoicase D) Malate synthase.
Genes A-C are involved in purine degradation and their position supports
an ancestral apicomplexan purine degradation pathway in
Nephromyces/Cardiosporidium. Malate synthase, D), acts on glyoxylate
and acetyl-CoA to produce malate to complete the pathway. Stramenopiles
are paraphyletic in the malate synthase phylogeny, possibly indicating a
deep gene duplication. Whereas the support for deeper nodes is variable
among all four genes, there is consistent support for a monophyletic origin
of Nephromyces/Cardiosporidium genes with Chromerids (red box). Major
lineages have been collapsed for presentation. Support values are
percentage bootstrap support above 50%.
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Table 2. Peroxiomal genes identified in Nephromyces and Cardiosporidium and their functional catagory. (X)
denotes presence of gene and (-) absence. Vitrella brassicaformis (Vb) Chromera velia (Cv) Cardiosporidium (C)
Nephromyces (N) Toxoplasma gondii (Tg) Plasmodium falciparum (Pf) Cryptosporidium parvum (Cp). Table
modified based on Ludwig-Klinger et al. (2017).
Protein

Abbr.

Isocitrate lyase
Malate synthase
Citrate synthase
Aconitase
Malate dehydrogenase

ICL
MLS
CS
ACO
MDH

Biogenesis factor 1
Biogenesis factor 2
Biogenesis factor 3
Ubiquitin carrier protein
Biogenesis protein 5
Biogenesis protein 6
Biogenesis protein 7
Biogenesis protein 10
Biogenesis factor 11
Biogenesis protein 12
Biogenesis factor 13
Membrane protein 14
Membrane protein 15
Biogenesis factor 16
Membrane protein receptor
Biogenesis protein 22
Biogenesis factor 26
Membrane channel
Membrane protein 4
ATP/ADP-transporter
Fatty acid ABC-transporter
ROS metabolism
Protein
2-Hydroxyacyl-CoA lyase
Phytanoyl-CoA hydrolase
a-Methylacyl-CoA-racemase
Acyl-CoA-oxidase
Multifunctional protein
Sterole carrier protein 2

Vb Cv C

N Tg Pf Cp

Glyoxylate pathway
x
x
x
x
x

x
x
x
x
x

Pex1
Pex2
Pex3
Pex4
Pex5
Pex6
Pex7
Pex10
Pex11
Pex12
Pex13
Pex14
Pex15
Pex16
Pex19
Pex22
Pex26
PMP22
PMP27
PMP34
PMP70
MPV17
Abbr.

x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
Vb

HPCL2
PHYH
AMACR
ACOX
DBP
SCPX

x
x
x
-

x
x
x

x
x
x
x

x
x
x

x
x
x

x

x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
Cv

x
x
x
x
x
x
x
x
x
x
x
x
x
C

x x
x x
- x
x x
x x
x x
x x
x x
x x
x x
- x x
- - x
- x x
- x - x x
x x
x x
N Tg

x
x
x
Pf

x
x
Cp

x
x
x
x
x

x
x
-

x
x
-

x
-

-

Peroxisome

Fatty acid oxidation
a-oxidation
B-oxidation
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x
x
x

Other oxidation

Multifunctional protein
Acetyl-CoA acyltransferase 1
2, 4-dienoyl-CoA reductase
d(3, 5)-d(2, 4)-dienoyl-CoA isomerase
ATP-binding cassette, subfamily D
Long-chain acyl-CoA synthetase
Solute carrier family 27, member 2
Acyl-CoA thioesterase 8
Nucleoside disphosphate-linked m.

PBE
ACAA1
PDCR
ECH
ABCD
ACSL
VLACS
PTE
NUDT19

x
x
x
x
x
x
-

x
x
x
x
x
x
x

x
x
x
x
x
-

x
x
x
x
x
-

Multifunctional protein
D-Amino-acid oxidase
Isocitrate dehydrogenase
N1-acetylpolyamine oxidase
L-Pipecolate oxidase
hydroxymethylgluatryl-CoA lyase
(S)-2-hydroxy-acid oxidase

AGT
DAO
IDH
PAOX
PIPOX
HMGCL
HAO

x
x
x
x
x
x

x
x
x
x
x
x

x
x
x
x

x
x
x
x

CAT
SOD
INOS
PRDX1
PRDX5

x
x
-

x
-

x
x
-

x
x
x
-

Amino acid metabolism

Antioxidant system
Hydrogen peroxide metabolism Catalase
Superoxide dismutase
Nitric-oxide synthase, inducible
Peroxiredoxin 1
Peroxiredoxin 5
Glutathione metabolism
Glutathione S-transferase kappa 1
Protein
Etherphospholipid biosynthesis
Dihydroxyacetone phosphate acyltr.
Alkyldihydroxyacetonephosphate syn
Fatty acyl-CoA reductase
Purine metabolism
Xanthine dehydrogenase
Urate oxidase
Retinol metabolism
Dehydrogenase/reductase SDR family
Sterol precursor biosynthesis
Mevalonate kinase
Phosphomevalonate kinase
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GSTK1
Abbr.

x x x
Vb Cv C

x
x
x
x
x
x
x
x
x
x
x
x
-

x
x
x
x
-

x
x
-

x - - N Tg Pf Cp

DHAPAT
AGPS
FAR

x
x
x

x
x
x

x
x
-

x
x

x
x

-

-

XDH
UO

x
x

x
x

x
x

x
x

-

-

-

DHRS4

x

x

x

x

-

-

-

MVK
PMVK

-

-

-

-

-

-

-

and SCPX in Nephromyces/Cardiosporidium and the absence of PMP22, GSTK1,
DHRS4, XDH, and UO in Toxoplasma. Additionally, Nephromyces encodes a copy of
Malate synthase (MLS) absent in both Cardiosporidium and Toxoplasma. Malate
synthase is a key gene in the glyoxylate cycle, a pathway maintained in the
photosynthetic Chromera velia and Vitrella brassicaformis, but lost in all other
apicomplexans (Ludewig-Klingner et al. 2018). Nephromyces/Cardiosporidium
also encode the enzyme serine-pyruvate transaminase (AGXT), which also uses
glyoxylate as a substrate. AGXT converts glyoxylate into glycine and pyruvate and
is often localized to peroxisomes, however the localization of AGXT in
Nephromyces/Cardiosporidium is unclear (Supplementary Table 1).

Discussion
The recent scrutiny by Moog et al (2017), and Ludewig-Klingner et al.
(2018) has built a case for the presence of peroxisomes in some apicomplexan
lineages. While some apicomplexans may have lost peroxisomes, it seems likely
that this loss is not a universally shared trait in the phylum. Despite the extensive
search for peroxisome-associated functions in apicomplexans, no genes involved
in purine degradation were found in other sequenced apicomplexan genomes,
with the lone exception of allantoicase in Plasmodium (Gardner et al. 2002). Our
in silico predictions indicate a complete purine degradation pathway in
Nephromyces and Cardiosporidium. In addition to highly expressed transcripts for
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the genes involved, all of the identified purine degradation genes and MLS have
been located on genomic contigs from Nephromyces. Based on neighboring genes
and the presence of introns in the Nephromyces genes matching the expressed
transcripts, these contigs almost certainly originate from the Nephromyces
genome (Table 1). Additionally, none of the purine degradation transcripts
attributed to Nephromyces were detected in uninfected tunicates (Table 3).
Phylogenetic trees of purine degradation genes are poorly supported at an interphylum level, indicating a rapid evolutionary rate. Whereas most genes are
phylogenetically uninformative across the spectrum of eukaryotes, these gene
trees have strong support for monophyly of purine degradation genes from
Nephromyces and Cardiosporidium with Chromerids (Figure 1). The combination
of gene trees, expression only when Nephromyces is present, and preliminary
genomic assemblies strongly suggest that these genes were present since the
divergence of Apicomplexa and Chromerida and have been vertically transmitted.
Thus, these genes have been subsequently lost across apicomplexans, possibly
multiple times. Although the exact placement of Nephromyces and
Cardiosporidium is not certain (Saffo et al. 2010), multi-gene phylogenies place
them in the subclass Hematozoa (Muñoz et al. in prep), suggesting that purine
degradation was independently lost multiple times in Apicomplexa as well as
maintained long after apicomplexans had become obligate parasites.
The presence of predicted purine degradation genes in Nephromyces and
Cardiosporidium, adds a function not previously demonstrated in apicomplexan
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peroxisomes (Table 2; Moog et al 2017; Ludewig-Klingner et al. 2018). While
Toxoplasma and Cardiosporidium/Nephromyces share many of the same
peroxisomal marker genes, no copy of PEX3 has been found in
Cardiosporidium/Nephromyces. PEX3 (along with PEX10, PEX12, and PEX19) is
one of the 4 genes reportedly required for peroxisome function (Schluter et al.
2006). However, the fundamentals of peroxisome biology have been described
from a limited set of eukaryotes, and organisms such as ciliates have peroxisomes
but also lack PEX3 (Ludewig-Klingner et al. 2017). Therefore, PEX3 may not be
critical to peroxisome function for alveolates, and possibly other under-studied
eukaryotic lineages. Extreme sequence conservation of PEX3 and PEX19 is only
found in opisthokonta and sequence divergence in other lineages may indicate
alternative functions (Hua et al. 2015).
Two other genes (Sterol carrier protein 2, SCPX and Solute carrier family
27, member 2, VLACS) missing from Cardiosporidium/Nephromyces, but found in
Toxoplasma, are involved in β-fatty acid oxidation. Both
Cardiosporidium/Nephromyces encode the seven other β-fatty acid oxidation
genes encoded in Toxoplasma, suggesting β-fatty acid oxidation forms part of the
functional capabilities of the Cardiosporidium/Nephromyces peroxisome. Fatty
acid oxidation is often a central component of peroxisome function and has been
hypothesized to be the impetus for the evolution of peroxisomes (Speijer 2011).
Based on transcript abundance, purine degradation in Nephromyces
peroxisomes appears to be heavily utilized. Only 0.13% of genes had a higher
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transcription rate than urate oxidase in our data from wild collected
Nephromyces, and the other genes in the purine degradation pathway are among
the most highly expressed transcripts in both wild and lab grown Nephromyces
samples (Table 3). This result aligns with the previously reported high levels of
urate oxidase protein in the renal sac of infected Molgula (Saffo 1988), indicating
that the expression levels reported here do translate to protein. Much of this
pathway is expressed over the 99th percentile of all transcripts in Nephromyces,
which corresponds to the top 100 genes. Expression of purine degradation genes
in Cardiosporidium is far lower, and in the 70-90 percentile range (Table 3). Such
high expression in Nephromyces represents an enormous metabolic investment
and it is unlikely that these transcripts go largely untranslated.
Both Nephromyces and Molgula manhattensis encode xanthine
dehydrogenase, and are able to convert xanthine into uric acid. Since we have
identified the tunicate host as the source of purines, this raises the question of
why Nephromyces is expressing xanthine dehydrogenase in the 97.87th
percentile, compared with similarly high tunicate expression (93.64th percentile).
Although the percentile ranking between these two organisms cannot be directly
compared, such high xanthine dehydrogenase expression in Nephromyces is
surprising. It seems unlikely that so much xanthine dehydrogenase production is
needed to convert only endogenous purines of Nephromyces. However, xanthine
is only detected in the renal sac in small quantities, not nearly as abundant as uric
acid, and xanthine dehydrogenase activity is restricted to the renal wall, not the
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Gene

Wild Neph

xanthine dehydrogenase
urate oxidase
5-hydroxyisourate hydrolase
OHCU decarboxylase
allantoinase
amindohydrolase
malate synthase
serine-pyruvate transaminase

97.87
99.87
99.16
93.38
99.09
99.75
59.17
99.85

Lab grown Lab grown Cardio
Cardio
Cardio
Neph 1
Neph 2 Fraction 1 Fraction 2 Fraction 3
93.17
99.44
91.31
98.38
79.25
93.81
99.57

94.83
99.54
88.41
98.23
89.18
93.11
99.79

none
86.75
87.67
73.61
87.43
84.64

76.88
87.24
83.27
90.32
92.27
80.81

69.5
70.98
79.1
71.89
92.08
77.79

Mm
93.64
85.65

Uninfected Uninfected Uninfected
Mm 1
Mm 2
Mm 3
N/A
91.17

Table 3. Expression percentile ranking of purine degradation genes, from total
expressed transcripts in Nephromyces (Neph), Cardiosporidium (Cardio) and
Molgula (Mm). The wild Nephromyces and Molgula manhattensis data
originate from the same RNA extraction and were bioinformatically
separated. Data was also generated from laboratory grown tunicates,
artificially infected with Nephromyces (Lab grown Neph 1 & 2).
Cardiosporidium fractions represent 1) unfiltered pericardial fluid, 2) the 25%
and 3) 30% fractions extracted from a sucrose gradient, and may contain
different proportions of Cardiosporidium life stages. The three uninfected
Molgula manhattensis were raised from gametes in the lab and never
exposed to Nephromyces infection. The (-) denotes the transcript was not
recovered in that dataset whereas (N/A) indicates the transcript was
assembled, but the transcripts per million (TPM) was <1.
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N/A
71.85

N/A
75.05

renal lumen (Nolfi 1970). One possible explanation is that Nephromyces exports
its xanthine dehydrogenase into the renal wall in order to drive the production of
xanthine from hypoxanthine before the purine salvage enzymes adenine
phosphoribosyltransferase and hypoxanthine-guanine
phosphoribosyltransferase can salvage hypoxanthine into adenine and guanine.
High expression of purine degradation genes in Nephromyces is clear, but
the purpose is uncertain. It does indicate purine degradation is an important
pathway for Nephromyces, however, the functional significance is not
immediately obvious. Pathway analysis predicts that Nephromyces is able to
convert xanthine into urea and ureidoglycolate, however neither compound is
biologically useful without further conversion. We propose that the products of
purine degradation in Nephromyces are converted to glyoxylate.
One possible route is the conversion of ureidoglycolate into glyoxylate.
There are two known enzymes able to catalyze this conversion: ureidoglycolate
lyase, found in fungi and bacteria, which catalyzes (s)-ureidoglycolate to
glyoxylate and urea, and ureidoglycolate amidohydrolase, found in plants and
bacteria, which catalyzes (s)-ureidoglycolate to glyoxylate, carbon dioxide, and
ammonia (Muñoz et al. 2006; Percudani et al. 2013; Wells & Lees 1991; Werner
et al. 2010; Shin et al. 2012; Serventi et al. 2010). Both ureidoglycolate lyase and
ureidoglycolate amidohydrolase are amidohydrolases - hydrolases that use
amide bonds as substrates. No orthologs to either ureidoglycolate lyase and

38

ureidoglycolate amidohydrolase have been found in the Nephromyces
transcriptome. However, an amidohydrolase is present, which is predicted to be
structurally similar to the ureidoglycolate amidohydrolase found in Arabidopsis,
including similar location and number of zinc binding domains. This
amidohydrolase also has a similarly high expression level as the other purine
degradation enzymes (Table 3). In order to determine if the amidohydrolase
found in Nephromyces is capable of catalyzing (s)-ureidoglycolate, functional
assays will need to be performed.
While the functionality of this particular amidohydrolase has yet to be
determined, its ability to act on an (s)-ureidoglycolate is an attractive hypothesis
for a few reasons. One, there are two known enzymes capable of breaking the
amide bond in (s)-ureidoglycolate that have independently evolved:
ureidoglycolate lyase and ureidoglycolate amidohydrolase. This pathway has not
been widely explored across eukaryotes and the modification to a class of
molecules able to break amide bonds to accommodate the structure of (s)ureidoglycolate may not be a complex evolutionary step. Two, (s)-ureidoglycolate
is unstable and will spontaneously convert to glyoxylate, albeit without the
stereospecific conversion present when catalyzed by ureidoglycolate
amidohydrolase (Werner et al. 2010). Spontaneous conversion of glyoxylate
results in a 50% loss of efficiency versus enzymatic conversion, presumably
creating strong evolutionary pressure to enzymatically degrade (s)ureidoglycolate to maintain stereochemistry.
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Glyoxylate is a common substrate for a number of enzymes including
glyoxylate oxidase, which catalyzes glyoxylate with water and oxygen to form
oxalate and hydrogen peroxide (Kasai et al. 1963). Notably, no copy of glyoxylate
oxidase has been identified in Nephromyces, which is surprising given that
another common component of the renal sac is calcium oxalate (Saffo &
Lowenstam 1978). We have not identified any genes suggesting that
Nephromyces or its bacterial endosymbionts can produce or process oxalate.
Calcium oxalate is also found in uninfected hosts indicating that the tunicate is
the source. Another enzyme that uses glyoxylate as a substrate, which is present
in Nephromyces/Cardiosporidium, is serine-pyruvate transaminase (AGXT), which
can be localized to peroxisomes or mitochondria, and catalyzes glyoxylate to
glycine and pyruvate (Takada & Noguchi 1985). An alternative enzyme for
processing glyoxylate is malate synthase (MLS), which is also targeted to the
peroxisome and missing from apicomplexans, including Cardiosporidium, but is
found in Nephromyces (Figure 1).
Malate synthase is one of two genes integral to the glyoxylate cycle, an
alternative pathway for part of the citrate cycle. In the glyoxylate cycle, isocitrate
is converted into glyoxylate and succinate by isocitrate lyase (McFadden &
Howes 1965). Glyoxylate is combined with acetyl-CoA to create malate (Molina et
al. 1994). This cycle allows for the creation of glucose from fatty acids directly
(Kornberg & Krebs 1957). The presence of malate synthase indicates at least a
piece of the glyoxylate cycle is present in Nephromyces. No copy of isocitrate lyase
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is predicted from the Nephromyces transcriptome, and only a small fragment of a
possible isocitrate synthase has been identified in Cardiosporidium. However,
under the model proposed here, the generation of glyoxylate is from uric acid,
and isocitrate synthase would not be required.
Both AGXT and MLS (in Nephromyces) show similarly high expression as
the purine degradation genes (Table 3), which is consistent with our proposed
uric acid to glyoxylate pathway. In particular, AGXT is among the most highly
expressed Nephromyces transcripts, with consistently higher expression than
MLS, possibly indicating it is the primary route of glyoxylate conversion. The
products of AGXT, glycine and pyruvate, are versatile substrates and used by a
number of pathways. Glycine is the simplest amino acid and an essential
component of many important biological compounds, as a nitrogen source in a
readily useable form. Pyruvate is extremely versatile and involved in several
critical biological pathways. A non-inclusive list includes amino acid
biosynthesis, acetyl-CoA biosynthesis, fatty acid biosynthesis, and the citric acid
cycle. These pathways represent both carbon and energy acquisition (Figure 2).
Additionally, Nephromyces has the ability to use MLS to convert glyoxylate and
acetyl-CoA into malate, a compound central to the citric acid cycle, allowing for
another mechanism of carbon and energy acquisition (Figure 2).
The hypothesized conversion of uric acid to glyoxylate in Nephromyces
creates several possibilities. First, it allows for the metabolic waste product, uric
acid, to be converted into glycine, pyruvate, and malate (Figure 2). Second, it
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Figure 2. Predicted purine degradation pathway in Nephromyces, within the peroxisome and
cytosol. Dark blue arrows represent enzymes identified in the Nephromyces transcriptome.
The light blue arrow represents the highly expressed amidohydrolase (red box) predicted to
convert ureidoglycolate into glyoxylate. Enzymes on the left side are localized to
peroxisomes, the right side to the cytosol, with the green vertical line representing the
peroxisomal membrane. The predicted pathway is able to convert uric acid into glyoxylate,
and subsequent conversion by serine-pyruvate transaminase (AGXT) or malate synthase,
creates glycine and pyruvate or malate respectively. The * by AGXT indicates ambiguous
predicted localization, to either peroxisomes or mitochondria
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provides an explanation for the exceptionally high expression of the purine
degradation pathway. Third, it gives Nephromyces access to a primary carbon,
nitrogen, and an energy source at no cost to its host. And finally, this change in
primary carbon, nitrogen, and energy could conceivably reduce the impact of
Nephromyces on its host, allowing Nephromyces densities to increase while
decreasing virulence. Reduction in virulence would have been a necessary first
step toward mutualism.
Uric acid as a primary carbon and energy source is not completely
unknown. Bacterial species have been found in chicken hutches that were able to
grow solely on uric acid (Rouf & Lomprey 1968; Thong-On et al. 2012), and some
species of fungi are able to grow on media solely containing uric acid
(Middelhoven et al. 1989). However, this is a novel substrate for an
apicomplexan to grow on, and while it is unlikely that Nephromyces could survive
on uric acid alone, it is a promising base for both carbon and nitrogen acquisition.
It is possible that the Nephromyces bacterial endosymbionts (Sabree et al. 2009;
Potrikus & Breznak 1980) are contributing to the proposed purine to glucose
pathway, but that is not currently supported by our data.
As the adaptive significance of uric acid deposits in tunicates, and
particularly in Molgula, are unknown, it is difficult to speculate on the effects of
Nephromyces uric acid degradation to the host. If these renal sac deposits are a
form of excretion by storage, as has been hypothesized (Goodbody 1965), then
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having a symbiont that is capable of digesting uric acid may be beneficial simply
by digesting an indigestible metabolite and converting uric acid into urea.
Alternatively, once the uric acid has been broken down, the tunicate may benefit
from metabolites derived from uric acid previously unavailable to the tunicate. If
Nephromyces is overexpressing xanthine dehydrogenase in order to outcompete
adenine phosphoribosyltransferase and hypoxanthine-guanine
phosphoribosyltransferase, diverting hypoxanthine from purine salvage to
purine degradation, there could be a potential cost to the host under purinelimited conditions.
Our data demonstrate that both the proposed mutualistic Nephromyces and
parasitic Cardiosporidium encode the genes for purine degradation, which have
been lost in other apicomplexans sequenced to date. Additionally, these genes
share a common ancestry with chromerid genes, indicating they are not the
product of a recent horizontal gene transfer from bacteria. These data also add
support to the growing body of evidence that indicate the presence of
peroxisomes in apicomplexans. Nephromyces and Cardiosporidium are predicted
to have peroxisomes and, unlike any other apicomplexan, are capable of
preforming both purine degradation and part of the glyoxylate cycle. The
presence of purine degradation, AGXT, and MLS allow for the intriguing
possibility of conversion of uric acid into a primary nitrogen, carbon and energy
source. This predicted metabolic activity would be a completely novel substrate
for an apicomplexan and may have been an important factor in the reduction of
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virulence in Nephromyces.
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CHAPTER 3
Abstract
Parasitism has been referred to as an “evolutionary dead end”, because
the transition to parasitism is unidirectional. Once an organism becomes an
obligate parasite, it is likely to remain an obligate parasite due to the loss of
metabolic pathways. Nephromyces is a genus in the parasitic phylum
Apicomplexa, but has an apparent mutualistic relationship with Molgula
tunicates. Support for a mutualistic relationship is based largely on a nearly
100% host infection rate with no known clearance of Nephromyces. Because
transition away from obligate parasite is so rare, little is known about the
evolutionary steps involved in such a transition - particularly in lineages with
such a long history of obligate parasitism as Apicomplexa. In order to examine
this unusual evolutionary transition, we sequenced transcriptomes from
Nephromyces and its parasitic sister taxon, Cardiosporidium cionae, which is an
excellent model for what Nephromyces might have looked like as a parasite. Both
C. ciona and Nephromyces have tunicate hosts and bacterial endosymbionts, but
each maintains a different lifestyle. A comparison of Nephromyces, C. ciona, and
their endosymbionts will be presented with a focus on system dynamics,
relationships, and clues to how this transition occurred.

Introduction
In 2010, Saffo et al. characterized the apicomplexan Nephromyces as
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having a mutualistic relationship with its host Molgula tunicates. The significance
of a mutualistic genus within a group of >6000 obligate parasites, some of which
cause massive human mortality, prompted us to initiate a genomic investigation
of Nephromyces. The unique evolutionary pressures caused by an obligate
parasitic lifestyle, namely host immune system evasion and the ready abundance
of pre-formed host metabolites, lead to predictable patterns of gene family losses
and expansions. Typically this consists of the expansion of gene families related
to host immune system evasion and other parasitism related functions, and the
subsequent loss of many of the core biosynthetic genes due to their presence in
the intracellular environment [1–5]. Due to these pressures, obligate parasitism
is often an evolutionary dead end.
Besides Nephromyces, the phylum Apicomplexa is composed entirely of
obligate metazoan parasites. As a result of an estimated 800 million years of
evolution as obligate parasites, [6], many of the genomic patterns associated with
parasitism have been described from the apicomplexan lineages. Gene
expansions can be seen in the plasmodium var protein family, which are involved
in host manipulation, evasion and in the expansion of rhoptry, microneme, and
dense granule proteins. The list of core biosynthetic pathways lost in
apicomplexans includes purine biosynthesis, purine degradation, biosynthesis of
many amino acids, and vitamin biosynthesis. These losses make the parasite
dependent on the host, not only for primary carbon and nitrogen, but also for any
metabolites it can no longer generate by either de novo synthesis or by
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conversion. High demand on the host for these metabolites to fuel parasite
growth increases the cost of infection, thereby increasing virulence. Parasites
must maintain a delicate balance between transmission, virulence, and host
immune system evasion.
The trade offs in this balance have been described in detail [7–11], but one
common solution many parasites adopt is maintaining low relative abundance
inside the host. Higher parasite abundance will increase the cost to that host, and
increase virulence. If the parasites kill the host before completing their lifecycle
or before transmission to a new host, their fitness falls to zero. Similarly, if
parasites have a high prevalence in a population and high lethality, they risk
decimating their host population. High-sustained infection prevalence is a good
indicator of low virulence, and low virulence is often achieved by self-limited
reproduction by the parasites. In this way, Nephromyces stood out as a very
atypical parasite. Nephromyces has a nearly 100% infection rate, sustained
almost year-round. Unexpectedly, based on typical host / parasite dynamics,
Nephromyces also reaches very high cell densities. These atypical epidemiological
factors were the basis for the Saffo et al. 2010 conclusion that Nephromyces must
be mutualistic. In order to reach high cell densities while maintaining low
virulence, Nephromyces was predicted to produce something of high value to the
host, to offset the cost associated with maintaining such high densities of an
obligate parasite.
The unusual epidemiology of Nephromyces becomes more apparent when
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contrasted with its parasitic sister taxon, Cardiosporidium cionae.
Cardiosporidium, first described in 1907 by Van Gaver and Stephan, and later
described by Ciancio et al 2008 is a blood parasite found in solitary nonmolgulidae ascidian hosts, including Ciona intestinalis. Cardiosporidium quickly
reaches and maintains ~95% infection prevalence by late July. In contrast to
Nephromyces, Cardiosporidium cell densities remain low, with orders of
magnitude difference in cell densities (based on DNA extraction quantities as a
proxy for cell density). Virulence in both of these apicomplexans is thought to be
low based on histological work by Ciancio et al. 2008 and Saffo and Nelson 1982.
Low virulence is also predicted from the high-sustained infection prevalence. The
contrast in cell densities between Nephromyces and Cardiosporidium, along with
the lack of apparent virulence, indicates an unusual relationship between
Nephromyces and its host.
In addition to being sister taxa, Nephromyces and Cardiosporidium share a
number of other traits. Both organisms are monoxenous, with ascidians as the
only host, both have infective stages that are transmitted through seawater,
localize within the pericardium of the host and each harbor a monophyletic
bacterial endosymbiont species that has been maintained since Nephromyces and
Cardiosporidium diverged (Figure 3). These similarities make Cardiosporidium an
ideal organism to compare with Nephromyces in order to resolve the genomic
changes taking place behind the transition from obligate parasitism to a
mutualistic host-symbiont relationship.
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However, there are some key differences, besides the epidemiological
factors, between Nephromyces and Cardiosporidium, including host species.
Cardiosporidium infects several genera of tunicates including Ciona, Halocynthia,
Styela, Ascidiella and possibly others [12, 13], while Nephromyces is restricted to
the Molgulidae family of tunicates [14]. Interestingly, Cardiosporidium has not
been found in any Molgulidae tunicates. Another key difference is that
Cardiosporidium is an intracellular blood parasite, while Nephromyces is
extracellular (another unusual trait for an apicomplexan). Additionally,
Nephromyces is exclusively found in a Molgulidae specific structure called the
renal sac, a large ductless structure of unknown function [15, 16].
Despite its name, the renal sac does not seem to function as a typical renal
organ, but was named for the large deposits of crystallized uric acid and calcium
oxalate within it. Many ascidians have localized deposits of uric acid, but
tunicates in the Molgulidae family have the largest [17, 18]. While the function of
these deposits in the tunicate remain unclear, previous work demonstrated that
Nephromyces is able to degrade uric acid because it retains the ancestral purine
degradation genes lost in all other apicomplexans (Chapter 2). Transcriptome
data and pathway analysis suggest that uric acid may be the primary source of
carbon and nitrogen for Nephromyces (Chapter 2). Uric acid is an atypical source
of carbon and nitrogen, but it is not unheard of. There are several species of
bacteria and fungi which can be cultured on media containing only uric acid [19–
21]. Due to their unusual environment inside the renal sac and because
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Nephromyces is extracellular, this organism may not have access to all the
required pre-formed metabolites. However, the genus Nephromyces is reported
to maintain three different bacterial endosymbionts [22].
In addition to the monophyletic alphaproteobacteria, Nephromyces also
harbors two other bacterial endosymbionts: a Betaproteobacteria and a
Bacteroidetes. Acquisition and maintenance of bacterial endosymbionts is a
common way for eukaryotes to gain new metabolic pathways and capabilities.
The functional capabilities of bacterial endosymbionts exploited by eukaryotic
hosts, for example include amino acid metabolism and vitamin metabolism [23],
nitrogen metabolism [24], defense [25], chemotrophic energy production [26],
and photosynthesis [27], to name a few. While bacterial endosymbionts are
common in many protist lineages, they are rare in the phylum Apicomplexa. The
only known apicomplexans to contain bacterial endosymbionts are
Cardiosporidium and Nephromyces. This limited distribution to apicomplexans
with ascidian hosts may be due to an unknown aspect of ascidian biology.
Previous speculation that Nephromyces’ bacterial endosymbionts are responsible
for the observed high levels of purine degradation have recently been rejected
(Chapter 2). However, the bacterial endosymbionts are likely instrumental to
Nephromyces’ ability to colonize the renal sac.
In order to examine the claim of mutualism, characterize the relationships
involved in this tripartite endosymbiosis, and determine how Nephromyces
achieves low virulence with high cell density, we sequenced the transcriptomes
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of Molgula manhattensis, Ciona intestinalis, Nephromyces, Cardiosporidium, and
their bacterial endosymbionts. Additionally, to better understand the dynamics of
the renal sac and the interplay between Nephromyces and its bacterial
endosymbionts, we sequenced and partially assembled the Nephromyces genome
and the genomes of all three types of the bacterial endosymbionts.

Results
RNA Sequencing
The contents of a single renal sac from an individual Molgula manhattensis
yielded 32 ng/µl RNA by Qubit and resulted in 195,694 transcripts from M.
manhattensis, Nephromyces, and the bacterial endosymbionts. After binning by
species, 60,223 transcripts were attributed to Nephromyces. The cardiac fluid
from 40 infected Ciona intestinalis individuals resulted in 109,446 transcripts,
including 15,541 Cardiosporidium transcripts.
The large number of transcripts identified from Nephromyces was due to
multiple species infection of a single host. Clustering sequences together resulted
in 26938 transcripts at 90%, 23850 at 80%, 21762 at 70%, 19540 at 60%, 16668
at 50%. Due to the multi species nature of Nephromyces infections, the
transcriptome is a pan-genome assembly rather than a precise uni-species
dataset, but we estimate that there are between 8000 and 12000 unique
transcripts in Nephromyces. Kyoto Encyclopedia of Genes and Genomes (KEGG)
functionally predicts 13336 transcripts in the full dataset. The tool BUSCO was
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used to assess the completeness of Nephromyces transcriptome resulting in
81.8% complete transcripts and 6.3% partial.
RNA extractions for Cardiosporidium samples yielded 164 ng/µl for nonsucrose gradient separated blood, 48 ng/µl from cells taken from the 25% layer,
and 24 ng/µl from cells taken from the 30% layer. These resulted in 97,417,356
reads from the non-sucrose separated sample, 115,085,369 reads from cells at
the 25% layer, and 116,393,114 reads from the 30% layer. Separated by species,
3877 transcripts were from C. intestinalis, 16,663 transcripts were from
Cardiosporidium, 1,689 transcripts were from the bacterial endosymbiont of
Cardiosporidium. KEGG functionally predicts 9,775 total transcripts for
Cardiosporidium, and BUSCO analysis for reports 69.7% complete and 11.9%
partial coverage. BUSCO analysis for the bacterial endosymbiont transcriptome
resulted in 14.8% complete and 19.6% partial against bacterial_od9.

Nephromyces genome
The Nephromyces genome assembly remains highly fragmented and
consists of 1176 contigs greater than 5kb with a maximum length of 287,191 bp
and an average length of 36 kb.
α-proteobacteria genome (Nαe)
Two different alphaproteobacteria endosymbionts were recovered from
our genomic data and assembled into a draft genome. The presence of two closely
related alpha proteobacteria genomes both with high AT bias (25% GC content)
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and regions of low complexity have limited our ability to assemble these
genomes completely (Table 4). The two genomes assemble into 11 contigs
ranging in size from 13 kb to 312 kb for a combined length of 995,540 and an
average of 90,503. Based on transcriptome sequencing we estimate that the
genome is largely complete. The draft genome contains 844 predicted coding
sequences, 35 tRNAs matching all codons, and 4 rRNAs. Of the 546 predicted
genes have KASS annotations (119 Genetic information processing, 32
Carbohydrate metabolism, 30 Energy metabolism, 29 Cellular processes, 26
Nucleotide metabolism, 26 Metabolism of cofactors and vitamins, 25
environmental information processing, 15 lipid metabolism, 12 amino acid
metabolism, 15 unclassified).
Bacteroidetes Genome (Nbe)
Nephromyces bacteroidetes genome is circular, 494,352 nucleotides long,
and extremely AT rich (22% GC content) (Table 4). The genome contains 503
predicted genes, 31 tRNAs predicted to recognize all codons, and 4 rRNAs. 391 of
the predicted genes have KASS annotations (110 Genetic information processing,
40 Carbohydrate metabolism, 38 Energy metabolism, 31 amino acid metabolism,
21 Metabolism of cofactors and vitamins, 17 Nucleotide metabolism, 11
unclassified, 10 Lipid metabolism, 9 Cellular processes).
Betaproteobacteria Genome (Nβe)
The Betaproteobacteria genome is circular and 866,396 bp long with 30%
GC content (Table 4). It contains 880 predicted genes, 40 tRNAs, and 4 rRNAs
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Nephromyces’s
Nephromyces’s
Alphaproteobacterial Bacteroidetes
genome (Nαe)
Genome (NBe)
contigs
size in BP
CDS
tRNA
rRNA
GC content

11
995,540
844
35
4
25%

1
494,352
503
31
4
22%

Nephromyces’s
Betaproteobacterial
Genome (Nβe)
1
866,396
880
40
4
30%

Table 4) Genomic assembly statistics for
Nephromyces three bacterial endosymbionts. Nαe
and Nbe were assembled from a hybrid assembly
of Illumina HiSeq and Pacific Biosciences data,
while Nβe was assembled with Pacific Biosciences.
Sequence data contained multiple closely related
strains and these assemblies represent pangenomes of the various symbionts.
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(two identical 16s copies and 2 identical 23s copies). 753 of the 880 predicted
genes have KAAS annotations (156 Genetic information processing, 61
Carbohydrate metabolism, 47 Energy metabolism, 11 Cellular processes, 45
Nucleotide metabolism, 68 Metabolism of cofactors and vitamins, 39
environmental information processing, 18 lipid metabolism, 62 amino acid
metabolism, 14 unclassified).

Bacterial Genome BUSCO Analysis
BUSCO analysis against bacteria_odb9 for the alphaproteobacteria
endosymbionts resulted in 99 complete BUSCO copies, 97 single copy and 2
duplicate, and 5 fragmented copies, and is predicted to be 66.9% complete and
3.4% incomplete. For the bacteroidetes endosymbiont BUSCO returned 88
complete single copy, no duplicates, and 10 fragmented for a 59.5% complete and
6.8% incomplete. The Betaproteobacteria endosymbiont had 116 complete
BUSCO copies, all single copy (78.4%), 15 incomplete (10.1%), and 17 missing
(11.5%).

Nephromyces and Cardiosporidium metabolic pathway characterization
Endocytosis
Both Nephromyces/Cardiosporidium are predicted to encode genes for
clathrin-dependant endocytosis. An additional 25 genes related to endocytosis
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are predicted in Nephromyces/Cardiosporidium than in P. falciparum. Many of the
additional genes found in Nephromyces/Cardiosporidium are in the VPS and
CHMP protein families and form part of the ESCRT machinery important in the
biogenesis of multivesicular bodies. Multivesicular bodies transport
ubiquitinated proteins to lysosomes for degradation. Other proteins not found in
P. falciparum include a number of genes in the AP2 complex, which are accessory
proteins in clathrin-mediated endocytosis. The AP2 complex plays an important
role in the regulation of the assembly of clathrin-coated vesicles.
Carbohydrate Metabolism
Basic carbon metabolism in Nephromyces/Cardiosporidium is similar to
other apicomplexans and encodes the complete pathways for the citrate acid
cycle, glycolysis, gluconeogenesis, and the pentose phosphate pathway.
Interestingly, Nephromyces/Cardiosporidium are predicted to encode far more
genes involved with inositol phosphate metabolism than either P. falciparum or
T. gondii. Despite the absence of genes involved in the synthesis of myo-inositol
in P. falciparum or T. gondii there is support that myo-inositol is used in
intracellular calcium signaling in these two organisms. How P. falciparum or T.
gondii are able to use myo-inositol without being able to synthesize it is unclear,
but it is presumed that they have divergent and unrecognizable myo-inositol
biosynthesis genes. However, both Nephromyces/Cardiosporidium are predicted
to be able to synthesize myo-inositol and these genes are readily identifiable as
orthologous to myo-inositol biosynthesis genes in other organisms. Both
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Nephromyces/Cardiosporidium have a copy of serine-pyruvate aminotransferase
(AGXT), which catalyzes glyoxylate to glycine and pyruvate. Additionally,
Nephromyces encodes malate synthase, which, in conjunction with acetyl-CoA,
forms malate from glyoxylate.
Fatty Acid Metabolism
Nephromyces/Cardiosporidium are predicted to be able to perform fatty
acid initiation and elongation in both the mitochondrial and cytoplasmic
pathways, as well as elongation in the endoplasmic reticulum. Additionally,
Nephromyces/Cardiosporidium are predicted to encode D-glycerate 3-kinase
(GLYK), aldehyde dehydrogenase (ALDH), alcohol dehydrogenase (ADH), glycerol
kinase (glpK), glycerol-3-phosphate O-acyltransferase (GPAT1), and 1-acyl-snglycerol-3-phosphate acyltransferase (plsC), and thus are able create
triglycerides from glucose.
Nucleic acid metabolism
Unique among apicomplexans, Nephromyces/Cardiosporidium contain a
complete pathway for the biosynthesis of inosine monophosphate (IMP). IMP is a
purine and the starting molecule for the biogenesis of guanine and adenine. De
novo biosynthesis of purines has been lost in all sequenced apicomplexans. Other
apicomplexans are capable of scavenging precursor molecules to IMP and
converting them into IMP, but Nephromyces/Cardiosporidium encode the entire
IMP biosynthesis pathway from 5-Phosphoribosyl diphosphate (PPRP). The
genes involved in this pathway include amidophosphoribosyltransferase (purF),
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phosphoribosylamine---glycine ligase (purD),
phosphoribosylformylglycinamidine synthase (purL),
phosphoribosylformylglycinamidine cyclo-ligase (purM),
phosphoribosylaminoimidazole carboxylase (PAICS),
phosphoribosylaminoimidazole-succinocarboxamide synthase (purC),
adenylosuccinate lyase (purB), IMP cyclohydrolase (purH). From IMP both
Nephromyces/Cardiosporidium have the metabolic machinery for the
biosynthesis of adenine and guanine. In addition to the biosynthesis of purines,
Nephromyces/Cardiosporidium are also the only known apicomplexans capable of
purine degradation (Chapter 2).
Biosynthesis of Amino Acids
Nephromyces is predicted to be able to synthesis 10 amino acids (alanine,
asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, methionine,
serine, and threonine). Cardiosporidium is predicted to be able to synthesis the
same amino acids with the exception of cysteine. In addition to the complete
pathways Nephromyces/Cardiosporidium have partial pathways for synthesis of
phenylalanine from phenylpyruvate and can convert tyrosine from
phenylalanine. Both Nephromyces/Cardiosporidium encode branched-chain
amino acid aminotransferase, which adds the final amine group to valine, leucine,
and isoleucine.
Vitamin and cofactor synthesis
Nephromyces has the predicted biosynthetic capabilities to produce
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riboflavin, acetyl CoA, nicotinate, folate, retinol, vitamin E, heme, and ubiquinone.
Cardiosporidium has similar predicted biosynthetic capabilities, but is only
capable of synthesizing 6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol and lacks
the final two enzymes in the production of vitamin E. Both
Nephromyces/Cardiosporidium encode a copy of lipoyl synthase (lipA), but lack
lipoyl(octanoyl) transferase (lipB) in the lipoic acid synthesis pathway. Lipoic
acid is an essential cofactor involved in the citric acid cycle, pyruvate
dehydrogenase complex, 2-oxoglutarate dehydrogenase complex, branched-chain
oxoacid dehydrogenase, and acetoin dehydrogenase.

Endosymbiont pathways (Figure 3)
Carbohydrate metabolism
The α-proteobacteria endosymbiont of Nephromyces (Nαe) has an
extremely reduced carbohydrate metabolism, including all of the genes involved
with gluconeogenesis and glycolysis. The only carbohydrate metabolism genes
present are a complete citrate acid cycle and pyruvate dehydrogenase E1
component (aceE), dihydrolipoamide dehydrogenase (pdhD), and pyruvate
dehydrogenase E2 component (aceF), which converts pyruvate to acetyl-CoA.
With such severe reduction in carbohydrate metabolism, pyruvate appears to be
the only carbon source the alphaproteobacteria is capable of processing.
The bacteroidetes endosymbiont (Nbe) has a similarly reduced
carbohydrate metabolism as in the α-proteobacteria, however the reduction is
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Figure 3) Metabolic pathway capabilities of Nephromyces (orange) and
its bacterial endosymbionts (alpha=teal, beta=purple,
bacteroidetes=green) solid colored boxes indicated a complete
pathway, light shaded boxes indicated a partial pathway, and white
boxes indicate the pathway is not present.
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not as extreme. Having lost gluconeogenesis the bacteroidetes endosymbiont can
process fructose into phosphoenolpyruvate and contains pyruvate
dehydrogenase E1 component (aceE), dihydrolipoamide dehydrogenase (pdhD),
and pyruvate dehydrogenase E2 component (aceF) to convert pyruvate into
acetyl-CoA. While the full citrate cycle is incomplete the partial cycle from 2oxoglutarate to oxaloacetate is complete, as well as the reductive pentose
phosphate pathway from glyceraldehyde-3P to ribulose-5P.
Nephromyces β-proteobacteria endosymbiont (Nβe) has the most
complete carbohydrate metabolism encoding the complete non-oxidative
pentose phosphate pathway, the citrate cycle from 2-oxoglutarate to
oxaloacetate, and the core glycolysis module involving three carbon compounds.

Fatty Acid metabolism
Paradoxically, while the enzymes involved with fatty acid biosynthesis
(from malonyl-CoA in Nαe and Nβe and from acetyl-CoA in Nbe) are present in all
three types of bacterial endosymbiont, all the genes involved in fatty acid
degradation have been lost in every symbiont. Nαe and Nβe have a reduced
glycerophospholipid metabolism and must convert phosphatidate to synthesis
phosphatidylethanolamine, phosphatidylglycerol, and phosphatidylserine, while
Nβe is able to de novo synthesize glycerophospholipids from glycerone.
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Nucleic acid metabolism
Purine metabolism is similarly reduced in both Nαe and Nbe. Both
endosymbionts lack all genes in the IMP biosynthesis pathway, as well as the
ability to convert IMP to guanine or adenine. With so few purine biosynthesis
capabilities, all of the guanine and adenine for DNA replication must be obtained
as preformed nucleobases. Nβe purine biosynthesis is complete encoding
adenylosuccinate lyase (purB), and IMP cyclohydrolase (purH) and is able to
synthesize IMP from 5-Phosphoribosyl diphosphate (PRPP) (with the histidine
synthesis pathway) as well as the genes required to convert IMP to both guanine
and adenine. However, none of the three endosymbionts encode any genes
involved in purine degradation.
Both Nαe and Nβe encode the necessary genes for pyrimidine
biosynthesis. However, because Nbe is missing several genes involved in
pyrimidine biosynthesis it seems likely that Nbe is dependent on Nephromyces
for both purines and pyrimidines

Biosynthesis of Amino Acids
Nαe is only capable of synthesizing the amino acids glutamine, glutamic acid, and
lysine. Of these three amino acids, lysine is the only amino acid that Nephromyces
is unable to synthesize.
Nbe is capable of synthesizing 11 amino acids: arginine, aspartic acid,
glutamine, glutamic acid, glycine, isoleucine, leucine, lysine, serine, threonine, and
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valine. Bacteroidetes is also able to synthesis phenylpyruvate, but lacks the
ability to the ability to synthesis phenylalanine. Biosynthesis of arginine,
isoleucine, leucine, lysine, and valine are not present in the Nephromyces
transcriptome and may represent the bacteroidetes contribution. Additionally,
Bacteroidetes synthesis of phenylpyruvate, but inability to synthesis
phenylalanine compliments Nephromyces synthesis of phenylalanine from
phenylpyruvate, but inability to synthesis phenylpyruvate.
Nβe encodes the genes for 11 amino acids: arginine, glutamine, glutamic
acid, glycine, histidine, lysine, phenylalanine, proline, serine, threonine, and
tyrosine. Nβe also encodes all the genes for synthesis of isoleucine, leucine, and
valine, but lacks the last gene in the pathway branched-chain amino acid
aminotransferase. However, Nephromyces encodes branched-chain amino acid
aminotransferase and may be able to complete isoleucine, leucine, and valine by
adding the final amine group.

Vitamin and cofactor synthesis
Nαe only encodes genes for the biosynthesis three vitamins and cofactors; heme, ubiquinone, and lipoic acid. Lipoic acid has been experimentally
shown to be exclusively synthesized in the apicoplast in apicomplexans;
additionally all lipoic acid used in the mitochondria needs to be scavenged from
the host. Lipoic acid may be an important product produced by the
alphaproteobacteria. In contrast Nbe is capable of biosynthesis of vitamin B6,
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lipoic acid, folate and vitamin K. Nβe is able to synthesize most cofactors
including riboflavin, vitamin B6, nicotinate, coenzyme-A, folate, heme, and
ubiquinone.

Secretion and Transporters
All three symbionts encode at least a partial bacterial sec secretion
system. Nβe is the most complete missing only secM. Nαe lacks secE, secG, and
secM. Nbe is the most incomplete missing secB, secD, secE, secM with so many
genes missing it is not clear if the sec secretion system is functional in Nbe. Both
Nβe and Nbe have the twin-arginine translocation pathway. Nαe has TatC, but
lacks TatA and is therefore incomplete [28]. While Nαe is missing the Tat
transport system, Nαe does encode the type 4 bacterial secretion system.
In addition to the more general secretion systems there are also more
specific ABC transporters. Nbe has the fewest ABC transporters only
phospholipid and possibly a heme transporter. Nαe also encodes a phospholipid
and heme transporter in addition to a lipoprotein transporter and possibly a zinc
transporter. Nβe’s genome contain the most ABC transporters, including Iron(III),
putracine, General L-amino acid, branched-chain amino acid, phosphate,
lipoprotein, lipopolysaccharide, and possibly a molybdate transporter.

Bacterial phylogeny
Nephromyces and Cardiosporidium alphaproteobacteria endosymbionts
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are monophyletic (98 bootstrap support) and are in the genus Rickettsia (94
bootstrap support). Nephromyces bacteroidetes endosymbiont is sister to the
genus Pedobacter (87 bootstrap support) in the family Sphingobacteriaceae. The
Betaproteobacteria fall within the genus Bordetella (98 bootstrap
support) (Figure 4).

Orthology
Nephromyces had 21,762 genes when clustered at 70% of these 20881
were assigned to orthogroups. 39.7% of orthogroups made contained
Nephromyces and there were eight genus specific orthogroups containing 21
genes (Figure 5). 3,455 orthogroups were shared by Nephromyces, Apicomplexa,
and Chromerids. 421 orthogroups were shared between Nephromyces and
Apicomplexa (Figure 6). 218 orthogroups were shared between Nephromyces
and Chromerids that were not found in Apicomplexa. Cardiosporidium had 7,395
genes, of which 6,977 were assigned to orthogroups. 31.5% of orthogroups
contained Cardiosporidium and there was one species-specific orthogroup
containing five genes. 2,778 orthogroups were shared between Cardiosporidium,
Apicomplexa, and Chromerids. 236 orthogroups were shared between
Cardiosporidium and Apicomplexa and not found in Chromerid. 219 orthogroups
were shared between Cardiosporidium and Chromerids that were not found in
Apicomplexa. Nephromyces and Cardiosporidium had 3, 106 shared orthogroups.
Nephromyces had 1,178 orthogroups not found in Cardiosporidium. 289
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Figure 4) Subsets from larger
maximum liklihood16s rRNA
trees composed of
Alphaproteobacteria,
Bacteroidetes, and
Betaproteobacteria sequences.
Nodes are labeled with percentage
bootstrap support values.
Nephromyces and
Cardiosporidium
alphaproteobacteria
endosymbionts are monophyletic
and sister to the family
rickettsiaceae. Nephromyces
bacteroidetes endosymbiont is in
the family sphingobacteriaceae.
Nephromyces betaproteobacteria
endosymbiont is sister to the
genus Bordetella.
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Figure 5) Collapsed Venn Diagram of orthologous gene groups from
Nephromyces (70% identity level), Cardiosporidium, Chromera (V.
brassicaformis, C. velia), and Apicomplexa (C. parvum, G. niphandrodes,
B. bovis, T. parva, P. falciparum, C. cayetanensis, E. brunetti, E.
falciformis, E. tenella, H. hammondi, N. caninum, S. neurona, T. gondii).
Orthology was predicted with OrthoFinder.
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Figure 6) Venn Diagram of orthologous gene groups from
Nephromyces (70% identity level), Cardiosporidium, Toxoplasma,
Cryptosporidium and Plasmodium. Orthology was predicted with
OrthoFinder.
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orthogroups were found in Cardiosporidium and not in Nephromyces.
Discussion
Our initial aim in sequencing and comparing the transcriptomes of
Nephromyces/Cardiosporidium was to better characterize mutualism in
Nephromyces. A mutualistic relationship was described based on the unusual
epidemiology Nephromyces, but high infection prevalence is not proof of mutual
benefit. While our current efforts do not conclusively characterize Nephromyces’
relation to its host, the data do provide insight into Nephromyces’ atypical
lifestyle. By comparing Nephromyces (a proposed mutualist) to Cardiosporidium
(a blood parasite) we are able to extricate the evolutionary effects of a changing
relationship from the evolutionary effects of an ascidian host.
Since all of the sequencing on Nephromyces has been on samples
containing multiple Nephromyces species, our Nephromyces data is therefore a
pan-transcriptome/genome. This approach limits our results and
conclusions. This is particularly evident in our genomic assemblies, which are
highly fragmented and almost certainly poly-species chimeric. In addition to
problems with assembling the genomes of closely related organisms, we are also
unable to estimate gene family expansions or reductions in Nephromyces. While
these limitations are significant, the pan-transcriptome/genome does reflect the
natural biology of Nephromyces. All of the renal sacs sampled from the host M.
manhattensis to date have contained multiple Nephromyces infections. Efforts to
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culture single species isolates in the lab have met with limited success. This
indicates that sustained Nephromyces infection is dependent on contributions
from the community of species and endosymbionts.
Notably, by sequencing multiple Nephromyces species we were able to
recover the transcriptomes/genomes of all three of Nephromyces endosymbionts.
Recovering multiple bacterial endosymbiont types provides key insights into how
this system works, and outweighs the disadvantages of a pantranscriptome/genome approach.
The transcriptomes for Nephromyces/Cardiosporidium are largely
complete (estimated by BUSCO), but Cardiosporidium is estimated to be about
10% less complete than Nephromyces. We have taken this difference into account
when comparing these two data sets. Both Nephromyces/Cardiosporidium encode
an estimated eight thousand genes, which is a large number of genes for an
apicomplexan. This estimate is similar to the number of genes in the most gene
rich apicomplexan, Toxoplasma, which also encodes eight thousand genes. This is
interesting given the phylogenetic placement of Nephromyces/Cardiosporidium in
the hematozoa. Hematozoa, which contains plasmodiidae and piroplasmida
lineages, have some of the smallest genomes with the least number of genes of
any sequenced apicomplexans. This high gene number in both
Nephromyces/Cardiosporidium may indicate that greater biosynthesis and
metabolic capabilities are necessary for living in an ascidian host.
The two most striking observations made over the course of this
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exploration involve purine metabolism. The first is purine degradation; both
Nephromyces/Cardiosporidium have the metabolic capabilities to convert
xanthine into glyoxylate. Glyoxylate can then be converted, with serine-pyruvate
aminotransferase (AGXT), into glycine and pyruvate; Nephromyces additionally
encodes malate synthase (MLS), which combines Glyoxylate and acetyl-CoA, into
malate. This is the proposed primary route of carbon, nitrogen, and energy
acquisition for Nephromyces (Chapter 2). This pathway is absent in all other
sequenced apicomplexans, but it appears the enzymes in this pathway were
retained from the last common ancestor of Apicomplexa, and not a more recent
horizontal gene transfer.
Nephromyces/Cardiosporidium also purine metabolism is de novo purine
biosynthesis. While some apicomplexan lineages have one or two genes to
synthesize inosine monophosphate (IMP) from immediate precursors,
Nephromyces/Cardiosporidium are predicted to encode the entire de novo purine
synthesis from 5-Phosphoribosyl diphosphate (PRPP). As the inability to
synthesize purines has been widely targeted for drug development against other
apicomplexan species, its presence in Nephromyces/Cardiosporidium is surprising
[29].
The presence of both purine degradation and purine synthesis could be
critical to Nephromyces’ unusual epidemiology. By obtaining the bulk of the
required carbon, nitrogen and energy from a metabolic waste product (i.e.
tunicates lack the enzymatic ability to degrade purines past uric acid),
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Nephromyces is able to limit its impact on the host while still reaching high
cellular densities. De novo synthesis of purines indicates that neither
Nephromyces/Cardiosporidium is dependent of the host for IMP. In fact, these
purine degradation and biosynthesis pathways may have been the integral
factors that allowed Nephromyces to leave the intracellular environment and
colonize the renal sac.
Another critical factor in Nephromyces’ ability to survive in the renal sac is
likely its bacterial endosymbionts. The α-proteobacteria endosymbionts found in
Nephromyces and Cardiosporidium are monophyletic, which indicates they have
been maintained and vertically transmitted since the divergence of Nephromyces
and Cardiosporidium. In addition to the α-proteobacteria, Nephromyces has
acquired a β-proteobacteria and a Bacteroidetes endosymbiont. The αproteobacteria and Bacteroidetes symbionts show a marked reduction in carbon
metabolism with the Nαe, only encoding genes for the citric acid cycle.
Bacteroidetes is only capable of processing three carbon compounds and encodes
a partial citric acid cycle. Such pronounced reduction suggests that Nephromyces
provides its symbionts a limited ‘diet’. In both symbionts, carbon metabolism
may be dependent on pyruvate, which is one of the products of AGXT. Related to
this limited carbon metabolism, all three of the bacterial endosymbionts
paradoxically encode complete fatty acid biosynthesis, but lack fatty acid
degradation. Presumably, the fatty acid biosynthesis is for the construction of
membranes, but without fatty acid degradation these symbionts are incapable of
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processing fatty acids as a carbon source. Both Nαe and Nβe lack complete
pathways for the creation of glycerophospholipids, and both contain
phospholipid ABC transporters. This could indicate a dependence on
Nephromyces for phospholipids.
None of the three endosymbionts of Nephromyces contain any genes
involved in purine degradation. The absence of this entire pathway in the
genomes of the endosymbionts is further support that the high levels of uric
oxidase detected are from Nephromyces and not from any of its bacterial
endosymbionts. Similarly, Nβe and Nαe do not encode any genes involved in de
novo purine biosynthesis, including genes for the conversion from IMP to adenine
and guanine. Nβe can likely synthesize purines from PPRP through the histidine
biosynthesis pathway and contains the genes to synthesize adenine and guanine
from IMP. The total lack of purine biosynthesis genes in both Nβe and Nαe makes
these symbionts dependent on Nephromyces for both adenine and guanine. If
Nephromyces were incapable of de novo purine biosynthesis then the entire renal
sac community would be dependent on either the tunicate host for all purines, or
on Nβe. This would be a significant burden on the host and would markedly
increase the cost of infection, which does not align with Nephromyces’ strategy of
low virulence and high-density infection of its host. This argument adds support
to the prediction that Nephromyces/Cardiosporidium are able to synthesize
purines.
Given the reduced genomes and correspondingly reduced metabolic
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capabilities, Nβe and Nbe encode a large proportionally high number of genes for
synthesizing amino acids, vitamins, and co-factors. Together Nβe and Nbe could
provide Nephromyces with all but one essential amino acid (tryptophan). Nβe is
predicted to synthesize leucine, isoleucine, and valine up to the last step, where
the final amine group is added. Conversely, Nephromyces only encodes the last
step in the conversion of these three amino acids. Similarly, Nbe encodes a partial
biosynthetic pathway for phenylalanine, which seems to be complemented by
Nephromyces. Nαe is capable of synthesizing three amino acids and only one,
which is an essential amino acid, is not encoded by Nephromyces (lysine). Vitamin
and cofactor biosynthesis in Nαe is also limited, synthesizing heme, ubiquinone,
and lipoic acid, with lipoic acid being the only product Nephromyces may be
incapable of synthesizing itself.
With such limited vitamin and amino acid metabolism encoded in the Nαe
genome it is unlikely that Nephromyces is maintaining Nαe just for lysine
biosynthesis, but from the data we are unable to propose what particular
function Nαe serves Nephromyces. In addition, all of the limited species infections
of Nephromyces we have been able to culture so far have an Nαe type of symbiont.
While neither the frequency of Nαe or the limited species cultures are strong
support for the Nαe symbiont being essential, it does suggest that Nαe may have
an important role in Nephromyces metabolism.
As more apicomplexan genomes are sequenced it is becoming apparent
that while they do share a large core subset of proteins, the differential losses and
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expansions are very lineage specific. This is likely due to adaptations required for
specific host biology. Each lineage displays a characteristic patchwork of different
gene losses and expansions. Many of these lineages contain orthologs with the
Chromerids that are not found in other apicomplexan lineages. Nephromyces and
Cardiosporidium have retained both purine biosynthesis and degradation, which
has been lost in all other apicomplexan lineages. There may be something
particular to ascidian biology that necessitates retaining and expressing these
purine metabolism pathways. Nephromyces and Cardiosporidium share the vast
majority of their genes with each other, as well as encoding the majority of the
commonly shared apicomplexan genes. With so many metabolic similarities
between Cardiosporidium and Nephromyces, we were unable to detect any clear
differences related to Nephromyces’ proposed mutualistic relationship.
While there are no obvious differences between Nephromyces and
Cardiosporidium, we are severely limited by a lack of lineage specific proteomic
work. In other apicomplexans the gene families that modulate host immunity are
highly lineage specific. In Nephromyces/Cardiosporidium, the mechanisms of host
manipulation are entirely unknown. Without a greater understanding of how
both Cardiosporidium and Nephromyces interact with their host at a proteomic
level, we are unable to conclusively say that there is a difference between these
two organisms.
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Methods
Molgula manhattensis collection
Molgula manhattensis tunicates were collected from a dock in Greenwich
Bay, Rhode Island (41°39'22.7"N 71°26'53.9"W) in July 2014. A single renal sac
was separated from one tunicate, and all extraneous tissue removed. The intact
renal sac was placed in liquid nitrogen for 5 min and then stored at -80°C.

Cardiosporidium cionae collection, isolation, and concentration
Ciona intestinalis were collected from Matunuck Marina, RI (41.3890° N,
71.5201° W), in August 2017. Tunics were removed and the body wall was
opened to allow access to the heart. A sterile syringe was used to remove cardiac
blood as cleanly as possible. Blood was kept at 4° C until Cardiosporidium
infection was verified using Giemsa stain to visualize Cardiosporidium. Heavily
infected samples were pooled together and centrifuged at 500g for 5 minutes.
The resulting supernatant was removed and the samples were frozen in liquid
nitrogen and stored at -80° C. Samples with high rates of infection were enriched
for Cardiosporidium using sucrose gradients [30, 31]. Gradients of 20, 25, 30, 35,
40% sucrose solutions in phosphate buffer were layered together. Approximately
5 ml of tunicate blood was added to the column and centrifuged at 1750g for 30
mins at 4° C. The 25% and 30% layers were collected (based on visual screens
showing high Cardiosporidium cell density and low tunicate cell density), washed
with PBS twice, pelleted and then frozen in liquid nitrogen and stored at -80° C.
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RNA Extraction
RNA extraction buffer (Zymo Research LLC. Irvine, CA) was added to
samples and ground with a pestle. Following grinding, the Zymo Quick-RNA kit
(Zymo Research LLC. Irvine, CA) was used and the manufacturer's protocol was
followed. RNA was converted to cDNA and sequenced at the School of Medicine
Genome Resource Center, University of Maryland. One paired-end RNA library
was run on one lane of the Illumina HiSeq platform. Resulting in 40,606,230 from
the M. manhattensis renal sac. For Cardiosporidium, three samples of C.
intestinalis blood were used: one with unseparated blood, one enriched with cells
collected at the 25% sucrose gradient, and one enriched with cells from the 30%
sucrose gradient were multiplexed on one lane of the Illumina HiSeq platform,
resulting in 92,250,706, 109,023,104, and 110,243,954 reads respectively.
Transcriptome data was assembled and proteins were predicted with
Trinity/Trinotate pipeline version 2.4.0 run on the server at Brown University
Center for Computation and Visualization [32]. Reads assembled into 145674 and
109,446 contigs from M. manhattensis and C. intestinalis respectively. Protein
sequences were predicted using Transdecoder [32]. Blastp was used to identify
bacterial sequences from assembled transcripts against NCBI’s refseq and
binned. Remaining Eukaryotic sequences were separated with blastp against a
custom database of alveolate and ascidian transcriptomes. Trimmed reads were
mapped back to each of the six bins (Nephromyces, M. manhattensis, Nephromyces
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bacteria, Cardiosporidium, C. intestinalis, and Cardiosporidium bacteria) and then
reassembled independently in Trinity. The Nephromyces transcriptome was
composed of multiple Nephromyces species, and CD-hit was used to cluster
transcripts based on 50 percent identity. Transcriptome completeness was
assessed with Busco v3 against the Eukaryotic and bacterial reference data sets
[33]. Transcripts were annotated using Interproscan [34].
DNA Extraction
The renal sacs from 8 lab grown M. manhattensis individuals were
dissected and their renal fluid was pooled in a 1.5ml Eppendorf tube. Contents
were centrifuged at 8000g for 5 min. to pellet Nephromyces cells, and following
centrifugation the renal fluid was discarded. 500µl of CTAB buffer with 5ul of
proteinase K and ceramic beads were added to the pelleted Nephromyces cells.
The sample was placed in a bead beater for 3 min. and then on a rotator for
1.5hrs at room temp. 500µl of chloroform was added, mixed gently and
centrifuged for 5 min. The top layer was removed and twice the sample volume of
ice cold 100% EtOH and 10% sample volume of 3M sodium acetate were added
to the sample and incubated a -20C overnight. The sample was centrifuged at
16000g for 30 min. and the liquid was removed. Ice cold 70% EtOH was added
and centrifuged at 16000g for 15 min. Liquid was removed and sample air dried
for 2 min. DNA was re-eluted in 50ul of deionized water.
Illumina Sequencing
A nanodrop (2000c, Thermo Scientific) was used to assess DNA purity and
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DNA concentration, and a genomic gel was run to assess DNA fragmentation.
Following quality control, an Illumina library was constructed. Library prep and
sequencing were done at the URI Genomics and Sequencing Center (URI GSC).
The completed library was sequenced on the Illumina MiSeq platform at the URI
GSC and the HiSeq platform at the University of Baltimore sequencing center on
three lanes.
Pacific Biosciences Sequencing
Using the contents of 150 M. manhattensis renal sacs (done in batches of 10
then pooled), the same DNA extraction protocol was performed as for Illumina
sequencing. DNA was sequenced using three SMRT cells on the Pacific
Biosciences platform at the University of Baltimore sequencing center.
Illumina assembly
One MiSeq lane and three lanes of HiSeq, all from the same library, were
trimmed using Trimmomatic [35] and then assembled using Spades [36]
assembler on the URI server BlueWaves.
Pacific Biosciences assembly
Pacific Biosciences reads were error corrected using pbsuite/15.8.24 [37]
on the Brown University server, Oscar. Reads were then assembled using Canu
[38]. Contigs generated by Canu were combined with Illumina MiSeq/HiSeq short
reads with Abyss v2.02 [39]. Nephromyces contigs were identified by mapping
Nephromyces transcriptome reads using Bowtie2. Contigs with greater than 90x
coverage as assessed with bedtools [40] were binned as Nephromyces.
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Bacterial endosymbiont genome assembly
Using the contigs from the Abyss assembly bacterial contigs were initially
identified by hexemers using VizBin [41]. Transcriptomic reads that were
identified as bacterial were mapped using Bowtie2 [42]. Bacterial contigs were
separated based on a 90x coverage threshold with bbmap. Binned bacterial
contigs were preliminarily annotated with Prokka [43]. Resulting annotations
were run through KEGG GhostKoala to assign and separate by taxonomy. Taxon
separated contig bins were merged and scaffolded using PBJelly from the PBsuite
of tools [37]. Trimmed Illumina MiSeq and HiSeq reads were remapped to
resulting contigs to insure accurate assembly using Bowtie2. Final assembled
bacterial genomes were re-annotated with Prokka with a genus specific database.
Bacterial phylogeny
16s rRNA sequences from Nephromyces bacterial endosymbiont genomes,
predicted by rRNAammer, and 16S rRNA sequences from Cardiosporidium
transcriptome were used in the phylogenetic analysis. All 16s rRNA rickettsiales,
sphingobacteriaceae, and alcaligenaceae sequences with a minimum length of
1300bp available on NCBI’s refseq were downloaded separately. Sequences were
aligned with MAFFT [44] with G-INS-I and trimmed to length in Geneious 6.
Maximum likelihood trees of the alignments were generated with RAxML v 8.2.0
using the GTRCAT model run for 10000 generations with 100 generation burn in
[45].
Orthology
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The following apicomplexan and Chromerid transcriptomes were
downloaded from EuPathDB: C. parvum Iowa, G. niphandrodes, B. bovis T2Bo, T.
parva Muguga, P. falciparum 3D7, C. cayetanensis, E. brunetti Houghton, E.
falciformis Bayer Haberkorn, E. tenella Houghton, H. hammondi HH34, N. caninum
LIV, S. neurona SN3, T. gondii ME49, C. velia CCMP2878, V. brassicaformis
CCMP3155. These transcriptomes were combined with Cardiosporidium and
Nephromyces (clustered at the 70% identity) Orthofinder v. 2.2.6 was used to
assign transcripts to orthologous groups.
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CHAPTER 4
Abstract
Monogenus multi-species infections are common in many Apicomplexans.
However, these multi-species infections are often overlooked unless specifically
targeted. Using amplicon primers designed to target 18s rRNA, COI, and 16s
rRNA we attempted to quantify the species diversity and incidence of multispecies infections of Nephromyces in the tunicate host Molgula manhattensis
collected in a limited geographic area from the waters of Rhode Island. Our data
indicate that Nephromyces is hyper diverse and multispecies infections are nearly
universal.

Introduction
Nephromyces is a genus of Apicomplexa with a symbiotic relationship with
their hosts, tunicates in the family molgulidae. First described in 1874 by de
Lacaze-Duthiers, Nephromyces was given several “identities” until it was finally
placed in Apicomplexa using molecular phylogenetics (Saffo et al. 2010). Part of
the confusion over its taxonomic affinity was because Nephromyces inhabits the
renal sac, a structure unique to the molgulid tunicates. While the function of the
renal sac in not understood, it contains high levels of uric acid and calcium
oxalate (Saffo and Lowenstam 1978). Based on the metabolic capacity of
Nephromyces, it appears to use uric acid for the purpose of primary carbon and
nitrogen acquisition (Chapter 2). In order to supplement a diet of uric acid,
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Nephromyces relies on bacterial endosymbionts for the biosynthesis of
metabolites from pathways missing from its genome (Chapter 3). Three different
types of bacterial endosymbionts have been found in the genus Nephromyces, an
alphaproteobacteria in Rickettsia, a betaproteobacteria in Bordetella, and a
bacteroidetes in the family sphingobacteriaceae (Chapter 3). Despite genomic
data, which indicates that these different types of bacteria are not functionally
equivalent, no species of Nephromyces has been shown to have more than one
type of bacterial endosymbiont (Seah et al. 2011).
Based on preliminary genomic and transcriptomic sequencing of
Nephromyces it became apparent that there was a surprising amount of genetic
diversity in the genus. In addition to the high levels of genetic diversity,
Nephromyces also had high incidences of multi-species infections within
individual renal sacs. Attempts to culture single species infections and limited
species (3-5 isolates) infections in the lab were met with mixed success, but even
limited species populations did poorly compared to the cultures that contained
species numbers that better approximated wild samples.
To quantify the biological diversity and the incidence of multispecies
Nephromyces infections found in molgulid tunicates, we used an amplicon
sequencing approach. Because polymorphic 18S rDNA sequences have been
reported in Plasmodium (Li et al. 1997), we targeted the Cytochrome Oxidase I
(CO1) mitochondrial gene, as well as the 18S. In order to account for the
endosymbiotic diversity within the Nephromyces population, we also targeted the

108

bacterial 16S rRNA. Genomic data indicate that members of Rickettsia, Bordetella,
and sphingobacteriaceae are endosymbionts of Nephromyces isolates, but their
diversity is unknown.

Methods
Fifty Molgula manhattensis tunicates were collected from a single floating
dock located in Greenwich Bay, RI (41° 39' 11.009" N 71° 27' 5.843" W), over a
period of 4 weeks in the summer of 2016. Renal sacs were dissected out of the
animals and contents were collected by a micropipette and placed in 1.5 ml
Eppendorf tubes. Dissecting tools were sterilized in a 10% bleach solution for 15
min and then rinsed between tunicates. Sample tubes were immediately frozen in
liquid nitrogen for five minutes and subsequently stored at -80° C.
DNA was extracted using the method described in (Chapter 2). Extracted
DNA was stored at -20° C. The 18S rRNA primers and CO1 primers were designed
to target Nephromyces based on available genomic data (Chapter 3). The
universal 16S rRNA primers from (Klindworth et al. 2013) were used to amplify
the bacterial endosymbionts from Nephromyces. The Illumina adaptor sequence
was added to the start of each primer resulting in the following sequences 18Sf
(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCGGTAATTCCAGCTCC), 18Sr
(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTGCTTTCGCAGTAGTYYGTCTTT
), CO1f
(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGYGGWGTAGGWSCWGGWTGGA),
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CO1r
(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACTTCWGGATGWCCAAARAA)
16Sf (TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG),
16Sr
(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC).
For each sample, PCR was performed with all three primer sets with the
following cycle 94° C 2 min (94° C 30 sec, 55° C 30 sec, 72° C 45 sec) x 35, 72° C 5
min. Resulting PCR products were visually inspected on an agarose gel and
quantity estimated with a nanodrop. Twenty microliters of PCR product from
each of the three primer sets was pooled into a single tube corresponding to an
individual tunicate. The pooled sample was cleaned using the ampure bead
purification with a 0.7% solution of Agencourt AMPure beads (Beckman Coulter).
The addition of well specific adaptors, library preparation, and sequencing was
done at the URI genomic sequencing center on the Illumina MiSeq platform.
Sequence data were de-multiplexed prior to analysis. Bduck from the
bbmap suit of tools was used to bin reads based on CO1 primers (Bushnell 2014).
The universal 18S rRNA and 16S rRNA primers were too conserved for reliable
binning based on primers, so reads were screened against the PR2 database
using the NCBI’s magicblast (Boratyn et al. 2018). Sequences with an 85% ID and
35% coverage were classified as 18S sequences and binned into a new file
composed of 18S reads. Adaptors and primer sequences were remove from the
forward and reverse reads from each of the three read sets using bduck.
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Cleaned and binned read sets were individually processed in R using
dada2 with the pool=”pseudo” setting (Callahan et al. 2016). Assembled 18S and
16S were assigned taxonomies with the PR2 database (Guillou et al. 2013).
Cytochrome oxidase 1 (CO1) sequences were assigned taxonomy using BLASTx
against NCBI’s refseq_protein database. All 18S and CO1 sequences that were not
apicomplexan were removed from the count table, taxonomy table, and sequence
files. Remaining sequences were aligned with MAFFT (Katoh and Standley 2013)
to 16S rRNA sequences from the three known bacterial endosymbionts found in
Nephromyces. Reference sequences were trimmed to the amplicon sequence
length and CD-hit was used to cluster sequences with 85% sequence identity. All
bacterial sequences, which did not cluster were deemed contamination and
removed from count table, taxonomy table, and sequences file.
Remaining 18S and CO1 sequences were aligned with MAFFT and
trimmed to the same length. Sequences were clustered at 100%, 99%, 98%, 97%,
96%, 95%, 94% sequence identity levels using CD-hit (Li and Godzik 2006).
Sequences from 18S, CO1 clusters and 16S bins corresponding to endosymbiont
type were processed individually in R. Figures were made in R using ggplot
(Wickham 2016).

Results
The amplicon sequencing run resulted in 25,895,690 reads with average
reads per sample of 137,743. After binning there were 4,930,010 CO1 reads,
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6,491,918 18S reads, and 14,468,228 16S reads. Following assembly in dada2
and decontamination there were 1,876,107 sequences corresponding to 329
amplicon sequence variants (ASVs) for 18S, 1,522,378 sequences corresponding
to 188 ASVs for CO1, and 62,905 sequences with 152 ASVs for 16S.
Of the 329 18S ASVs there is an average of 79.26 ASVs per tunicate
individual with a max of 145 ASVs and a min of 34 ASVs. When clustered at the
more taxonomically relevant 98% identity there are 23 clusters with an average
of 5.1 per tunicate individual with a max of 11 and a min of 3 (Figure 7). The most
common ASVs were seen in 59.57% of samples the least common in 2.12%, when
clustered at 98% these numbers rise to 86.17% and 2.12%.
There is a total of 188 CO1 ASVs with an average of 52.8 ASVs per
tunicate a max of 101 and a min of 16. When clustered to the 98% identity level
there are a total of 26 clusters an average of 6.24 and 10/2 max/min (Figure 8).
The most common AVSs were found in 53% of tunicates sampled and the rarest
ASVs were in 2%. After clustering at 98% the most common clusters were in
75.5% of tunicates the rarest in 2%.
From a total of 152 16s ASVs classified as Nephromyces bacterial
endosymbionts 49 were recovered from Bordetella, 89 from Rickettsia, and 14
from sphingobacteriaceae. The average number of 16S ASVs per tunicate is 13.94
with a max of 49 and a min of 0 (Figure 9). Forty percent of samples contained all
three types of bacterial endosymbiont and 90% contained at least two of the
bacterial endosymbiont types. There were two samples, which did not contain
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Figure 7) Grouped scatterplot of Nephromyces 18s rRNA ASV’s clustered
at different percent identity levels. Each dot represents the number of
ASV’s from an individual tunicate sample, squares indicate mean per
sample (labeled to the side), and error bars indicate one standard
deviation. Without clustering the average number of ASV’s is 79.26 per
sample and max of 145 and a min of 34. When clustered at 98% identity
the average number of sequences per sample falls to 5.1 with a max of
11 and a min of 3.

113

100

Number of Sequence per Sample

75

52.8
50

25

7.94

6.24

6.24

5.4

5.38

4.68

0
100

99

98

97

96

95

94

Sequence Clusters based on Percent Identification

Figure 8) Grouped scatterplot of Nephromyces COI ASV’s clustered
at different percent identity levels. Each dot represents the number
of ASV’s from an individual tunicate sample, squares indicate mean
per sample (labeled to the side), and error bars indicate one
standard deviation. Without clustering the average number of ASV’s
is 52.8 per sample and max of 101 and a min of 16. When clustered
at 98% identity the average number of sequences per sample falls
to 6.24 with a max of 10 and a min of 2.
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Figure 9) Grouped scatterplot of 16s rRNA ASV’s from Nephromyces
bacterial endosymbionts. Purple is all bacterial combined, blue is
the Bordetella only, red is Rickettsia, and green in
sphingobacteriaceae. Each dot represents the number of ASV’s
from an individual tunicate sample, squares indicate mean per
sample (labeled to the side), and error bars indicate one standard
deviation. An average of 13.98 bacterial ASV’s per sample with 7.08
Bordetella, 5.1 Rickettsia, and 1.8 sphingobacteriaceae.
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any ASVs assigned as Nephromyces bacterial endosymbionts.
Of the 25 samples that contained two bacterial endosymbionts the
Bordetella type was in 23 of the samples, Rickettsia was in 21 of the samples, and
the sphingobacteriaceae type was present in 6 of the samples. Bordetella and
Rickettsia were found together in 76% (19) of renal sacs with two detected
bacterial endosymbiont types, Bordetella and sphingobacteriaceae in 16% (4),
and Rickettsia and sphingobacteriaceae in 8% (2).

Discussion
The high numbers of ASVs obtained in this study reveal that Nephromyces
is extremely diverse, and in all instances, Nephromyces infections are multispecies infections. There was one renal sac that only contained a single 18S rRNA
sequence, but that renal sac had multiple CO1 sequences and is likely the result of
poor 18S PCR amplification of this sample. The diversity observed from amplicon
sequencing is extreme, but it is supported by genomic and transcriptomic
sequencing on Nephromyces (Chapter 2), as well as by cloning of full-length 18S
sequences. Despite the substantial diversity, the results are consistent across
multiple datasets. The different number of 18S and CO1 ASVs indicate that each
Nephromyces species encodes multiple copies of 18S with different sequences, as
previously described from Plasmodium (Li et al. 1997). While CO1 is also likely
found in multiple copies in a cell, based on genomic data we do not have any
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reason to suspect that CO1 copies differ in sequence. A similar level of diversity is
observed among the 16S ASVs, which is consistent with a vertically transmitted
bacterial endosymbiont.
When ASVs for 18S and CO1 are clustered at a 98% sequence identity to
give an approximate species number, we estimate that there are an average of ~5
different Nephromyces species per M. manhattensis host, with some M.
manhattensis containing as many as 10-11 Nephromyces species. Whereas
multispecies apicomplexan infections are relatively common (Anderson et al.
2000; Lee et al. 2011; Arnott et al. 2012; Lalremruata et al. 2017), the diversity
found among Nephromyces infecting a single host species is striking. The precise
reasons for such high diversity are not known. However, we hypothesize that
high levels of diversity may be due to the dependence of Nephromyces species on
essential amino acids, co-factors, and vitamins produced by their bacterial
endosymbionts.
Based on the different metabolic capabilities of the Nephromyces
bacterial endosymbionts, we postulated that Nephromyces might be dependent
on metabolites produced by bacterial endosymbionts in conspecifics (Chapter 2).
The high proportion of tunicates containing at least two of the bacterial
endosymbiont types, 90%, supports this hypothesis. Only two samples did not
contain any bacterial endosymbionts and three contained only one type of
bacterial endosymbiont. This may be due to sampling error and the
endosymbionts were either not amplified in the initial PCR, or one endosymbiont
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was preferentially amplified.
In samples where only two types of bacterial endosymbionts were
detected the Bordetella/Rickettsia pairing were the most common (76% of renal
sacs with two bacterial types). Based on the genomes of the endosymbionts
Bordetella encodes the most complete vitamin and amino acid biosynthesis
capabilities, and is predicted to be providing essential amino acids and vitamins
to Nephromyces. Despite a largely complete genome assembly of the Rickettsia
symbiont, its functional role is not clear. It encodes the least complete amino acid
and vitamin synthesis of any of the three endosymbiont types found in
Nephromyces, and all the amino acids and vitamin biosynthesis capabilities are
also encoded by both the Bordetella and sphingobacteriaceae. However, given the
high prevalence of Rickettsia in our samples and its presence in 82% of renal sacs
with only two types of symbionts, it does appear that the Rickettsia symbionts are
providing an essential function not encoded by either the Bordetella or the
sphingobacteriaceae.
Based on previous (Seah et al. 2011) and our own microscopy results
(Figure 10), no Nephromyces individual has been observed containing multiple
types of bacterial endosymbiont. If our hypothesis is correct and Nephromyces
needs metabolites from multiple symbiont types, Nephromyces species with dual
endosymbionts could survive in hosts without conspecifics, as has been
repeatedly observed in insects (McCutcheon and Moran 2007; Bennett and
Moran 2013; Rao et al. 2015; Brown et al. 2018). One possibility is that since the
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Nephromyces labeled
with bacteroidetes
speciﬁc 16S rRNA FISH
probes (630x
magniﬁcation)
20 µm

Nephromyces labeled
with α-proteobacteria
speciﬁc 16S rRNA FISH
probes (1000x
magniﬁcation)
20 µm

Figure 10) Photos of Nephromyces taken on a Zeiss confocal microscope
labeled with two 16S rRNA FISH probes, one targeting
sphingobacteriaceae (green, top, 630x) and Rickettsia (red, bottom,
1000x). Images from left to right were captured under fluorescence,
TPMT, and both overlaid. The top pictures are of the tachyzoite life stage
and the bottom show the oocyst or merozoite stage. Bacterial
endosymbionts have been observed in all of Nephromyces life stages, but
no Nephromyces has been shown to contain multiple types of bacterial
endosymbiont. (Courtesy of Liz Hunter)
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bacterial endosymbionts of Nephromyces are vertically transferred through the
oocyst stage, there simply may not be enough space for multiple endosymbiont
cells. In insects with dual endosymbionts the bacteria are typically vertically
transmitted through a much larger egg cell than the oocyst stage of Nephromyces.
Alternatively, it may be disadvantageous to carry multiple endosymbionts when
multispecies infections are universal in molgulid renal sacs. Given the extreme
Muller’s ratchet known to occur in bacterial endosymbionts (Moran 1996), it may
be evolutionarily cheaper to maintain one bacterial endosymbiont and rely on
conspecifics with other types of bacterial endosymbiont. Such a system could not
evolve unless there was a high probability of a multispecies infection of any given
host.
In a system with so much co-dependence there is the potential for
“cheaters” to develop and indeed we have found Nephromyces species, that do not
seem to contain any bacterial endosymbiont and are presumed to parasitize the
system. The absence of bacterial endosymbionts is based on single species
isolates and fluorescent in situ hybridization (FISH) microscopy (Figure 6), but as
the lack of signal in FISH microscopy is not definitive of absence, this has not yet
been confirmed.
Given the high sequence diversity among our Nephromyces datasets,
universal prevalence of multispecies infections within individual renal sacs, and
that 90% of renal sac samples contain at least two types of bacterial
endosymbionts, Nephromyces may not be capable of establishing single species
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infections in the wild. Combined with the metabolic capabilities of the different
bacterial endosymbiont types (Chapter 2), Nephromyces likely exists as a codependent species complex or species swarm. This raises interesting questions
about the evolution of co-dependence and co-evolution of Nephromyces species
that require further exploration.
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CHAPTER 5
CONCLUSION
The impetus for this research was the characterization of Nephromyces
symbiotic relationship with its host (Saffo et al 2010). In a phylum composed of
parasites Nephromyces alone provided greater benefits to its host than costs. This
characterization was premature and no work was done to demonstrate the
details of the relationship between Nephromyces and Molgula tunicates. As is the
case with most symbiosis, the relationship between organisms is complex and
can be dependent on external factors. Despite the extensive research into
Nephromyces there is not enough support to either confirm or refute the
classification of Nephromyces/Molgula relationship as mutualistic. However, the
claim of mutualism was entirely based on the unusual epidemiology of
Nephromyces and our work does provide insight into how Nephromyces is able to
maintain nearly universal prevalence, reach extremely high cell densities, and
remain avirulent.
Central to Nephromyces epidemiology is Nephromyces ability to degrade
purines into glyoxylate and subsequently convert glyoxylate into malate,
pyruvate, and glycine. This pathway provides a primary nitrogen, carbon and
energy source from uric acid. Malate is part of the citrate cycle critical in the
generation of ATP and NADH or it can be converted into oxaloacetate for
gluconeogenesis. Pyruvate is extremely versatile and is easily converted into fatty
acids, acetyl-CoA, or gluconeogenesis. Glycine, the most basic amino acid, can be
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processed into other amino acids and represents nitrogen capture. Tunicates
have lost the ability to degrade purines past uric acid essentially making uric acid
nitrogenous waste. By using a metabolic waste product, for the host, as a primary
substrate, Nephromyces can presumably utilize uric acid at little to no cost to the
host. This novel substrate decouples the relationship between high parasite
growth and virulence, which Nephromyces to reach high cell densities and remain
avirulent.
With the exception of malate synthase Cardiosporidium encodes the same
purine degradation capabilities as Nephromyces and is capable of converting uric
acid into pyruvate and glycine. However, due to the different hosts,
Cardiosporidium has access to far smaller quantities of uric acid than
Nephromyces and therefore must rely on additional sources of nutrition from the
host. Molgula storage and concentration of uric acid to the renal sac has enabled
Nephromyces to develop its unusual uric acid based metabolism.
It has been proposed that the mutualistic benefit to its host is the
processing of indigestible uric acid. This may be the case, but it is likely an
oversimplification. First, it is unclear if Molgula ever recovers anything back from
the uric acid imported into the renal sac. It is possible that valuable metabolites
like amino acids or vitamins are exported out of the renal sac, but this has not
been demonstrated. Second, the purpose of the renal sac has not been
established. Sequestration of uric acid to the renal sac may have developed over
time as a way of ridding Molgula of an apicomplexan blood parasite; by providing
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a parasite with a metabolic waste product as an alternative to infecting blood
cells. In this case, Molgula benefits from losing a parasite, but this relationship is
hardly mutualistic, it is more of a clever host defense mechanism. Third,
Nephromyces has been shown to express xanthine dehydrogenase at high levels
(99 percentile of all gene expression). Hypoxanthine is the interchange between
purine recycling and purine degradation. Xanthine dehydrogenase converts
hypoxanthine to xanthine and xanthine to uric acid; this represents the beginning
of purine degradation. The competing enzyme, hypoxanthine-guanine
phosphoribosyltransferase (HGPRT), converts hypoxanthine to inosine
monophosphate (IMP) and from IMP to adenine or guanine. Since the source of
uric acid within the renal sac has been shown to be from the tunicate it is curious
that Nephromyces would have such high expression of xanthine dehydrogenase
(Saffo 1988). A possible explanation of Nephromyces high expression of xanthine
dehydrogenase is as a form of host manipulation. By outcompeting host
production of HGART, Nephromyces forces greater production of uric acid than
may be ideal for the host. This is potentially a cost to the host, particularly in
times when purines are scarce
Almost as surprising as an apicomplexan with a uric acid based
metabolism was where the genes in the purine degradation pathway come from.
All other sequenced apicomplexans have lost the purine degradation pathway. It
was thought that the high levels of uric oxidase measured inside the renal sac
originated from the Nephromyces bacterial endosymbionts. Our data conclusively
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show that the genes involved in purine degradation are encoded in Nephromyces
and Cardiosporidium genome. Additionally, these genes are not the result of a
gene transfer event, but are the genes that were present when Apicomplexa split
with the Chromerids. This pathway had previously been attributed to the
bacterial endosymbionts, but is in fact encoded by
Nephromyces/Cardiosporidium. If the bacterial endosymbionts are not being
utilized for purine degradation then they must be contributing in another way.
Using 16s rRNA we have determined that the α-proteobacteria in
Nephromyces and Cardiosporidium are monophyletic and therefore present when
Nephromyces/Cardiosporidium lineages split. This indicates that there may be
some aspect of ascidian biology that makes maintaining a bacterial endosymbiont
worthwhile. Particularly as bacterial endosymbionts are not found in other
apicomplexan lineages. We have yet to determine exactly what the critical
function of the α-proteobacteria is, however because it is maintained in
Cardiosporidium, which is intracellular, and in Nephromyces, which is
extracellular in the renal sac, the function seems to be not exclusively connected
to renal sac biology.
We do not have any genomic data on the Cardiosporidium αproteobacteria endosymbiont at this time, making any comparisons between
Nephromyces and Cardiosporidium α-proteobacteria endosymbiont is
preliminary. The genome from the α-proteobacteria in Cardiosporidium will need
to be sequenced and assembled for more robust analysis. Preliminarily based on

127

RNAseq data, Cardiosporidium α-proteobacteria appears to have more
biosynthetic capabilities than Nephromyces’. This includes several essential
amino acids and vitamins not present in the α-proteobacteria of Nephromyces.
In addition to α-proteobacteria in the genus Rickettsia, the genus
Nephromyces also maintains a β-proteobacteria in the genus Bordetella and a
Bacteroidetes bacterial endosymbiont in the family Sphingobacteriaceae. We
have assembled the complete genome for Nephromyces Sphingobacteriaceae
endosymbiont and Nephromyces Bordetella. NBe and Nβe have the biosynthesis
capabilities for a number of amino acids and vitamins, which are not encoded in
the Nephromyces genome. Providing Nephromyces with amino acids and vitamins
eliminates the need for Nephromyces to scavenge those metabolites from the
host. Presumably, this reduces Nephromyces dependence on the host and also
provides a reliable source of these metabolites, which may not be available in the
renal sac.
Despite the three types of bacterial endosymbionts (Nαe, NBe, Nβe) being
inside different Nephromyces species, we do see some similar patterns to the dual
endosymbiont example in glassy winged sharpshooters. While we do not see the
single pathway integration where one symbiont produces fabF and the other
produces the remainder of the pathway. The lack of overlapping functions seems
to indicate that despite being in different Nephromyces species, that the close
proximity in the renal sac is sufficient to allow for metabolite exchange between
bacterial endosymbionts in conspecific Nephromyces species. The result is
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completely unexpected and represents an unusual evolutionary quirk for the
community inside the renal sac. If the renal sac community is in close enough to
allow for the development of non-overlapping functions in bacterial
endosymbionts in different species, it must be concluded that conspecific
Nephromyces species are frequently exchanging metabolites. Based on our
isolation and culturing experiments, we hypothesize that Nephromyces may be
incapable of existing in isolation without conspecific Nephromyces species which
contain a different type of bacterial endosymbiont than their own. We have not
found a Nephromyces species containing two different types of bacterial
endosymbionts, however we can’t conclusively say that Nephromyces species
with dual endosymbionts don’t exist.
It remains unclear why a system dependent on conspecifics would
develop when maintaining multiple endosymbionts would eliminate the need for
competing Nephromyces species and guarantee that whatever host Nephromyces
infected would be able to be colonized independent of conspecifics. Perhaps the
cost of maintaining multiple endosymbionts is greater than the cost of sharing.
Indeed we have found that some Nephromyces species do not maintain any
endosymbiont and presumably parasitize the community, i.e. relying on the
products of other Nephromyces’ bacterial endosymbionts. In order for such a
system to develop any given Nephromyces species must colonize a renal sac
where there will be complimentary Nephromyces species. The rate at which this
happens needs to be greater than the cost of maintaining two endosymbionts
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otherwise we would presumably see dual endosymbiont Nephromyces species.
A number of factors seem to contribute to the development of this codependent species complex. First, the infection prevalence of Nephromyces is
nearly 100% nearly year round. Second, Nephromyces seems capable of infecting
at any point in the tunicates adult life stage. Third, we have uncovered a
staggering amount of Nephromyces diversity. Some individual M. manhattensis
contain as many as 11 distinct Nephromyces species. Based on amplicon
sequencing data there is an estimated 60 species of Nephromyces in Greenwich
Bay, RI alone. The extreme amount of both species and sequence diversity in
Nephromyces is not observed in Cardiosporidium and is likely connected to the
unusual renal sac community dynamics. With so many species, each with a
lineage of vertically inherited bacterial endosymbionts, we predict that even
bacterial endosymbionts of the same type may differ widely in their metabolic
capabilities. Presumably bacterial endosymbionts, even within the same taxa,
could contribute different metabolites to the renal sac community. Given the
tremendous amount of diversity, our sequencing of just a few of the different
bacterial endosymbionts is insufficient to develop a complete picture of the
intricacies of this system. It is likely that different bacterial endosymbionts within
the same type may differ in metabolic capabilities.
Adding to our uncertainties we do not currently know if there are any
genetic barriers preventing reproduction between different Nephromyces species.
Sexual reproduction occurs inside the renal sac in the presence of multiple other
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Nephromyces species; interbreeding between species seems likely, unless there
are strong genetic barriers between species. Indeed, the proximity and the
interdependence of the system in general seems to indicate a great deal of
interspecific breeding.
As our genomic assemblies of Nephromyces are incomplete, due in large
part to the difficulties in assembling a metagenome of closely related species, we
are not able to say how Nephromyces unusual epidemiology, environment, and
community composition has affected its genome. Given the difficulties with
Nephromyces sequencing and assembling, the genome of Cardiosporidium is a
more attractive target. There are plans to sequence the genome, but currently we
do not have any genomic data for Cardiosporidium. We do have good
transcriptomic data for both Nephromyces and Cardiosporidium, meaning we can
compare the protein coding genes of Nephromyces and Cardiosporidium to each
other, as well as to other apicomplexans.
Nephromyces and Cardiosporidium have very similar metabolic capabilities
based on KEGG pathway analysis. This includes purine degradation to glyoxylate
and then to glycine and pyruvate, which shows that this pathway was being
utilized before Nephromyces colonized the renal sac. Based on expression data,
this pathway is more important for Nephromyces than Cardiosporidium.
Expression of these genes in Cardiosporidium is still high (80-90th percentile, the
highest expression of all Cardiosporidium genes). Such high expression suggests
that Cardiosporidium has access to high concentrations of uric acid inside
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tunicate blood cells, which may still represent an important source of carbon and
nitrogen.
Despite the differences in epidemiology, habitat, and life histories between
Nephromyces and Cardiosporidium, their metabolomes are quite similar,
including the complete apicomplexan infection machinery. While Nephromyces
may have a mutualistic relationship with its host, it is entering the renal sac like
an apicomplexan parasite. Related to this infection machinery, both
Cardiosporidium and Nephromyces have the same known dense granule,
microneme, and rhoptry proteins. Proteins from these organelles have been
shown in other apicomplexans to be important for invasion, immune evasion, and
host manipulation. Based on Orthofinder analysis we find surprisingly few
lineage-specific genes that might be involved in dealing with an ascidian immune
system. We also find few genes without orthologous in either Nephromyces or
Cardiosporidium compared to other apicomplexans. It is possible that these genes
without orthologous are involved in the specific challenges imposed by
intracellular ascidian life cycle in Cardiosporidium and the renal sac for
Nephromyces. However, because these genes do not have known orthologs
studied in other species, we are unable to determine function bioinformatically.
Nephromyces and Cardiosporidium have a large number of protein
coding genes and metabolic capabilities. With respect to gene number and
function Nephromyces/Cardiosporidium are similar to Toxoplasma. This is
surprising because phylogenetically Nephromyces/Cardiosporidium belong to
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hematozoa, the lineage that contains Plasmodium, Babesia, and Theileria. The
other members of hematozoa have lost peroxisomes, which we have
demonstrated in Nephromyces/Cardiosporidium. Additionally, hematozoa show
more metabolic reduction. Babesia, and Theileria in particular have the smallest
genomes of any apicomplexan and the fewest number of protein coding genes
(Kappmeyer et al. 2012; Brayton et al. 2007). The placement of
Nephromyces/Cardiosporidium in hematozoa adds to the growing body of
support that, these gene losses in Apicomplexa were gradual and lineage specific,
with losses occurring later than predicted. These gene losses often occur in
parallel in different lineages confounding assumptions based on the most
parsimonious solutions. Indeed we see in nearly every apicomplexan lineage,
lineage specific orthologs present only in chromerids and lost in all other
apicomplexans. In the case of Nephromyces/Cardiosporidium lineage specific
orthologs include purine degradation and de novo purine biosynthesis. These
retained pathways appear to have particular significance to
Nephromyces/Cardiosporidium, but lineage specific gene retention is consistent
with the general patterns observed across the phyla Apicomplexa.
This work represents a step toward fully understanding the
complexities of this unusual system, but leaves many questions unresolved. First,
sequencing the genome of both Cardiosporidium and Cardiosporidiums bacterial
endosymbiont would allow for more robust comparison to Nephromyces
Rickettsia endosymbiont. This would provide a better understanding of the
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evolutionary history of both Nephromyces and its endosymbionts. Secondly, the
biochemical pathways were based on bioinformatics with minimal confirmation
at the protein level, the presented pathways need to be confirmed. Another step
would be to show that uric acid is central to the metabolism of Nephromyces. A
potential method to demonstrate this pathway is by injecting isotope labeled uric
acid into the renal sac, and then using a new method for identifying the proteins
from a specific organism in a metaproteomic sample (Kleiner et al. 2018). If this
could be adapted to this system we could potentially confirm uric acid as the
primary carbon and nitrogen source for Nephromyces, and determine the
metabolites exchanged with the bacterial endosymbiont. This could also show if
any of the carbon or nitrogen from uric acid makes its way across the renal wall
back to the tunicate. If useful metabolites are exported or leaked out of the renal
sac this would be the best support yet that the relationship between Nephromyces
and Molgula is in fact mutualistic.
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APPENDICES

Appendix Table 1) Nephromyces peroxisomal-related genes Identified PeroxDB and KAAS.
Complete transcripts were run through Wolf PSORTII, Ppero, TargetP, Topcons and Predotar
to identify possible signal motifs inclding PTS1
Gene
MLS
MLS
MLS
MLS
MLS
MLS
MLS
MLS
MLS
MLS
MDH
PEX1
PEX2
PEX2
PEX4
PEX4
PEX5
PEX5
PEX7
PEX7
PEX7
PEX7
PEX7
PEX10
PEX12
PEX12
PEX12
PEX14
PEX14
MPV17
MPV17
MPV17
ABCD
ABCD
ABCD
ABCD
ABCD
ABCD3

Ppero pts1 TargetP topcons
predotar
PSORTII
No
_
Yes
possibly plastid
cyto: 8, extr: 5, chlo: 1
No
_
Yes
none
cyto: 11, nucl: 2, vacu: 1
M 3, cyto_mito:
No
possibly
chlo: 5.5, chlo_mito: 5.33333, No
mito: 4, cyto:
2.83333,mitochondrial
plas: 1
No
M
No
possibly mitochondrial
chlo: 9, mito: 4, plas: 1
Nocysk_plas: _1
No
none
cyto: 8, nucl: 3, vacu: 1, golg: 1,
No
none
cyto: 7, nucl: 3, chlo: 2, golg: 1,No
cysk_plas: _1
No
_
No
possibly plastid
cyto: 8, extr: 5, chlo: 1
Noplas: 1 M
No
possibly mitochondrial
chlo: 6, cyto: 3, mito: 3, nucl: 1,
_ 1, cysk:No1
possibly plastid
cyto: 6, extr: 3, chlo: 1, nucl: 1,No
mito: 1, E.R.:
M 3, cyto_mito:
No
possibly
chlo: 5.5, chlo_mito: 5.33333, No
mito: 4, cyto:
2.83333,mitochondrial
plas: 1
S
No
none
extr: 9, chlo: 2, nucl: 1, cyto: 1,No
mito: 1
S 1, vacu:
No1
none
chlo: 5, nucl: 2, cyto: 2, plas: 2,No
mito: 1, extr:
No
_
No
none
nucl: 13.5, cyto_nucl: 7.5
_
No
none
nucl: 6, cyto: 5, mito: 1, extr: 1,Nocysk: 1
_ 1
No
none
cyto: 5, chlo: 3, nucl: 2, plas: 2,No
mito: 1, extr:
_ 1
No
none
cyto: 5, chlo: 3, nucl: 2, plas: 2,No
mito: 1, extr:
M
No
possibly mitochondrial
mito: 7, chlo: 4, nucl: 2, cyto: 1No
none
plas: 5, nucl_plas: 4.5, cyto: 3,No
chlo: 2, nucl:_ 2, mito:No
1, extr: 1
No
_
No
none
nucl: 7, cyto: 7
No
_
No
none
nucl: 14
No
_
No
none
nucl: 14
_
No
none
extr: 7, nucl: 4, chlo: 2, cyto: 1No
_
No
none
extr: 7, nucl: 4, chlo: 2, cyto: 1No
No
S
No
possibly ER
nucl: 12, extr: 2
_
No
none
plas: 7, E.R.: 4, cyto: 1, mito: 1,No
extr: 1
_ 1, plas:No
none
nucl: 3, extr: 3, vacu: 2, E.R.: 2,No
golg: 2, cyto:
1
_ 1, plas:No
none
nucl: 3, extr: 3, vacu: 2, E.R.: 2,No
golg: 2, cyto:
1
No
_
No
none
nucl: 10, cyto: 3, plas: 1
Nocyto: 1.5 _
No
none
pero: 11, cyto_nucl: 2, nucl: 1.5,
Perhaps
yes1, golg:
_ 1
No
possibly plastid
E.R.: 5, plas: 3, chlo: 2, vacu:
2, pero:
No
S
No
none
plas: 8, vacu: 4, E.R.: 2
S 1, extr:
No1
ER
chlo: 4, nucl: 3, vacu: 2, E.R.: 2,No
cyto: 1, mito:
_
No
none
plas: 9, vacu: 2, nucl: 1, cyto: 1,NoE.R.: 1
_ 1
No
none
plas: 5, vacu: 4, E.R.: 2, nucl: 1,No
cyto: 1, mito:
_
No
none
plas: 9, mito: 2, chlo: 1, E.R.: 1,No
pero: 1
_ 1, golg:
No1
none
chlo: 4, vacu: 4, plas: 2, nucl: 1,No
mito: 1, extr:
_ 1, golg:
No1
none
chlo: 4, vacu: 4, plas: 2, nucl: 1,No
mito: 1, extr:
_
No
none
chlo: 7, cyto: 3, mito: 3, pero: 1No
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ABCD3
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACAA1
ACOX
ACOX
ACOX
ACOX
ACOX
ACOX
ACOX
ACOX
ACOX
ACOX
ACOX
AGXT
AGXT
AGXT
AGXT
AGXT
AK
AK
AK
AK
ANT

_
No
possibly ER
plas: 8, vacu: 3, E.R.: 2, mito: 1No
Noplas: 1, pero:
_ 1
No
none
cyto: 8, chlo: 2, nucl: 1, mito: 1,
No 3, nucl:
_ 1.5, plas:
No 1, vacu: 1 none
chlo: 4, cyto: 3.5, golg: 3, cyto_nucl:
No 3, nucl:
_ 1.5, plas:
No 1, vacu: 1 none
chlo: 4, cyto: 3.5, golg: 3, cyto_nucl:
Noplas: 1, pero:
_ 1
No
none
cyto: 8, chlo: 2, nucl: 1, mito: 1,
No
mitochondrial
chlo: 11.5, chlo_mito: 7, mito:No
1.5, cyto: 1M
No
_
No
none
chlo: 9, mito: 3, nucl: 2
No
mitochondrial
chlo: 11.5, chlo_mito: 7, mito:No
1.5, cyto: 1M
Nocysk: 1, golg:
_ 1
No
none
chlo: 5, nucl: 4, cyto: 2, mito: 1,
_
No
none
cyto: 6, chlo: 4, nucl: 2, plas: 1,No
extr: 1
_
No
none
cyto: 6, chlo: 4, nucl: 2, plas: 1,No
extr: 1
Nocysk: 1, golg:
_ 1
Yes
none
chlo: 5, nucl: 4, cyto: 2, mito: 1,
Nocysk: 1, golg:
_ 1
No
none
chlo: 5, nucl: 4, cyto: 2, mito: 1,
_
No
none
nucl: 7, cyto: 4, mito: 2, chlo: 1No
_
No
none
nucl: 7, cyto: 4, mito: 2, chlo: 1No
_
No
none
nucl: 7, cyto: 4, mito: 2, chlo: 1No
_
No
none
nucl: 7, cyto: 4, mito: 2, chlo: 1No
_
No
none
nucl: 7, cyto: 4, mito: 2, chlo: 1No
_
No
none
nucl: 7, cyto: 4, mito: 2, chlo: 1No
_
No
none
nucl: 7, cyto: 4, mito: 2, chlo: 1No
Nocysk: 1 _
No
none
nucl: 6, mito: 4, cyto: 2, chlo: 1,
Nocysk: 1 _
No
none
nucl: 6, mito: 4, cyto: 2, chlo: 1,
_
No
none
cyto: 9, nucl: 2, mito: 2, plas: 1No
_ 1 No
none
cyto: 7.5, cyto_nucl: 5, E.R.: 4,No
nucl: 1.5, mito:
_ 1 No
none
cyto: 7.5, cyto_nucl: 5, E.R.: 4,No
nucl: 1.5, mito:
_
No
none
cyto: 9, nucl: 2, mito: 2, plas: 1No
No
_
No
none
pero: 11, cyto: 2, golg: 1
Yes
_
No
none
pero: 11, cyto: 2, golg: 1
Yes
_
No
none
pero: 11, cyto: 2, golg: 1
Yes
_
No
none
pero: 11, cyto: 2, golg: 1
Yes
_
No
none
pero: 11, cyto: 2, golg: 1
Yes
_
No
none
pero: 11, cyto: 2, golg: 1
Yes
_
No
none
pero: 11, cyto: 2, golg: 1
No
M
No
possibly mitochondrial
chlo: 11, mito: 3
_
No
none
cyto: 7, mito: 4, chlo: 1, extr: 1,Nogolg: 1
_
No
none
cyto: 8, mito: 4, chlo: 1, extr: 1No
M
No
possibly mitochondrial
chlo: 9, mito: 2, pero: 2, E.R.: 1No
M
No
possibly mitochondrial
chlo: 9, mito: 2, pero: 2, E.R.: 1No
_ 1, cysk:No
none
nucl: 8, cyto: 2.5, cyto_E.R.: 2,No
chlo: 1, mito:
1
_ 1, cysk:No
none
nucl: 8, cyto: 2.5, cyto_E.R.: 2,No
chlo: 1, mito:
1
_ 1, cysk:
No1
none
cyto: 7.5, cyto_E.R.: 5, chlo: 3,No
E.R.: 1.5, nucl:
Noextr: 1, pero:
_ 1
No
none
cyto: 5, nucl: 4, chlo: 2, mito: 1,
_
No
none
nucl: 5, chlo: 4, cyto: 3, extr: 1,No
cysk: 1
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ANT
ANT
ANT
ANT
CAT
CAT
CAT
CAT
CAT
CAT
CAT
CHY
CHY
CHY
CHY
CHY
CPK
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2
DECR2

_
No
none
nucl: 6, cyto: 4, chlo: 2, extr: 1,No
vacu: 1
Nochlo: 2, mito:
_ 1, extr:
No 1, vacu: 1 none
nucl: 5, cyto: 3.5, cyto_E.R.: 2.5,
_
No
none
nucl: 6, cyto: 4, chlo: 2, extr: 1,No
vacu: 1
Noextr: 1, vacu:
_ 1
No
none
nucl: 7, cyto: 3, chlo: 1, mito: 1,
Yes
_
No
none
pero: 12, cyto: 1, golg: 1
Yes
_
No
none
pero: 12, cyto: 1, golg: 1
Yes
_
No
none
pero: 12, cyto: 1, golg: 1
Noextr: 1, vacu:
_ 1, cysk_plas:
No
none
nucl: 7, pero: 2, chlo: 1, mito: 1,
1
No cysk_plas:
_ 1.5, mito:
No 1
none
nucl: 7, cyto: 2, pero: 2, cysk: 1.5,
No cysk_plas:
_ 1.5, mito:
No 1
none
nucl: 7, cyto: 2, pero: 2, cysk: 1.5,
No cysk_plas:
_ 1.5, mito:
No 1
none
nucl: 7, cyto: 2, pero: 2, cysk: 1.5,
S
No
possibly ER
chlo: 8, nucl: 2, extr: 2, plas: 1,No
E.R.: 1
S
No
possibly ER
chlo: 8, nucl: 2, extr: 2, plas: 1,No
E.R.: 1
No
M
No
none
chlo: 10, mito: 3, nucl: 1
No
M
No
none
chlo: 10, mito: 3, nucl: 1
Novacu: 1, cysk:
_ 1, golg:
No1
none
nucl: 6, cyto: 3, chlo: 1, mito: 1,
No
_
No
none
cyto: 12, nucl: 1, pero: 1
_ 1
No
none
cyto: 5, chlo: 4, extr: 2, nucl: 1,No
cysk: 1, golg:
S
chlo: 6.5, chlo_mito: 4.5, cyto:Yes
2, vacu: 2, mito:
1.5,No
plas: 1, extr: 1 ER
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes
_
No
none
pero: 10, cyto: 3, golg: 1
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
_
No
none
pero: 7, chlo: 3, cyto: 3, golg: 1Yes
_
No
none
pero: 7, chlo: 3, cyto: 3, golg: 1Yes
_
No
none
pero: 7, chlo: 3, cyto: 3, golg: 1Yes
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
_
No
none
pero: 7, chlo: 3, cyto: 3, golg: 1Yes
_ 1
No
none
cyto: 5, chlo: 4, extr: 2, nucl: 1,No
cysk: 1, golg:
Perhaps yes
S
No
possibly plastid
chlo: 13, plas: 1
S
No
none
chlo: 11, extr: 2, cyto: 1 Perhaps yes
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes chlo: 2, golg:
M 1 Yes
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes
_
No
none
pero: 10, cyto: 3, golg: 1
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Yes chlo: 2, golg:
M 1 No
none
pero: 7, cyto: 3.5, cyto_nucl: 2.5,
Perhaps yes
S
No
possibly plastid
chlo: 13, plas: 1
S
No
none
chlo: 11, extr: 2, cyto: 1 Perhaps yes
Perhaps
_
No
none
pero: 11, chlo: 1, nucl: 1, cyto:
1 yes
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DECR2
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DHRS4
DJP1
DJP1
DJP1
DJP1
DJP1
DJP1
E1.3.3.6
E1.3.3.6
E1.3.3.6
E1.3.3.6
ECH
ECH
ECH
ECH
ECH
ECH
ECH
ECH
ECH
ECH
ECH
ECH
ECH
ECH1
ECH1
ECH1
ECH1
ECH1

Perhaps
_
No
none
pero: 11, chlo: 1, nucl: 1, cyto:
1 yes
Yes
_
No
none
pero: 9, cyto: 4, nucl: 1
Yes
_
No
none
pero: 9, cyto: 4, nucl: 1
No 2, nucl:S1, mito: No
ER
chlo: 7, E.R.: 2.5, extr: 2, E.R._plas:
1
_
No
none
cyto: 12, mito: 1, cysk_nucl: 1 No
No
No
none
cyto: 10, chlo: 2, nucl: 1.5, cysk_nucl:
1.5 _
S 1
No
ER
extr: 5, chlo: 3, vacu: 3, nucl: 1,No
mito: 1, golg:
S 1
No
ER
extr: 5, chlo: 3, vacu: 3, nucl: 1,No
mito: 1, golg:
No 2, nucl:S1.5, cyto_nucl:
No
chlo: 6, E.R.: 2.5, extr: 2, E.R._plas:
1.5, mito: ER
1
No 2, nucl:S1, mito: No
ER
chlo: 7, E.R.: 2.5, extr: 2, E.R._plas:
1
No
_
No
none
chlo: 8, pero: 3, cyto: 2.5, cyto_nucl:
2
_ 1.5, golg:
No 1
none
pero: 6, cyto: 3.5, cyto_nucl: 3,Yes
chlo: 2, nucl:
Yes
_
No
none
pero: 11, cyto: 3
No
_
No
none
chlo: 12, extr: 2
Yespero: 2, nucl:
_ 1.5 No
none
chlo: 8, cyto: 2.5, cyto_nucl: 2.5,
_
No
none
cyto: 8, nucl: 4, mito: 1, pero: 1No
_
No
none
cyto: 8, nucl: 4, mito: 1, pero: 1No
_
Yes
none
nucl: 10, plas: 2, chlo: 1, extr: 1No
No
_
No
none
nucl: 10, cyto: 4
_
No
none
nucl: 6, cyto: 6, plas: 1, pero: 1No
No
_
No
none
nucl: 12, cyto: 1, plas: 1
M
No
none
chlo: 6, nucl: 4, cyto: 2, mito: 2No
No
possibly mitochondrial
extr: 7, chlo: 4, vacu: 1, golg: 1,No
cyto_nucl: _1
_
No
none
mito: 7, chlo: 5, nucl: 1, cyto: 1No
_
No
none
chlo: 7, mito: 4, nucl: 2, plas: 1No
No
_
No
none
mito: 8, nucl: 5, chlo: 1
No
_
No
none
mito: 8, nucl: 5, chlo: 1
Yes 2, nucl: _1.5, cyto:No
none
pero: 4, E.R.: 3, plas: 2, cyto_nucl:
1.5, chlo: 1, vacu:
1
Yescyto_nucl:
_ 1.5, chlo:
No 1, vacu: 1 none
pero: 5, E.R.: 3, plas: 2, nucl: 1.5,
Yescyto_nucl:
_ 1.5, chlo:
No 1, vacu: 1 none
pero: 5, E.R.: 3, plas: 2, nucl: 1.5,
_ 1
No
none
cyto: 6, E.R.: 3, nucl: 2, chlo: 1,No
mito: 1, extr:
Yes cyto_nucl:
_ 1.5, chlo:
No 1, vacu: 1 none
pero: 5, E.R.: 3, plas: 2, cyto: 1.5,
none
chlo: 5, cyto: 3.5, cyto_nucl: 3,No
plas: 2, extr:_ 2, nucl:No
1.5
_
No
none
E.R.: 3, pero: 3, nucl: 2.5, chlo:Yes
2, plas: 2, cyto_nucl:
2, vacu: 1
_
No
none
chlo: 4, cyto: 4, extr: 3, plas: 2,No
nucl: 1
_
No
none
E.R.: 3, pero: 3, nucl: 2.5, chlo:No
2, plas: 2, cyto_nucl:
2, vacu: 1
_1
No
none
chlo: 4, cyto: 4, plas: 2, extr: 2,Yes
nucl: 1, golg:
No
_
No
none
mito: 8, nucl: 5, chlo: 1
No 2.5, plas:
_ 1.5, mito:
No 1
none
cyto: 5, extr: 4, E.R.: 2.5, E.R._plas:
_
none
pero: 4, chlo: 3, E.R.: 3, plas: 2,Yes
vacu: 1, cyto_nucl:
1No
No 2.5, E.R.:_2.5, mito:
No2
none
cyto: 4, extr: 3, E.R._plas: 3, plas:
Nonucl: 2.5, _extr: 2 No
none
chlo: 6, cyto: 3.5, cyto_nucl: 3.5,
_
none
pero: 4, chlo: 3, E.R.: 3, plas: 2,Yes
vacu: 1, cyto_nucl:
1No
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ECH2
ECH2
fabG
fabG
FACL
FACL
FACL
FACL
FACL
FACL
FACL
FACL
FAR
FBPA
FBPA
FBPA
FBPA
FBPA
FBPA
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
G6PI
G6PI
GAPDH
GAPDH
GAPDH
GAPDH
GAPDH
GAPDH
GAPDH
GAPDH
GAPDH
GAPDH
GCDH

Yes
_
No
none
pero: 12, cyto: 2
Yes
_
No
none
pero: 12, cyto: 2
Yes nucl: 2.5,Mchlo: 2 No
none
pero: 6, cyto: 3.5, cyto_nucl: 3.5,
Yes nucl: 2.5,Mchlo: 2 No
none
pero: 6, cyto: 3.5, cyto_nucl: 3.5,
_
No
none
nucl: 4, mito: 4, chlo: 3, cyto: 3No
_
No
none
nucl: 4, mito: 4, chlo: 3, cyto: 3No
_
No
none
nucl: 4, mito: 4, chlo: 3, cyto: 3No
_
No
none
nucl: 4, mito: 4, chlo: 3, cyto: 3No
No 1.5, cyto:
_ 1, mito:
No 1
none
chlo: 6, extr: 4, vacu: 1.5, E.R._vacu:
No 1.5, cyto:
_ 1, mito:
No 1
none
chlo: 6, extr: 4, vacu: 1.5, E.R._vacu:
_
No
none
nucl: 4, mito: 4, chlo: 3, cyto: 3Yes
_
No
none
nucl: 4, mito: 4, chlo: 3, cyto: 3No
No
S
No
none
chlo: 11, mito: 2, nucl: 1
Nomito: 1 _
No
possibly mitochondrial
cyto: 7, pero: 3, chlo: 2, nucl: 1,
Nomito: 1 _
No
possibly mitochondrial
cyto: 7, pero: 3, chlo: 2, nucl: 1,
Nomito: 1 _
No
possibly mitochondrial
cyto: 7, pero: 3, chlo: 2, nucl: 1,
Nomito: 1 _
No
possibly mitochondrial
cyto: 7, pero: 3, chlo: 2, nucl: 1,
Nomito: 1 _
No
possibly mitochondrial
cyto: 7, pero: 3, chlo: 2, nucl: 1,
_ 2, mito:
No 1, golg: 1 none
plas: 4.5, nucl_plas: 4, chlo: 3, No
nucl: 2.5, cyto:
_
No
none
cyto: 6, cysk: 6, nucl: 2 Perhaps yes
No
_
No
none
cyto: 6, cysk: 6, nucl: 2
S
No
none
chlo: 8, vacu: 3, nucl: 2, mito: 1No
S
No
none
chlo: 8, vacu: 3, nucl: 2, mito: 1No
Nomito: 3, cyto:
_ 2.5, No
chlo: 4, nucl: 3.5, cyto_nucl: 3.5,
plas: 1 possibly mitochondrial
S 1, plas:
No1
none
chlo: 3, extr: 3, nucl: 2, cyto: 2,No
vacu: 2, mito:
S
No
ER
chlo: 10, cyto: 2, nucl: 1, vacu:No
1
S
No
ER
chlo: 10, cyto: 2, nucl: 1, vacu:No
1
S 1, plas:
No1
none
chlo: 3, extr: 3, nucl: 2, cyto: 2,No
vacu: 2, mito:
S 1
No
possibly ER
chlo: 7, cyto: 2, plas: 2, mito: 1,Noextr: 1, vacu:
S 1
No
possibly ER
chlo: 7, cyto: 2, plas: 2, mito: 1,Noextr: 1, vacu:
_
No
none
plas: 8, cyto: 2, E.R.: 2, chlo: 1,No
golg: 1
_
No
none
plas: 8, cyto: 2, E.R.: 2, chlo: 1,No
golg: 1
No
M
No
possibly mitochondrial
cyto: 14
Perhaps
yes2, nucl:
M 1.5, golg:
No 1
none
pero: 6, cyto: 3.5, cyto_nucl:
3, chlo:
M 1, E.R.:
No 1
none
cyto: 5.5, cyto_nucl: 3.5, chlo: No
3, mito: 3, vacu:
Perhaps
yes2, nucl:
M 1.5, golg:
No 1
none
pero: 6, cyto: 3.5, cyto_nucl:
3, chlo:
No
M
No
none
cyto: 14
No
M
No
none
cyto: 13, mito: 1
No
M
Yes
none
cyto: 13, mito: 1
No
M
No
possibly mitochondrial
cyto: 14
No
M
No
none
cyto: 14
M 1, E.R.:
No 1
none
cyto: 5.5, cyto_nucl: 3.5, chlo: No
3, mito: 3, vacu:
Nopero: 2, plas:
_ 1
No
none
mito: 4, chlo: 3, nucl: 2, cyto: 2,

139

GK
GNPAT
GNPAT
GNPAT
GNPAT
GNPAT
GNPAT
GNPAT
GOT
GOT
GOT
GOT
GOT
GOT
GPD
GPD
GPD
GPD
GPD
GPD
GSTK1
GSTK1
GSTK1
GSTK1
GSTK1
GSTK1
GSTK1
GTO
GTO
GTO
HAO
HAO
HAO
HAO
HAO
HAO
HAO
HAO
HAO
HAO
HEX1
HEX1
HEX1

No
_
No
none
cysk: 10, cyto: 3, nucl: 1
Perhaps
yes1, cyto:
S 1, vacu:
No1, golg: 1
ER
pero: 4, E.R.: 3, plas: 2, chlo:
1, nucl:
S 1, extr:No
ER
E.R.: 3, chlo: 2, nucl: 2, cyto: 2,No
plas: 2, mito:
1, pero: 1
Yes
_
No
none
pero: 11, cyto: 2, nucl: 1
S 1, pero:
Yes1
ER
cyto: 4, E.R.: 3, nucl: 2, mito: 2,No
plas: 1, vacu:
S 1, pero:
No1
ER
cyto: 4, E.R.: 3, nucl: 2, mito: 2,No
plas: 1, vacu:
_ 1, vacu:
No1
none
pero: 4, E.R.: 3, nucl: 2, plas: 2,No
chlo: 1, cyto:
Perhaps
yes1
S
No
none
chlo: 6, E.R.: 3, plas: 2, pero:
2, vacu:
Yes
none
cyto: 10, nucl: 1, mito: 1, cysk:No
1, golg: 1 _
_
No
none
cyto: 11, mito: 1, cysk: 1, golg:No
1
No
_
No
none
cysk: 8, cyto: 4, nucl: 2
Nonucl: 1, golg:
_ 1 No
none
cyto: 8, cysk: 3.5, cysk_plas: 2.5,
No
_
No
none
cyto: 10, cysk: 3, mito: 1
No 6.5, cyto_mito:
M
No
possibly mitochondrial
chlo_mito: 7.33333, mito: 7, chlo:
4.33333
Yes nucl: 2.5 _
No
none
pero: 8, cyto: 3.5, cyto_nucl: 3.5,
Yes nucl: 2.5 _
No
none
pero: 8, cyto: 3.5, cyto_nucl: 3.5,
cyto: 4.5, nucl: 3, cyto_E.R.: 3,No
chlo: 2, extr:_ 1, vacu:No
1, cysk: 1, golg:none
1
Nocysk: 1, golg:
_ 1
No
possibly plastid
nucl: 5, chlo: 3, cyto: 3, pero: 1,
_
No
possibly plastid
cyto: 6, chlo: 4, nucl: 2, golg: 2No
_
No
none
cyto: 7, chlo: 5, vacu: 1, cysk: 1No
_ 1.5, golg:
Yes 1
none
chlo: 6, cyto: 3.5, cyto_nucl: 3,No
pero: 2, nucl:
No chlo: 3, nucl:
_ 2.5, No
none
pero: 4, cyto: 3.5, cyto_nucl: 3.5,
golg: 1
_
No
none
pero: 10, nucl: 2, chlo: 1, cyto:Yes
1
_ 2.5, golg:
No 1
none
chlo: 4, pero: 4, cyto_nucl:Perhaps
3, nucl:yes
2.5, cyto:
No chlo: 3, nucl:
_ 2.5, No
none
pero: 4, cyto: 3.5, cyto_nucl: 3.5,
golg: 1
_ 1.5, golg:
No 1
none
chlo: 6, cyto: 3.5, cyto_nucl: 3,No
pero: 2, nucl:
_
No
none
pero: 10, nucl: 2, chlo: 1, cyto:No
1
_
No
possibly mitochondrial
nucl: 4, cyto: 4, mito: 4, chlo: 2No
No
M
No
possibly plastid
cyto: 13, nucl: 1
Noplas: 1 M
No
plastid
mito: 6, chlo: 3, cyto: 3, nucl: 1,
No
_
No
none
cysk: 12, chlo: 1, cyto: 1
No
_
No
none
cysk: 12, chlo: 1, cyto: 1
No
_
No
none
cysk: 12, chlo: 1, cyto: 1
_
No
none
cyto: 6, cysk: 3, chlo: 2, nucl: 2,No
plas: 1
No
_
No
none
cysk: 9, nucl: 4, chlo: 1
_ 1, golg:No
none
cyto: 8, cysk: 2.5, cysk_plas: 2,No
chlo: 1, nucl:
1
No
_
Yes
none
cysk: 13, cyto: 1
_
Yes
none
cyto: 8, mito: 3, chlo: 2, pero: 1No
_
No
none
cyto: 8, mito: 3, chlo: 2, pero: 1No
No
_
No
none
cyto: 12, nucl: 2
No
_
No
none
cyto: 9, E.R.: 3, golg: 2
_
No
none
cyto: 9, nucl: 2, cysk: 2, golg: 1No
_
No
none
cyto: 6, cysk: 4, extr: 2, chlo: 1,No
golg: 1
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HEX1
HEX1
HEX1
HEX1
HEX1
HEX1
HEX1
HEX1
HEX1
HK
HK
HK
HK
HK
HK
HK
HMGCL
HMGCL
HMGCL
HMGCL
HMGCL
HMGCL
HMGCL
HMGCL
HMGCL
HPR
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4

_
No
none
cyto: 6, cysk: 4, extr: 2, chlo: 1,No
golg: 1
_
No
none
cyto: 10, extr: 2, cysk: 1, golg: N
1o
_1
No
none
nucl: 4, cyto: 4, extr: 2, cysk: 2,No
plas: 1, golg:
_1
No
none
nucl: 4, cyto: 4, extr: 2, cysk: 2,No
plas: 1, golg:
_
No
none
cyto: 8, E.R.: 3, golg: 2, mito: 1No
_
No
none
cyto: 8, golg: 3, E.R.: 2, chlo: 1No
_
No
none
cyto: 8, E.R.: 3, golg: 2, mito: 1No
_
No
none
cyto: 8, golg: 3, E.R.: 2, chlo: 1Yes
No
_
No
none
cyto: 9, E.R.: 3, golg: 2
Perhaps
yes
_
No
none
cyto: 7, chlo: 3, nucl: 3, golg:
1
_ 1, golg:No
none
cyto: 4, chlo: 3, nucl: 2, extr: 2,No
plas: 1, cysk:
1
_
No
none
cyto: 8, nucl: 2, extr: 2, cysk: 1,No
golg: 1
No 1.5, cysk:_ 1.5, nucl:
No1
none
cyto: 8, chlo: 2, cysk_plas: 2, plas:
Perhaps
yes1.5, extr:
_ 1, vacu:
No 1
none
chlo: 5.5, nucl: 5, chlo_mito:
4, mito:
Perhaps
yes1
_
No
none
cyto: 8, nucl: 2, extr: 2, cysk:
1, golg:
Perhaps
yes
_
No
none
cyto: 7, chlo: 3, nucl: 3, golg:
1
_
No
none
cyto: 9, cysk: 3, nucl: 1, golg: 1No
_
No
none
cyto: 9, cysk: 3, nucl: 1, golg: 1No
_
No
none
cyto: 5, extr: 5, chlo: 2, nucl: 1,No
golg: 1
No
M
No
possibly mitochondrial
mito: 7, chlo: 6, nucl: 1
_
No
none
cyto: 9, cysk: 3, nucl: 1, golg: 1No
_
No
none
cyto: 10, nucl: 2, vacu: 1, cysk:No
1
_
No
none
cyto: 10, nucl: 2, vacu: 1, cysk:No
1
_
No
none
cyto: 10, nucl: 2, vacu: 1, cysk:No
1
_
No
none
cyto: 10, nucl: 2, vacu: 1, cysk:No
1
No
none
cyto: 10, nucl: 1, extr: 1, vacu:No
1, cysk: 1 _
No 1.5, chlo:
S 1, vacu:
No1
ER
extr: 8, mito: 2, E.R.: 1.5, E.R._plas:
_
No
possibly plastid
chlo: 7, extr: 3, cyto: 2, nucl: 1,No
vacu: 1
Yes
No
possibly plastid
pero: 10, chlo: 2, nucl: 1.5, cyto_nucl:
1.5 _
yes 1.5 _
No
possibly plastid
pero: 10, chlo: 2, nucl: 1.5,Perhaps
cyto_nucl:
_
No
possibly plastid
extr: 5, chlo: 4, cyto: 4, nucl: 1No
Yes cyto: 1.5,_golg: 1 No
mitochondrial
pero: 9, nucl: 2.5, cyto_nucl: 2.5,
No cyto: 2.5 _
No
none
pero: 8, nucl: 3.5, cyto_nucl: 3.5,
No cyto: 2.5 _
No
none
pero: 8, nucl: 3.5, cyto_nucl: 3.5,
Perhaps
_
No
none
pero: 10, cyto: 2, nucl: 1, golg:
1 yes
Perhaps yes
_
No
none
pero: 12, cyto: 2
Perhaps yes
_
No
none
pero: 12, cyto: 2
No
_
No
none
pero: 12, cyto: 2
Yes
_
No
none
pero: 12, cyto: 2
Yes
_
No
none
pero: 13, cyto: 1
Yes
_
No
none
pero: 13, cyto: 1
No
_
No
none
pero: 10, cyto: 3, nucl: 1
Yes
_
No
none
pero: 9, cyto: 3, nucl: 2
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IDI
katE
katE
katE
katE
katE
katE
katE
katE
katE
katE
katE
katE
katE
katE
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
LYS4
MDAR
MDAR
MDAR
MDAR
MYA2
MYA2
NUDT12
OPDC-PRT
OPDC-PRT
PAOX
PAOX
PAOX
PDCR
PDCR

Noplas: 1, E.R.:
_ 1, cysk:No1
cyto: 7, mito: 2, chlo: 1, nucl: 1,
_ 1
No
nucl: 5, mito: 5, cyto: 1, plas: 1,Noextr: 1, cysk:
_ 1
No
nucl: 5, mito: 5, cyto: 1, plas: 1,Noextr: 1, cysk:
Yes
_
No
pero: 12, cyto: 2
No
_
No
nucl: 9, mito: 4, extr: 1
_ 1
No
nucl: 5, mito: 5, cyto: 1, plas: 1,Noextr: 1, cysk:
No
_
No
nucl: 11, mito: 2, plas: 1
Yes
_
No
pero: 12, cyto: 2
No
_
No
nucl: 11, mito: 2, plas: 1
No
_
No
nucl: 11, mito: 3
_ 1
No
nucl: 5, mito: 5, cyto: 1, plas: 1,Noextr: 1, cysk:
_ 1
No
nucl: 5, mito: 5, cyto: 1, plas: 1,Noextr: 1, cysk:
_ 1
No
nucl: 5, mito: 5, cyto: 1, plas: 1,Noextr: 1, cysk:
_ 1, cysk:
No1
nucl: 5, cyto: 2, plas: 2, pero: 2,Nochlo: 1, extr:
Noplas: 1, extr:
_ 1
No
cyto: 7, nucl: 2, pero: 2, mito: 1,
Nogolg: 1 S
No
cyto: 7, chlo: 3, nucl: 2, vacu: 1,
No
_
No
nucl: 8, cyto: 5, extr: 1
_
No
cyto: 8, chlo: 3, nucl: 2, cysk: 1No
No
_
No
cyto: 11, nucl: 2, cysk: 1
_
No
nucl: 7, cyto: 4, chlo: 2, mito: 1No
_
No
nucl: 5, chlo: 4, cyto: 4, vacu: 1No
Nogolg: 1 S
No
cyto: 7, chlo: 3, nucl: 2, vacu: 1,
No
_
No
chlo: 8, cyto: 5, cysk: 1
No
M
No
mito: 7.5, chlo: 6, cyto_mito: 4.5
Nogolg: 1 _
No
cyto: 5, mito: 4, chlo: 2, nucl: 2,
Nogolg: 1 _
No
cyto: 5, mito: 4, chlo: 2, nucl: 2,
No
_
No
cyto: 8, chlo: 5, mito: 1
_
No
nucl: 4, cyto: 4, chlo: 3, mito: 3No
No3.5
M
No
chlo: 10.5, chlo_mito: 7.5, mito:
Yes
M
No
mito: 8, chlo: 6
_
No
cysk: 8, nucl: 4, chlo: 1, cyto: 1No
No
M
No
mito: 8, chlo: 6
_
No
cysk: 8, nucl: 4, chlo: 1, cyto: 1No
No
_
No
cyto: 11, nucl: 2, vacu: 1
No
_
No
cyto: 11, nucl: 2, vacu: 1
_
No
chlo: 7, extr: 3, cyto: 2, nucl: 1,No
vacu: 1
_
No
extr: 9, cyto: 2, nucl: 1, mito: 1,NoE.R.: 1
_
No
extr: 9, cyto: 2, nucl: 1, mito: 1,NoE.R.: 1
M
No
cyto: 8, nucl: 3, chlo: 1, plas: 1,No
cysk: 1
Yescysk: 1 _
No
nucl: 5, chlo: 4, cyto: 3, mito: 1,
_
No
nucl: 9, chlo: 2, cysk: 2, cyto: 1No
yes 1.5 _
No
pero: 10, chlo: 2, cyto: 1.5,Perhaps
cyto_nucl:
Yes
_
No
pero: 11, cyto: 2, nucl: 1
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none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
mitochondrial
none
none
possibly plastid
mitochondrial
mitochondrial
mitochondrial
possibly mitochondrial
mitochondrial
mitochondrial
mitochondrial
none
mitochondrial
none
none
none
none
none
none
possibly mitochondrial
none
none
none
none

HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
HXGPRT
I5PDH
I5PDH
IDH
IDH
IDH
IDH
IDH
IDH
IDH
IDH
IDH1
IDH1
IDH1
IDH1
IDH1
IDH1
IDH1
IDI
IDI

_ 1
No
none
pero: 6, E.R.: 3, plas: 2, chlo: 1,Yes
cyto: 1, vacu:
No
_
No
none
pero: 12, nucl: 1, cyto: 1
No cyto: 2.5 _
No
none
pero: 8, nucl: 3.5, cyto_nucl: 3.5,
No
_
No
none
pero: 12, nucl: 1, cyto: 1
Yes
_
No
none
pero: 12, cyto: 2
Perhaps yes
_
No
none
pero: 12, cyto: 2
No
none
cyto: 7, nucl: 3, cysk: 2, chlo: 1,No
mito: 1 _
No
none
cyto: 7, nucl: 3, cysk: 2, chlo: 1,No
mito: 1 _
No
none
cyto: 7, nucl: 3, cysk: 2, chlo: 1,No
mito: 1 _
No
none
cyto: 7, nucl: 3, cysk: 2, chlo: 1,No
mito: 1 _
No
none
cyto: 7, nucl: 3, cysk: 2, chlo: 1,No
mito: 1 _
Perhaps
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:
1 yes
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
Yes
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
Perhaps
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:
1 yes
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
_
No
none
cyto: 11, nucl: 1, extr: 1, pero:No
1
No
_
No
none
cysk: 11, cyto: 3
No
_
No
none
cysk: 11, cyto: 3
No
_
No
none
cysk: 11, cyto: 3
No cyto: 2, plas:
_ 1 No
none
chlo_mito: 6, chlo: 5.5, mito: 5.5,
No cyto: 2, plas:
_ 1 Yes
none
chlo_mito: 6, chlo: 5.5, mito: 5.5,
No
_
No
none
cysk: 14
No
_
No
none
cysk: 14
Yes
_
No
none
pero: 13, cyto: 1
Yes
_
No
none
pero: 13, cyto: 1
No
_
No
none
cysk: 11, cyto: 3
No
none
nucl: 6, cyto: 3, chlo: 2, cysk: 2,No
mito: 1 _
No
S
No 1
possibly ER
extr: 11, cysk_plas: 1.33333, mito_plas:
1.33333,
E.R.:
No
S
No 1, E.R.: 1possibly ER
extr: 10, cysk_plas: 1.33333, mito_plas:
1.33333,
vacu:
Yes
_
No
none
pero: 12, cyto: 2
_
No
none
cysk: 9, chlo: 2, cyto: 2, nucl: 1No
_ 1 No
none
cyto: 7.5, cyto_E.R.: 4.5, chlo: No
3, cysk: 2, vacu:
Nomito: 1, extr:
_ 1, cysk:
No 1
none
cyto: 5.5, chlo: 5, cyto_E.R.: 3.5,
Noextr: 1
_
No
possibly mitochondrial
chlo: 5, cyto: 3, mito: 3, nucl: 2,
Noextr: 1
_
No
mitochondrial
chlo: 5, mito: 5, cyto: 2, nucl: 1,
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PDCR
PECR
PECR
PEPCK
PEPCK
PEPCK
PEPCK
PEPCK
PEPCK
PNC1
PNC1
PNC1
PNC1
PRDX1
PRDX1
PRDX1
PRDX1
PRDX1
PRDX1
PXMP2
SHBP
SHBP
SLC25A17
SLC25A17
SOD2
SOD2
SOD2
SOD2
SOD2
SOD2
SOD2
SOD2
SOD2
SOD2
TPI
TPI
TPI
TPI
TPI
TPI
TPI
TPN
TPN

Yes
_
No
none
pero: 11, cyto: 2, nucl: 1
S 2, vacu:
No1, E.R.: 1
ER
extr: 4, mito: 3, cyto: 2.5, chlo:No
2, cyto_nucl:
S 2, vacu:
No1, E.R.: 1
ER
extr: 4, mito: 3, cyto: 2.5, chlo:No
2, cyto_nucl:
_
No
none
chlo: 3, mito: 2, plas: 2, E.R.: 2,No
nucl: 1.5, cysk_nucl:
1.5, cyto: 1, extr:
1, vacu: 1
_
No
none
chlo: 3, mito: 2, plas: 2, E.R.: 2,No
nucl: 1.5, cysk_nucl:
1.5, cyto: 1, extr:
1, vacu: 1
_
No
none
chlo: 6, extr: 3, vacu: 3, nucl: 1,No
cyto: 1
_
No
none
chlo: 3, extr: 3, cyto: 2, E.R.: 2,No
nucl: 1.5, cysk_nucl:
1.5, mito: 1, vacu:
1
_
No
none
chlo: 6, extr: 3, vacu: 3, nucl: 1,No
cyto: 1
_
No
none
chlo: 3, extr: 3, cyto: 2, E.R.: 2,No
nucl: 1.5, cysk_nucl:
1.5, mito: 1, vacu:
1
_
No
none
chlo: 10, cyto: 2, nucl: 1, plas: N
1o
_
No
none
chlo: 6, cyto: 3, extr: 3, nucl: 1,No
plas: 1
_
No
none
chlo: 6, cyto: 3, extr: 3, nucl: 1,No
plas: 1
No
_
No
none
cyto: 10, cysk: 3, golg: 1
_ 1
No
none
chlo: 4, nucl: 3, extr: 3, cyto: 2,No
cysk: 1, golg:
No
none
cyto: 9, cysk: 2, chlo: 1, nucl: 1,No
pero: 1 _
_ 1
No
none
chlo: 4, nucl: 3, extr: 3, cyto: 2,No
cysk: 1, golg:
No
_
No
none
nucl: 7, cyto: 6, plas: 1
_
No
none
cyto: 6, nucl: 3, extr: 3, chlo: 1,No
cysk: 1
_
No
none
cyto: 6, nucl: 3, extr: 3, chlo: 1,No
cysk: 1
M
No
possibly mitochondrial
plas: 6, chlo: 5, mito: 2, pero: 1No
_
No
none
cyto: 7, E.R.: 3, extr: 2, chlo: 1,No
mito: 1
_
No
none
cyto: 7, E.R.: 3, extr: 2, chlo: 1,No
mito: 1
_
No
none
plas: 9, golg: 2, cyto: 1, vacu: 1,NoE.R.: 1
_
No
none
plas: 9, golg: 2, cyto: 1, vacu: 1,NoE.R.: 1
M 3, chlo:
No 2, plas: 1mitochondrial
mito: 5.5, nucl: 4.5, cyto_mito:No
3.5, cyto_nucl:
No
mitochondrial
mito: 6, nucl: 5.5, cyto_nucl: 5,No
chlo: 1 M
Noplas: 1, pero:
S 1
No
possibly mitochondrial
cyto: 7, chlo: 2, nucl: 2, mito: 1,
Noplas: 1, pero:
S 1
Yes
possibly mitochondrial
cyto: 7, chlo: 2, nucl: 2, mito: 1,
Nonucl: 1, plas:
M 1, E.R.:No1
possibly mitochondrial
chlo: 4, vacu: 3, mito: 2, extr: 2,
No
M
No
mitochondrial
mito: 12, chlo: 2
Nonucl: 1, plas:
M 1, E.R.:No1
possibly mitochondrial
chlo: 4, vacu: 3, mito: 2, extr: 2,
Nonucl: 1, plas:
M 1, E.R.:No1
possibly mitochondrial
chlo: 4, vacu: 3, mito: 2, extr: 2,
Nonucl: 1, plas:
M 1, E.R.:No1
possibly mitochondrial
chlo: 4, vacu: 3, mito: 2, extr: 2,
No cysk_nucl:
_ 1.5 No
none
mito: 6, cyto: 4, pero: 2, nucl: 1.5,
_
No
none
chlo: 9, nucl: 2, extr: 2, cyto: 1No
S
Yes
none
chlo: 6, cyto: 4, nucl: 2, extr: 1,No
E.R.: 1
No
_ 2, extr:
No 1
none
cyto: 4, nucl: 3.5, mito: 3, cysk_nucl:
2.5, pero:
No
_
No
none
cyto: 10, chlo: 2, mito: 2
No
_
No
none
cyto: 10, chlo: 2, mito: 2
No
_
No
none
cyto: 10, chlo: 2, mito: 2
_
No
none
cyto: 8, nucl: 4, chlo: 1, extr: 1No
none
nucl: 6.5, cyto_nucl: 5.5, cyto: No
3.5, chlo: 2, _mito: 1, No
extr: 1
S
No
ER
chlo: 10, mito: 2, nucl: 1, extr: No
1
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TPN
TPN
TPN
TPN
TPN
TR
TR
TR
TR
TR
TR
TR
TR
TR
TR
TR
TR
uaZ
UGP
UGP
UGP
UGP
UGP
UGP
UGP
UGP
UOX
UOX
VPS1
XDH
XDH
ZADH2
ZADH2
ZADH2
ZADH2
ZADH2
ZADH2
ZADH2
ZADH2
ZADH2
ZADH2

S
No
chlo: 10, mito: 2, nucl: 1, extr: No
1
_
No
chlo: 12, mito: 1, E.R._vacu: 1 No
No
_
Yes
E.R.: 14
Nogolg_plas:M1
No
nucl: 8, mito: 3, chlo: 1, cyto: 1,
Nogolg_plas:M1
No
nucl: 8, mito: 3, chlo: 1, cyto: 1,
No
M
No
chlo: 8, mito: 6
_ 1, pero:
No1
cyto: 6.5, cyto_nucl: 4, chlo: 3,Yes
E.R.: 2, mito:
_ 1, pero:
No1
cyto: 6.5, cyto_nucl: 4, chlo: 3,Yes
E.R.: 2, mito:
_ 1, pero:
No1
cyto: 6.5, cyto_nucl: 4, chlo: 3,Yes
E.R.: 2, mito:
_ 1, pero:
No1
cyto: 6.5, cyto_nucl: 4, chlo: 3,Yes
E.R.: 2, mito:
_ 1, pero:
No1
cyto: 6.5, cyto_nucl: 4, chlo: 3,Yes
E.R.: 2, mito:
_ 1, cysk:No1
chlo: 4, cyto: 3, extr: 3, nucl: 1,No
E.R.: 1, pero:
_ 1
No
chlo: 6, extr: 3, cyto: 2, nucl: 1,No
mito: 1, E.R.:
_ 1
No
chlo: 6, extr: 3, cyto: 2, nucl: 1,No
mito: 1, E.R.:
_ 1, pero:
No1
E.R.: 5, cyto: 3, mito: 2, chlo: 1,Yes
plas: 1, vacu:
No
M
No
chlo: 12, mito: 2
No
M
No
chlo: 8, mito: 6
No
_
No
cyto: 11, cysk: 2, chlo: 1
_
No
cyto: 7, nucl: 5, vacu: 1, golg: 1No
_
No
cyto: 7, nucl: 5, vacu: 1, golg: 1No
_
No
cyto: 10, nucl: 2, chlo: 1, pero:No
1
Nopero: 1, golg:
_ 1
No
cyto: 6, nucl: 4, chlo: 1, vacu: 1,
Nocysk: 1 _
No
chlo: 7, cyto: 3, nucl: 2, mito: 1,
Nocysk: 1 _
No
chlo: 5, nucl: 4, cyto: 3, mito: 1,
Nocysk: 1 _
No
chlo: 7, cyto: 3, nucl: 2, mito: 1,
Nocysk: 1 _
No
chlo: 5, nucl: 4, cyto: 3, mito: 1,
No
_
No
cyto: 10, nucl: 3, pero: 1
No
_
No
cyto: 10, nucl: 3, pero: 1
No
_
No
cyto: 9, nucl: 4, chlo: 1
_
No
nucl: 9, cyto: 2, chlo: 1, plas: 1,No
cysk: 1
_
No
nucl: 9, cyto: 2, chlo: 1, plas: 1,No
cysk: 1
No
chlo: 4, nucl: 4, cyto: 4, extr: 1,No
golg_plas: 1_
_
No
cyto: 5, nucl: 4, cysk: 4, golg: 1No
Novacu: 1 _
No
cyto: 7, chlo: 2, nucl: 2, mito: 2,
_
No
cyto: 9, nucl: 2, mito: 2, E.R.: 1No
No
_
No
extr: 10, chlo: 3, mito: 1
No
_
No
extr: 9, chlo: 4, mito: 1
mito: 4.5, chlo_mito: 4.5, nucl:No
4, chlo: 3.5,_cyto: 2 No
mito: 4.5, chlo_mito: 4.5, nucl:No
4, chlo: 3.5,_cyto: 2 No
_
No
chlo: 6, extr: 6, cyto: 1, vacu: 1Yes
No
M
No
chlo: 10, mito: 2, extr: 2
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ER
possibly plastid
possibly plastid
possibly mitochondrial
possibly mitochondrial
possibly mitochondrial
none
none
none
none
none
none
none
none
none
possibly mitochondrial
possibly mitochondrial
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none

Appendix Table 2) Cardiosporidium peroxisomal-related genes Identified PeroxDB and KAAS.
Complete transcripts were run through Wolf PSORTII, Ppero, TargetP, Topcons and Predotar to
identify possible signal motifs inclding PTS1
Gene PSORTII
Ppero pts1
TargetP
topcons
predotar
PEX4
_
No
none
chlo: 6, nucl: 5, cyto: 2, extr: No
1
PEX5
_
No
none
mito: 5, chlo: 4, nucl: 2, cyto:No
2, cysk: 1
PEX5
No
_
No
none
cyto: 7, nucl: 4, plas: 3
PEX5
_
No
none
mito: 5, chlo: 3, cyto: 3, nucl:No
2, cysk: 1
PEX6
Perhaps
_
No
none
cyto: 7, nucl: 3, chlo: 2, cysk:
2 yes
PEX7
_
No
ER
chlo: 7, nucl: 3, mito: 3, cysk:No
1
PEX7
_
No
none
chlo: 7, nucl: 3, mito: 3, cysk:No
1
PEX7
_
No
none
chlo: 7, nucl: 3, mito: 3, cysk:No
1
PEX7
_
No
none
chlo: 7, nucl: 3, mito: 3, cysk:No
1
PEX7
_
No
none
chlo: 7, nucl: 3, mito: 3, cysk:No
1
PEX7
_
No
none
chlo: 7, nucl: 3, mito: 3, cysk:No
1
PEX7
_
Yes
none
chlo: 7, nucl: 3, mito: 3, cysk:No
1
PEX7
_
No
none
chlo: 7, nucl: 3, mito: 3, cysk:No
1
PEX10 cyto: 6, nucl: 4, chlo: 1, mito:No
_ 1
No
none
1, extr: 1, cysk:
PEX10 cyto: 6, nucl: 4, chlo: 1, mito:No
_ 1
No
none
1, extr: 1, cysk:
PEX10 cyto: 6, nucl: 4, chlo: 1, mito:No
_ 1
Yes
none
1, extr: 1, cysk:
PEX10 mito: 7, chlo: 5, nucl: 2
No
_
Yes
none
PEX14 cyto: 6, chlo: 3, nucl: 2, plas: No
_
No
none
2, extr: 1
PEX14 chlo: 7, cyto: 2, nucl: 1, plas: No
_ 1, E.R.: 1 No
none
1, extr: 1, vacu:
MPV17 mito: 4, E.R.: 4, chlo: 3, plas: No
M
No
possibly mitochondrial
3
ABCD vacu: 10, golg: 2, plas: 1, extr:
No1
_
No
possibly plastid
ACAA1 nucl: 3, mito: 3, E.R.: 2.5, E.R._plas:
No
_ 2, plas: 1.5,
Novacu: 1, pero: 1none
2.5, cyto:
ACAA1 chlo: 13.5, chlo_mito: 7.5 No
M
No
none
ACAA1 cyto: 8, chlo: 3, nucl: 1, vacu:No
_
Yes
none
1, golg: 1
ACAA1 nucl: 4.5, cyto_nucl: 3.5, chlo:
No3, mito: 2, golg:
C 2, cyto: 1.5,
No plas: 1
none
ACAA1 chlo: 12, nucl: 1, plas: 1
No
_
No
none
ACAA1 chlo: 12, nucl: 1, plas: 1
No
_
No
none
ACAA1 nucl: 4.5, cyto_nucl: 4, cyto: No
C 2, golg: 2,Noplas: 1
none
2.5, chlo: 2, mito:
ACOX chlo: 9, cyto: 2, plas: 2, mito:No
_
Yes
none
1
ACOX pero: 4, E.R.: 3, plas: 2, cyto_nucl:
Perhaps yes
_ cyto: 1.5,No
2, nucl: 1.5,
chlo: 1, vacu: 1 none
AGPS cyto: 7, cysk: 3, mito: 2, pero:No
No
none
1, golg: 1 _
AGPS cysk: 8, nucl: 3, cyto: 3
No
_
No
none
AGPS cyto: 7, cysk: 4, nucl: 3
No
_
No
none
AGPS cyto: 7, cysk: 3, mito: 2, pero:No
No
none
1, golg: 1 _
AGXT cyto: 6, chlo: 4, mito: 3, vacu:No
_
No
none
1
ANT
_ 1, golg: 1 No
none
chlo: 3, nucl: 3, mito: 3, cyto:No
2, plas: 1, vacu:
ANT
_ 1, golg: 1 No
none
chlo: 3, nucl: 3, mito: 3, cyto:No
2, plas: 1, vacu:
CAT
Yes
_
No
none
pero: 13, cyto: 1
CPK
S
No
none
cyto: 5, nucl: 4, plas: 2, E.R.: No
2, mito: 1
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CPK
CPK
CPK
CPK
DJP1
DJP1
DJP1
DJP1
DJP1
E1.3.3.6
ECH
ECH
ECH
ECH
EHHADH
FBPA
FBPA
FR
FR
FR
FR
FR
FR
FR
G6PI
G6PI
GAPDH
GAPDH
GK
GK
GOT
GOT
GOT
GPD
GPD
GSTK1
GSTK1
HAO
HEX1
HEX1
HK
HK
HK

S
No
none
cyto: 5, nucl: 4, plas: 2, E.R.: No
2, mito: 1
S
No
none
cyto: 5, nucl: 4, plas: 2, E.R.: No
2, mito: 1
S
No
none
cyto: 5, nucl: 4, plas: 2, E.R.: No
2, mito: 1
_ 1, vacu: 1 No
ER
chlo: 4, nucl: 3, cyto: 2, extr: No
2, mito: 1, plas:
_
No
none
nucl: 11, chlo: 1, plas: 1, extr:No
1
_
No
none
nucl: 6, cyto: 3, mito: 3, chlo:No
2
No
_ 2
No
none
mito: 5, nucl: 3.5, cyto: 3, cysk_nucl:
2.5, chlo:
_ 1
No
none
cyto: 6, nucl: 3, mito: 2, chlo:No
1, plas: 1, extr:
_ 1, vacu: 1,
NoE.R.: 1
none
cyto: 5.5, golg: 4, cyto_nucl: No
3.5, chlo: 1, mito:
M
No
none
chlo: 8, mito: 3, cyto: 2, plas:No
1
_ 1, cysk: 1 No
none
mito: 5, chlo: 2, nucl: 2, cyto:No
2, plas: 1, pero:
_
No
none
cyto: 7, chlo: 2, nucl: 2, pero:Yes
2, plas: 1
_
No
none
nucl: 6, mito: 5, chlo: 2, cyto:No
1
_
No
none
nucl: 6, mito: 5, chlo: 2, cyto:No
1
No
M
No
none
chlo: 12, cyto: 1, mito: 1
_
Yes
none
chlo: 5, cyto: 4, extr: 3, nucl: No
1, mito: 1
No1
_
No
none
cyto: 10, chlo: 2, nucl: 1, golg:
_
No
none
cyto: 8, nucl: 3, extr: 1, E.R.: No
1, cysk: 1
_
No
none
cyto: 8, nucl: 3, extr: 1, E.R.: No
1, cysk: 1
_
No
none
chlo: 4, nucl: 4, mito: 4, cyto:No
2
_
No
none
chlo: 4, nucl: 4, mito: 4, cyto:No
2
_
No
none
chlo: 4, nucl: 4, mito: 4, cyto:No
2
_
No
none
chlo: 4, nucl: 4, mito: 4, cyto:No
2
No
S
No
none
chlo: 13, cyto: 1
No
mitochondrial
cyto: 5, chlo: 4, nucl: 3, mito:No
1, cysk: 1 M
M
No
none
cyto: 5, chlo: 4, nucl: 4, cysk:No
1
No
M
No
none
cyto: 13, mito: 1
No
_
No
none
cysk: 8, cyto: 5, chlo: 1
Yes
_
No
none
cysk: 11, chlo: 2, cyto: 1
_
No
none
cysk: 11, chlo: 2, cyto: 1Perhaps yes
No
M
No
none
chlo: 10, mito: 4
Yes
_
No
none
pero: 11, cyto: 2, nucl: 1
_
No
none
pero: 11, cyto: 2, nucl: 1Perhaps yes
S
No
none
plas: 8, golg: 3, E.R.: 2, vacu: No
1
S
No
ER
plas: 8, golg: 3, E.R.: 2, vacu: No
1
Yescyto: 3.5, chlo:
_ 2, golg: 1No
ER
pero: 4, cyto_nucl: 4, nucl: 3.5,
_ 1, golg: 1No
none
pero: 5, cyto: 4.5, cyto_nucl:Yes
4, nucl: 2.5, chlo:
Yes
_
No
none
pero: 12, cyto: 2
_
No
none
cyto: 11, extr: 1, cysk: 1, golg:No1
_
No
none
cyto: 11, extr: 1, cysk: 1, golg:No1
No
_ 1.5, mito:No
chlo: 4, E.R.: 3, cyto: 2.5, cyto_nucl:
2.5, nucl:
1, vacu: 1, pero: 1none
No
none
cyto: 5, chlo: 3, nucl: 2, golg:No
2, extr: 1, E.R.:_ 1
No chlo: 2, mito:
_ 2
No
none
cyto: 5.5, E.R.: 4, cyto_nucl: 3.5,
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HK
HK
HK
HMGCL
HMGCL
HPR
HPR
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
HSD17B4
I5PDH
IDH
IDH1
IDH1
IDI
katE
katE
katE
LYS4
LYS4
LYS4
LYS4
LYS4
MDAR
MYA2
MYA2
MYA2
MYA2

No 2, plas: 1.5,
_ E.R.: 1.5, No
none
cyto: 5, golg: 3, mito: 2, E.R._plas:
nucl: 1
No
_
Yes
none
nucl: 12, cyto: 1, mito: 1
No 2, plas: 1.5,
_ E.R.: 1.5, No
none
cyto: 5, golg: 3, mito: 2, E.R._plas:
nucl: 1
_
No
none
nucl: 6, cyto: 5, chlo: 2, plas: No
1
_
No
none
nucl: 6, cyto: 5, chlo: 2, plas: No
1
No
_
No
mitochondrial
cyto: 13, chlo: 1
No
_
No
none
cyto: 13, nucl: 1
M
No
none
chlo: 8, cyto: 4, nucl: 1, plas: No
1
No
M
No
possibly mitochondrial
cyto: 8, chlo: 3, pero: 2, cysk_nucl:
1
Yes2.5, nucl: 1.5_
No
possibly mitochondrial
pero: 10, cyto: 2.5, cyto_nucl:
none
pero: 6, cyto: 4.5, cyto_nucl:Yes
3.5, nucl: 1.5,Mchlo: 1, golg:No
1
No
possibly mitochondrial
pero: 9, cyto: 2.5, cyto_nucl:Yes
2.5, nucl: 1.5,_chlo: 1
No
none
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
No
mitochondrial
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
No
mitochondrial
chlo: 8.5, chlo_mito: 7, mito:No
4.5, nucl: 1 M
No
mitochondrial
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
No
mitochondrial
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
No
mitochondrial
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
Yes
_
No
mitochondrial
pero: 11, cyto: 2, nucl: 1
No
none
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
No
mitochondrial
chlo: 8.5, chlo_mito: 7, mito:No
4.5, nucl: 1 M
No
mitochondrial
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
No
mitochondrial
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
No
mitochondrial
chlo: 8, nucl: 2, pero: 2, cyto:Yes
1, golg: 1 M
No
S
Yes
none
chlo: 14
_
No
none
nucl: 5, cyto: 4, chlo: 2, cysk:No
2, vacu: 1
Perhaps yes
_
No
none
pero: 12, cyto: 2
M
No
possibly mitochondrial
mito: 7, chlo: 6, cyto_nucl: 1No
Nocyto: 2.5, pero:
_ 2, golg: 1No
none
chlo: 6, cyto_nucl: 3, nucl: 2.5,
M
No
none
chlo: 9, mito: 2, nucl: 1, plas:No
1, E.R.: 1
Yes
_
No
none
pero: 13, cyto: 1
No
none
pero: 9, nucl: 2, chlo: 1, cyto:No
1, mito: 1 _
Yes
none
pero: 8, cyto: 3, nucl: 1, mito:No
1, extr: 1 _
Noplas: 2.5, chlo:
_ 2, mito: 2,No
cyto: 3, nucl_plas: 3, nucl: 2.5,
extr: 1, pero: 1 none
No
_
No
none
chlo: 10, cyto: 4
_
No
none
cyto: 6, cysk: 4, chlo: 3, nucl:No
1
M
No
none
mito: 7, chlo: 4, nucl: 2, cyto:No
1
No3, nucl: 2, cyto:
M 1
No
none
mito: 7.5, cyto_mito: 4.5, chlo:
Yes
ER
cyto: 4, chlo: 3, mito: 3, extr:No
2, plas: 1, E.R.:S 1
_
No
none
nucl: 8, cyto: 3, chlo: 1, plas: No
1, golg: 1
_
No
none
cyto: 7, nucl: 5, chlo: 1, golg:No
1
_
No
none
cyto: 6, nucl: 5, chlo: 1, cysk:No
1, golg: 1
_
No
none
cyto: 6, nucl: 5, chlo: 1, cysk:No
1, golg: 1
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OPDC-PRT
PDCR
PDCR
PDCR
PDCR
PEPCK
PNC1
PRDX1
PXMP2
SHBP
SOD2
SOD2
SOD2
SOD2
TPI
TPI
TPN
TPN
TR
TR
TR
TR
uaZ
uaZ
uaZ
ZADH2
ZADH2
ZADH2
ZADH2

_
No
chlo: 8, nucl: 3, cyto: 2, cysk:No
1
_ 1
No
pero: 7, cyto: 3.5, cyto_nucl:Yes
2.5, chlo: 2, golg:
_ 1
No
pero: 7, cyto: 3.5, cyto_nucl:Yes
2.5, chlo: 2, golg:
_ 1
No
pero: 7, cyto: 3.5, cyto_nucl:Yes
2.5, chlo: 2, golg:
_ 1
No
pero: 7, cyto: 3.5, cyto_nucl:Yes
2.5, chlo: 2, golg:
_ 1, plas: 1 Yes
cyto: 3, E.R.: 3, nucl: 2, vacu:No
2, golg: 2, mito:
No
cyto: 10, nucl: 1, extr: 1, cysk:No1, golg: 1 _
_
No
chlo: 9, cyto: 2, nucl: 1, mito:No
1, extr: 1
M
Yes
mito: 7, chlo: 5, nucl: 1, cysk:No
1
No
cyto: 10, plas: 1, extr: 1, cysk:No
1, golg: 1 _
S
No
chlo: 9, extr: 3, nucl: 1, cyto: No
1
S
No
cyto: 9, chlo: 2, nucl: 2, cysk:No
1
M1
No
chlo: 5, mito: 4, E.R.: 2, nucl:No
1, extr: 1, pero:
_
No
cyto: 8, nucl: 2, plas: 2, cysk:No
1, golg: 1
S1
No
chlo: 4, extr: 4, cyto: 2, E.R.: No
2, nucl: 1, mito:
S1
No
chlo: 4, extr: 4, cyto: 2, E.R.: No
2, nucl: 1, mito:
_ 1
No
cyto: 5, nucl: 4, chlo: 2, pero:No
1, cysk: 1, golg:
_
cyto: 7, chlo: 2, nucl: 2, mito:No
1, extr: 1, cysk_plas:
1 No
S 1, E.R.: 1 No
vacu: 4, chlo: 3, mito: 2, golg:No
2, nucl: 1, extr:
No
chlo: 5, mito: 3, vacu: 3, golg:No
2, nucl: 1 S
_
No
cyto: 6, E.R.: 5, mito: 2, pero:No
1
_
No
cyto: 6, E.R.: 5, mito: 2, pero:No
1
No
pero: 9, cyto: 2.5, cyto_nucl:Yes
2.5, nucl: 1.5,_golg: 1
Yes
_
No
pero: 11, cyto: 2, golg: 1
No
pero: 9, cyto: 2.5, cyto_nucl:Yes
2.5, nucl: 1.5,_golg: 1
No 2, cysk_nucl:
_ 2, mito: 1 Yes
chlo: 6, nucl: 2.5, cyto: 2, pero:
No 2, cysk_nucl:
_ 2, mito: 1 Yes
chlo: 6, nucl: 2.5, cyto: 2, pero:
M
Yes
chlo: 9, extr: 2, nucl: 1, cyto: No
1, mito: 1
_
Yes
chlo: 6, cyto: 6, nucl: 1, cysk:No
1
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ER
possibly plastid
possibly plastid
possibly plastid
possibly plastid
none
none
none
ER
none
ER
ER
possibly mitochondrial
none
none
ER
none
none
none
ER
ER
none
none
none
none
none
none
possibly plastid
none

Appendix Figures 1) Comparison of biological process GOSlim terms from lineage
specific orthologous genes from both Nephromyces (blue) and Cardiosporidium (red),
respectively. GOSlim terms are grouped by their major function, showing no clear
pattern of gene losses by functional category between Cardiosporidium and
Nephromyces.
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Appendix Figure 2) Comparison of molecular function GOSlim terms from lineage
specific orthologous genes from both Nephromyces (blue) and Cardiosporidium (red),
respectively. GOSlim terms are grouped by their major molecular function, showing
no clear pattern of gene losses by functional category between Cardiosporidium and
Nephromyces.
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